CA2228647A1 - Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings - Google Patents

Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings Download PDF

Info

Publication number
CA2228647A1
CA2228647A1 CA002228647A CA2228647A CA2228647A1 CA 2228647 A1 CA2228647 A1 CA 2228647A1 CA 002228647 A CA002228647 A CA 002228647A CA 2228647 A CA2228647 A CA 2228647A CA 2228647 A1 CA2228647 A1 CA 2228647A1
Authority
CA
Canada
Prior art keywords
methyl
oxo
oxazolidinyl
acetamide
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002228647A
Other languages
French (fr)
Inventor
Douglas K. Hutchinson
Michael D. Ennis
Robert L. Hoffman
Richard C. Thomas
Toni-Jo Poel
Michael Robert Barbachyn
Steven J. Brickner
David J. Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2228647A1 publication Critical patent/CA2228647A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

A compound of formula (I), or pharmaceutical acceptable salts thereof wherein X is NR1, S(O)g, or O; R1 is H, C1-6 alkyl optionally substituted with one or more OH, CN, or halo, or R1 is -(CH2)h-aryl, -COR1-1, -COOR1-2, -CO-(CH2)h-COR1-1, C1-6 alkyl sulfonyl,-SO2-(CH2)h-aryl, or -(CO)i-Het; R2 is H, C1-6 alkyl, -(CH2)h-aryl, or halo; R3 and R4 are the same or different and are H or halo; R5 is H, C1-12 alkyl optionally substituted with one or more halo, C3-12 cycloalkyl, C1-6 alkoxy. The compounds are useful antimicrobial agents.

Description

W O 97/09328 PCT~US96/12766 PHENYLOXAZOLIDINONES HAVING A C-C BOND
TO 4-8 MEM13ERED ~;l~;~OCYCLIC RINGS

BACKGROUND OF THE INVENIION
The present invention relates to new and useful N-phenyloY~7Qli~linnn~
~ cc,.,.~uu~lds and their ,u-eparations, and more particularly t,o N-phenylnY.~7nli-1in-~ne ..,pu~ds in which the phenylo-~7~ inonP moiety is linked to a variety of saturated, or partially saturated, 4-8 membered hete.u.,~cle~. ~cnt~ininF osygen, nitrogen, and sulfur through a carbon carbon bond.
The compounds are useful ~ntimirrobial agents, effective ~E~inQt a mlmhPr of human and veterinary pathogens, in~ inE~ gram-po~i~ive aerobic b~t~ri~ such as mnl~irly-rPci~t.~nt staphylocûcci and ~ ptococ~;i, as well as anaerobic or~ni~m.
such as bacteroides and clostridia spe~iPF., and acid-fast org~nicm# such as Mycoba~t~, .,u~,., tuberculosis and Mycoba~ r~ auium. The co~po~ds are particularly useful be~n-lQe they are elr~ive n~in~ the latter or~niQm-~ which are known to be respon~iblP for inf~inn in persons with AIDS.

INFOR~!LATION DISCLOSIJRE
A series of Del~l~n~e patent applic~qtion~ (Derwent Ab.,h cl~ 61219Y/35, 67436R-B, 84475A/47) ~i~rlo~e a sal~urated nitrogen hele~ le linked through the nitrogen atom to a phenyloyn7nli~linnnp moiety.
French Patent (E'R2600450 A1 820827) ~li~lo~p~ cy~lnhpypnnn~ ~tt~h~ at the 3-position to a phenylnYs~7oli~linonP~
Other references ~ close fully aromatic hetel~o~ ,les ~tt ~hP~l to a phenyk~y~7nli~linnnp7 in~ ing Eu~vpean Patent pllhlie~ti~n 0352 781 A2, US
Patent 5,130,316, US Patent 5,254,577, US Patent 4,948,801, and WO 9309103-A1, whereas in our ~-~'eht invention the hetel~,~lei8 sat~ated or partially saturated.

SU~IARY OF 'l~; INVENTION
The present invention provides new cv~pou~ds of the Formula ( I ) W O 97/09328 PCT~US96/12766 _ (CH2)n ~ .R2 Q~
--(CH,~m~ HN,1~l~R, ( I ) or ph~ ellt;c~l acceptable salts thereof wherein:
X i8 NRl, S(O)8, or O;
Rl is a) H, b) Cl 6 alkyl, optionally subbliluled with one or more OH, CN, or halo, c) {CH2)h-aryl, d) -CORl l.
e) -COORl 2.
f~ -CO~CH2)h-CORl-g) -S02-Cl 6 alkyl, h) ~O2~CH2)h-aryl, or i) ~CO)i-Het;
Rl-li8 a) H, b) Cl 6 alkyl, optionally 8llhE' :l ~.~e-l with one or more OH, CN, or halo, c) -(CH2)h-aryl, or d) ~CH2)h-ORl-3;
Rl-2 i8 a) Cl 6 alkyl, optionally 8--h~ .l with one or more OH, CN, or halo, b) ~CH2)h-aryl, or c) ~CH2)h-ORl-3;
30 Rl 3 i8 a) H, b) Cl 6 alkyl, c) ~CH2)h-aryl, or d) -CO(Cl 6 alkyl);
35 R2 i8 a) H, W O 97109328 PCT~US96112766 b) C1-6 alkyl, c) ~CH2)h-ar~l, or d) halo;
R3 and R4 are the saIne or diflelent and are a) H, or b) halo;
R5 i8 a) H, b) Cl l2 alkyl, optio~ ly sn~E~it~lted with one or more halo, c) C3 12 cycloalkyl, d) Cl 6 alko~y;
g i_ 0, 1, or 2;
h is 1, 2, 3, or 4;
iisOor l;
15 m is 0, 1, 2, 3, 4, or 5;
n is 0, 1, 2, 3, 4, or 5;
and with the prov~io that m and n taken together are 1, 2, 3, 4, or 5.
More particularly, the present invention provides co l~ou~ds of forml1lA ( I ) wherein Rl is H, fluoroethyl, cyAnAn~A l yl, methyl sulfonyl, formyl, hyd~ y_c~Lyl~
20 acetyl, mp~ y~-c~yl~ benzylu~y~etyl~ ac~ y~ tyl, dichlorDace lyl, mPt~r. y c&Lullyl, tert-butosy carbonyl, benzyloxy cl~LuLIyl, 3-Lydlo~y~l~pionyl, 3-mPt~ upionyl~ 4-oxoppnt-nAyl~ 2-indole carbonyl, 5~ A70hP carbonyl, 5-nitro-2-thiazoyl, 4-oso-2-t~i~7r~linyl~ or 5-methyl-1,3,~ t~ iA7ol-2-yl.
R2isH,F,orCH3;
25 R3 and R4 are the same or different and are H or F; and R5 is methyl or methyl E--h~ ed with one or more F or Cl.
The present i~ Lioll aLo provides a mpt~ for treat,ing microbial infP~+icmR
in p~t;AntQ by ~miniQt~ing to a patient in need thereof an en'__Live A~U~ t of ac~ o~ 3 of Formula ( I ). The ~uu~d can be ~ mini~red orally, pa~e~k.ally 30 or topically in a pharmA~pllt~cAl C~J~ ORi I on Preferably, the c~nl-o-~.--1 is -~iminirt ~d in an ~m~)nnt of from about 0.1 to about 100 mg/l~g of body weighVday.
.

DETAILED DESCRIPIION OF THE INVENTION
For the ~ ose of the pre. ent invention, the term "Cl 6 alkyl" and the tenn 35 "Cl l2 alkyl" refer to any straight or branched alkyl group having one to sis or one to twelve carbons r~ . ~Lvely ~uch as, for P~mrle, methyl, ethyl, n-propyl, W O 97/09328 PCT~US96112766 iao~ Jyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, n-hexyl, isohe~, n-heptyl, n-octyl snd the like.
The term "Cl 6 alkyl sulfonyl" refers to any strsight or brsnched alkyl group having one to 8ix csrbons ~t~rhP~l to -S02 formi~g such groups as, for ~Y~mrle, 5 methyl sulfonyl, ethyl sulfonyl, isopropyl sulfonyl and the like.
The term "C3 12 cycloslkyl" refers to three to twelve csrbon stoms forming cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.
The term "Cl 4 alkoxy" and the term "Cl 6 slko~cyn refer to sny straight or brsnched slkyl group having one to four or one to si~ carbons, r~e~ivt ly, 10 ~ xl to an oxygen forming such groups as, for ~-~rnrl~, m-'~nYy~ ethoy, n-P1~PUAY, isuur~UuAy~ n-butyloxy, isoblllylu.~y, sec-butylo~cy, t-butyloxy, n-pentyloy, Y1~"'Y, n-hesyloy, iso-hesylo~y and the like.
The term halo refers to fluoro, chloro, bromo, or iodo.
The term "aryl" refers to a phenyl, pyridyl or naptbyl moiety which can be 15 optionally ~l~h5~ ;lul~d with one or more F, Cl, Br, I, CN, OH, SH, Cl 6 alkyl, Cl 6 alkoy, or Cl 6 thioalkyl.
The term "Het" refers to 5 to 10 m~mh~red hele~J~;lic rings co..t.~in;.~g one or more o~cygen, nitrogen, and sulfilr forming such groups as, for ~-~mpl.e, ~yr;di~
~hi~ph~ne, furan, pyr~7oline~ pyrimitlin~ 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-20 pyrimirlinyl, 4-pyrimi~inyl, 5-pyrimidinyl, 3-pyridazinyl, 4-pyridazinyl, 3-~y-~yl, 2-quinolyl, 3-quinolyl, l-isoquinolyl, 3-isoquinolyl, 4-isoquinolyl, 2-qllinn7~.1inyl, 4-q~in~7r~1inyl~ 2-ql-in-~Y~linyl, l-pht~ 7inyl, 4-o~co-2-imi-1~701yl, 2-imi-l~7o1yl, 4-imi~ 7~1yl, 3_;R~Y~7'71Y1, 4--;R~1~7~1Y1~ 5-;ROY~701Y1~ 3--pyrazolyl, 4--pyrazolyl, 5-pyrazolyl, 2-u~Lzolyl, 4-o~cazolyl, 4-oxo-2-oxazolyl, 5-osazolyl, 4,5,-dil.
25 1,2,3~-~t~ iol~ 1~2~3~ 7~ 1,2,4~ 7~ 2~5~ 7~ 1,3,4~-~2-t~ 7olyl~ 4-thiazolyl, 5 t~in7Olyl, 3-i~o~ n7ole~ 4 i~ 7~ , 5-i~ 7ole~ 2-indolyl, 3-indolyl, 3-in~l~7olyl~ 2-b-~n7~ 701yl, 2-ben7~l i~7olyl, 2-bPn7imi~ 7c!1yl, 2-b.on7or..-~yl, 3-b~ --~yl, b~n7oi~o~ 7~1~, ben7~ r)le 2-~ 1, 3-furanyl,2-thienyl, 3-t~ienyl, 2-pyrrolyl, 3-pyrrolyl, 3-isuy~r.olyl, 4-i~yy~Olyl, 5-i~...Jlyl, 30 1,2,3,~Y~t~in7ol~-l-oYide, 1,2,4~-~ 7~l-3-yl, 1,2,4-o-~t3i~701-5-yl, 5-o_o-1,2,4-1,2,~ t~ in7~l-3-yl~ 1,2,~ t~ in7~1-5-yl, 3-o~o-1,2,~ t~ 7~1-5-yl, 1,3,g t~ in7ol-5-yl, 2-oxo-1,3,~ t~ 7ol-5-yl, 1,2,4-triazol-3-yl, 1,2,1 ~in70l-5-yl, 1,2,3,4-tet,razol-5-yl, 5-osazolyl, l-py-~Olyl~ 1-pyrazolyl, 1,2,3-tnazol-1-yl, 1,2,4-triazol-1-yl, l-t,etrazolyl, 1-indolyl, l-indazolyl, 2-i~in~l~lyl~ 7-o~o-2-iR~in~lolyl,1-35 purinyl, 3-iRot~i~7olyl~ 4-;RO~ 701Y1 and 5-i~ 7olyl~ 1,3,4,-nY~ 7n1e~ 4-oso-2-7~linyl, or 6-methyl-1,3,~ t~ n7ol-2-yl~ t~iM7o~ n~ 1,2,3,4-thiatriazole, 1,2,4-W O 97/09328 PCT~US96/12766 ~lit~i~7okmp Each of these moi-ptip~ may be sllhsl:l .lP~l as a,upio~u~;ate.
The term 'lpharm~rellt;r~lly acceptable salts" refers to salts useful for sl~mini~terin~ the co l,uuu~ds of this invention and inrln~le hydluchloride, ~ hydrobromide, hydroio~ e, sulfate, phn~Fhs~te,f~ret~tP~propion~3t~ rtslt~
5 mesylate, m~le~te~ m~l~te~ sllrrin~e~ tartrate, citrate, 2-hydL~JAyeLllyl slllf~)n~, ~ fumarate and the like. These salts may be in hydlated form.
In the structural re~ules~ t:~ n of Formula ( I ) the dotted line in the hete~ . Lc ring means that this bond can be either single or double. In the casewhere the dotted line is a double bond, the R2 group will not be ~ul~8e~
In a plere~ . ad emho-limPnt of the N-phenyloY~7n~ innnP compounds of the present invention, the X group is preferably NR1, SO2, or oxygen.
The Rl sllhEtitllPnt on the nitrogen atom can be il~t-ùduced by synthetic mPt~lo~lc known to those skilled in the art from comm~rcially available r~nt~
The ~lerellcd Rl EnhstitllPnt is H, fluoroethyl, cy~n-~mPt~yl~ methyl sulfonyl, 15 for}nyl, 11Yd1~JAY~C~Y1~ acetyl, mlPthnYyacetyl, benzyloAy~ce~yl, ac~lvAy,lcetyl, dichloroacetyl, mPthnyy call,ollyl, tert-butoxy c~Lu~yl, benzyloxy carl,ollyl, 3-lly~llvAy,ul~uionyl, 3 mPtl~n.y~ul~ionyl~ 4-uAu~G-~ n~yl~ 2-in-l~lP~ ù~yl~ 5_iC~Ys~
ca Lollyl, 5-nitro-2-~i~7O1yl, 4-oxo-2~ 7olinyl~ or 5-methyl-1,3,~ t~ 7Ol-2-yl.
The most ,ulafél ed R1 8~-h~ ent is formyl, mPthflyy carbonyl, or hydluAy~cetyl.Where hete~ lic rings are the sa~ul&l,ed del;v~Lves, the ,ulefe- ed R2 EllhEt;tnPnt is hy-llog~ uoro, or methyl.
The p-cr~l ~d R3 and R4 ~nhEt;tllPnt~ are inflPpentlPntly hydlu~n or fluoro.
The plefel ~ ed R5 snhstihl~nt is methyl.
The most plefe..ed col~pou,lds in this series would be prepared as the 25 optically pure PnAnt;~mP,rs having the (S)-configuration acc~,l.ling to the Cahn-Ingold-Prelog notation at C5 of the ~Y~7~ inonP ring. Optically pure mAt,eri could be prepared by one of a nllmhPr of asymmPt~ic synthPsp~ For PYAmpl~, t ~ lt of in~o~rmPtliAts c~.l.pcu~d 12 in CHART B with an appropriate base, followed by A~ition of (R)-glycidyl bulyldte would afford the cvl~r~,l,on~ing 30 ~Y~7~ inonp in optically pure form with the requisite (S)- configuration at the 5-po~it;~n of the l YA7oli~1inonP ring. Although the (s)-pnAnt;~mpr of this series of co~pou~d8i8,ul~fe~ ed since it is pharmArolngirAlly active as an Ant;h~rtArial agent, the racemic mo-lifirAt;~ n is also useful in the same mAnnPr as the pure (S)-~nAnt;cmf~r; the di~..~llce being that twice as much racemic mAt~riAl is reu,ui.ed 35 to elicit the same AntihArteriAl effect.
CHART A illustrates mPtl~o~c for prepAring compounds of Formula ( I ) SU~S 111 UTE SHEET (RULE 26) having a he~ . le cont~ininE~ nitrogen. As shown in CHART A, the ~ey int~ -P-l;Ate 1 can be used to make derivatives by reSl~tion~ known to those skilled in the art. For example, acylation affords 2 and 3, the subsequent deprotection of 2 provides 2', ~lkylation affords ~; (the st-~~L~ t.~ inrlll~line hydlv~y, nitro, halo, 5 aryl, and sulfonyl; structure 6 also en-omrA~es products having a heteroAtomic nn-~lPl~ sulfonylation affords ~, and all~u,-y~-;ylation affords 4.
A mP~l~o~l for preparing co Ipouuds of interme~liAt~ 1 having a 4-mPmhered hetero~ ~.,le cu ..t~i..ing nitrogen in highly en~nt;~mPrically enriched fo~n is ~lepi~ted in CHART B. The first step involves treAt~nPnt of structure 7 with ethyl 10 cy~noAcetst,e in the presence of an appropriate base, such as sodium hydride or potassiurn carbon~t,e at a tempc~Lur~ in the range of-10~C to 100~C. The subsequent alkylation using alkyl halides or tosylates affords nitrile de,;v~ 8.The nitrile de~;valive 8 is then ~duced by catalytic Lyd~ At;~n in the presence of an a~opL;ate catalyst, such as pAllA-linm on carbon, W-2 Raney nickel or plAt;nnm 15 on sulfide carbon, in an appropriate solvent, such as ethyl A~etDte, THF, mPt~nol or c~mhin~t;Qn~ thereof, to give amino-aniline 9, which upon L- ~ t with an a~ o~;ate base, preferably methyl or ethyl Grignard, affords the lact,am 10.
Reduction of 10 by using an appropriate reducing agent, such as LAH or borane, gives the ~t;~line 11, which reacted with benzyl chloL~,fo.~ate, at a te ~pe~&l,u~ in 20 the range of -10~C to 10~C, affords the correspnn~ling benzyl carbAmAt~ d~,;v~ .e 12. The treAt~n~nt of 12 with n-butyllit~ m in an appropriate solvent such as T~, at a temperature in the range of -78~C to -40~C, followed by A~lit;nn of comm~orcially available (R)-glycidyl buL~al~e dropwise would afford the ~r~ ling mrA7o~ inone 13 in enAnt;omPrically enriched form at the 5-poQi~;c~n25 of the ~YA~ lin-~n~ ring. As shown in CHART B, c.,Lupuu~d 1S can be convcrl~cd to the cv.l~O,u~>n~ling alkyl or aryl ~lllf~nAte 14 by ~ --rnt with alkyl or aryl sulfonyl rhlnri-lP in the pregence of triethylamine or pyridine (wherein R' is Cl~ alkyl or (un)sllh~ le~l phenyl). The rPslllt~nt slllfi~nAt~ 14 is then treated with an lkali metal azide such as sodium or potn~Q;l~m azide, in an aprotic dipolar solvent such as 30 DMF or N-lllel~hyl~yl~oli~innnp (N~), with an optional catalyst such as 18 ~ wu-6, at a te u~c~ture in the range of 50~C to 90~C to afford azide dc..v~lives. The azide dc.;vziLvcs can be reduced to the ccr,~O~u~ding amine 15 by hy~..~t;~n in the ,u~ a~ of a pAll~inm, plAt;nllm or nickel catalyst, in an appI~ ;ate solvent such as ethyl A~etqte, THF, or m~t~Annl Alternatively, amine 15 can be ~rep&led by 35 treating 14 with an app.o~,ate solvent such as mPtl~nol and/or l~ which is W O 97/09328 PCT~US96/12766 saturated with QmmoniQ and hl~QtinF the mixture to 100~C in a sealed tube. The reQrtion occurs over hours, e.g., 40 - 70 hour~. Amine 15 is then acylated ~th an acid chloride or anhydride in the pre~ence of a base such as pyridine or ~triethylamine at temperc~ s ranging from -40~C to 40~C to provide the N-acyl 6 nY~7nli~iinnnP 16. Finally, catalytic hydrogenQ+i-~n of 1O in the presence of a noble metal catalyst, such as pQllQ~ m on carbon or palladiuAm hydroxide on carbon affords the Q~eti~linP 17. The Q7Ptirline 17 can be used to prepare d~.;v~Li . vlllpou~ds ~l~mon~ated in CHART A.
The following compounds of Formula ( I ) having a 4-membered heteA~ le 10 cQnt~inin~ nitrogen, for eYQmpl~, are prepared ~ ly by the m~tlloll4 d~rrihe~l in CHART A and CHART B:
(S)-N-[[3-[3-Fluoro~-[l~c~hLoLeA~zyloxy){3-methyl)-3-Q7eti(linyl]-phenyl]-2 o~co 5~-r7nli~inyl]methyl] s~r~,t~
(S)-N-[[3-t3-Fluoro-4-[3-methyl-3-Q7eti-linyl]-phenyl]-2-oAy-o-5 15 n~7nli~inyl]methyl] rl~t5~ P
(S)-N-[t3-[3-Fluoro-4-[l-(c~rLc,..y~ethyl)-3~3-methyl)-~7~ti~inyl]-phenyl]-2-oso-6~Q7~ inyl]methyl] nr~etSlm (S)-N-tt3-t3-Fluoro-4-[l-(m~tl~nYyacetyl)-3{3-met~hyl)-Q7p-ti~inyn-phenyl]-2 6-0-~7~1irlinyl]methyl]-~< e+~
20(s~N-tt3-[3-Fluoro~-[l{~ormyl)-3{3-met~hyl)-Q7pti~inyl]-phenyl]-2Ao~o-5 n n7nli~1inyl]methyl] nr~t~ e;
(S~N-[t3-[3-Fluoro~4-tl-(dichloA uaee~yl)-3{3-methyl)-Q7eti~inyl]-phenyl]-2 6-nY~7nli-1inyl]methyl] rr~ts~mi~
(S~N-tt3-t3-Fluoro 'A-tl~3-m~t~ yAuroAuionyl)-3~3-methyl)-Q7eti~inyl]-phenyl]
25 2-oxo-5~nY~7oli-linyUmethyl] Q~ t~i-le;
(S)-N-tt3-t3-Fluoro 4-tl{3-hy~huAy~luAuionyl)-3~3-methyl)-~7eti~linyl]-phenyl]
2-oso-5~YQ7nli-1inyl]met,hyU ~lr~.. i~lP
(S)-N-tt3-t3-Fluoro-4-tl-(4-nvnpentDnoyl)-3-(3-methyl)-~7~ inyl]-phenyU-2-oso-5-n-Q7oli~inyl]methyl] ~r~et~" " jl~P
30(S~N-tt3-t3-Fluon~4-[l-acetyl-3{3-methyl~Q7et;~inyl]-phenyl]-2-ox~5-n Q7~ inyl]methyl] Q~
(S~N-tt3-t3-Fluoro~-[1~2-fluoroethyl)-3~3-methyl)-Q7Pti~linyl]-phenyl]-2 6~YQ7nli~inyl]met~Ayl] s~-~t~,."i~lP;
(S)-N-tt3-t3-Fluoro l-[l~cyQn-~Tn~t~ yl)-3{3-methyl)-Q7eti~inyl]-phenyU-2-oso-36 6~-~7O1i-1inyl]methyl] Q~'.f ~...;tlP;
(S)-N-[[3-t3-Eluoro 4-[1{5-nitro-2-'~iQ7olyl~3~3-methyl~7Pti-3inyl]-phenyl]-2-W O 97/09328 PCT~US96/12766 oxo-5~Y~7Oli~inyl~methyl]-acet~mi~e;
(S)-N-[[3-[3-Fluoro4-[l-(mP~h~np~ fonyl)-3-(3-methyl)-~7pt~ nyl]-phenyl]-2 oxo-5-oY~7o~ inyllmethyl]-~qr~-pts~m (S~N-[[3-[3-Fluoro4-[l-(benzyloxyacetyl)-3-(3-methyl)-~7eti~linyl]-phenyl]-2 oxo-5~7Oli~inyl]methyl]-~retQmi~p~;
(S~N-[t3-t3-Fluoro4-tl~h~ o,~y~cetyl)-3-(3-methyl)-~7eti~inyl]-phenyl]-2-oxo-6~YQ7oli~linyl~methyl] ~ f' A second mçtho~l for preparing co-llpou-,ds of inler...P~ te 1 having a 4-mpmhpred helel~y~ lc cont~ining nitrogen, wherein R2 is H, in highly 10 Pn~nt;cmprically enriched fonn is depicted in CHART C. The first step involves reaction of structure 18 with a p,vt~Lad ~niline l9 in the presence of an appropriate base, such as sec-butyllit~illm, in an appropriate solvent, euch as 1'~, at a tempel~Lu~ range of 40~C to -78~C to afford cu.~ poullds 20. ~P~ction of 20 withbenzyl chlol.)foll"ate at 0~C to 2~~C gives ~o...po~ l 21 which react6 further at 25~C
15 to 100~C to give cu~poulld 22. Tre~tmpnt of 22 with excess tAethylsilane and trifluoloa~3tic acid in a suitable solvent such as methylene chloAde, at a te pe~LL"e range of 10~C to 40~C gives ~ u~ ou"d 23. The rçm~ining synthetic steps which lead to ~L, u. Lu,~ 17 are similar to the prccedures olltlinP l in CHART B.
The following co~.~p-Ju~ds of Fonnula ( I ) having a 4-mPmhered hel~ lc 20 co..l Q;~ gl~iLlUg~:ll, forP ~mplP,areprepareddi~ lybythemPt~ p8rlihetlin CHART A and CHART C:
(S~N-tt3-t3-Fluoro-4-tl-(carbobenzyloxy)-3-n7et~ nyl]phenyl]-2-oxo-5 7~ inyl]metbyl];~r~t~...iClP;
(S~N-[t3-t3-Fluoro4-[3-n7.eti-linyl]phenyl]-2-oxo-5-25 n~Q7nli~inyl]met,hyl]nt~t~ e (S)-N-tt3-t3-Fluoro4-tl~c~LuAyl..eL~lyl~3-Q7et;~inyuphenyl]-2-oso-5 n~s~7nli~1inyl]methyl]n~etsmil1P;
(S~N-[t3-t3-Fluoro4-tl~formyl~3-~ ff~linyl]phenyl]-2-oxo-5-n Q7Oli~inyl]methyl]~r.e~L~ P., CHART D depict,s a mPt~l for ,u~ e Cu~pOul ds of int~, ..... r.. l;Qte 1 having a 5-mPmhPred hekr~-,le ~u~t~ ing nit~ogen. As shown in CHART D, the first st,ep involves t,he coupling of v~yllr;l~uLylL~ 24 (co~ et.,;ally available) and cu l,uuulld 25. The cu~t,uu-ld 25 can be prepared accol.ling t,o the procedures described in PCT/US92/08267 and PCT/US93/09589. The coupling occurs in the 35 presence of pQllQ-lillm catalyst to afford c~ u~ 26. The reaction i8 carried out at a high temperature for several hours, e g, reflux for 5-8 hours The compound 26 is then treated with a sollltin n of N-benzyl-N-(mpthnyymethyl)tri nethyl8ilyl-methyl~-nine (prepared according to the lite.a~u~2 from commPrcial y available ~ m~t,~risll) and trifluol~&c~lic acid in an appropriate solvent to provide 27 The 5 reaction occurs over several hours, e g, 8-17 hours The N-benzyl group of 27 is then removed by catalytic h~ds~e~tiorl in the prc~_..ce of a noble metal catalyst, such as palladillm on carbon or p~ m hydroxide on carbon to afford 28 The co...l,uu~d 28 can be used to prepare the derivative cl-mrol nfl~ ~emnnct~ated in CHART A Follo~rng a similar procedure and m~kinE! non-critical variations but 10 s~lhE' ;1 1 ;~g di.'rele t vinyl tributylstannyl do.;valiv~s for ~ 2 24, a variety of other hete.u~ ~c..c derivatives of cc ~ po ~ r~ 2~ can be obtained as il.udl,l-ted in EXAA~LE 80 A'.ternatively, ~not~Pr mPt~o~ for prep~rin~ cu~ uu~.ds of interme~ t,P 1 having a 5 mpmhçred hete~ le rnnt~ining nitrogen is ~lPpi~te~ in CHART E As 15 shown in CHART E, nu. leophilic aromatic 8l~h~' it,~ltion of 7 with lil~.e~ nn~te (commPrcial available) affords the adduct 29 The l~aC~suss occurs in an app,op-.ate solvent such as Th~, at a te lJ~,.aLu~ in the range of -100~C to 60~C The uul.d 29 is readi y a kylated by a reaction .cnown to those s.cilled in the art to provide nitrile S0 Cata.yt.c retll-rti~n of 30 in the presence of a ps~ inm, 20 ~nl~tinnm or nickel catalyst, in ar appropriate solvent such a~ m~ nol cu~
both nitro and nitri.e to amine~ with c~ ~ o~ t i..~...olDclll~r ~.-li7~ n to a.fford the lacta.-n 31. The lactam 31i8 then decarbosylated to provide 32, which upon reduction with an appropriate re~1llring agent guch as lit~lil1m ~11lmim1m hydride or borane, ir. an appropriate solvent such as 1~ or ether, af.~ords 25 co.,.poud 33. The rpm~ininF synthetic steps which lead to structure 34 are simi.ar to the ,uruced~8 outlined in CHART B
The following co l u~ of Formula ( I ) having a 5-m~mhqred h~ lc c~ t~i; g nitrogen, for ~mple~ are ~u.~,uarc~l di~ ly by the m~t~ln ~ Rrrihe~l in CHART A, CHART D and CHART E:
(S~N-tt3-t3-Fluoro~-t l (hydl o~y ~cetyl)-3-py~olidinyl]phenyl]-2-oso-5-0 ~7~ inyl]methyl]~
(S)-N-t[3-t3-Fluoro-4-[1-(formyl)-3-pyrrolidinyl]phenyl]-2-olco-5-7nlitlinyl]methyl]A.~F t~ le;
(S)-3-[4-t5-t(Acetylamino)methyl]-2-oxo-3-n-~70~ inyl]-2 fluorophenyl]-l pyrrnli~in~rbosylic acid met~yl ester Following the general procedure ~lPpictPd in CHART D for the preparation of cG..,puu-.d 2ff and m~king non-critical variations but sl1hE~itvtinf~ 6~tributylstannyl)-3,4-dihydro-2H-dih~.l,~p~ n for structure 24, the following co ~puulld is prepared:
(S)-N-tl3-[3-Fluoro4-(3,4-dihydro-2H-pyran-6-yl)phenyl]-2-oxo-5-~; nYsl7~ 1inyl]methyl]sl-~et~mi~e.
A mPtl o~l for preparing compounds of formula ( I ) having a 6-mPmhPred heter~,~lc cont~ining a sulfur atom, oxygen atom, sulfone group or slllft- i-1e group in highly en~nt;omPrically enriched form wherein R3 or R4 is halo is depicted inCHART F. As shown in CHART F, structure 35 (wherein X is 0 or S ) i8 reacted 10 v,lith a p.vte.;led aniline 19 in the presence of an a~,u~uu~iate base, such as ~ec-bUtylli~illm~ in an appropriate solvent, such as 1~, at a te- pe1~lul~ range of -40~C to -78~C to afford cv~uu~ds 3ff. R~n.~ n of 3ff with benzyl chlolv~L~late at 0~C to 25~C gives co~pou~d 37. The subsequent elimin~t;~n reaction known to those skilled in the art affords regioAio~nPrs 38 and 3~ as a ~i~LlLrG. Following the 15 general p1~edul~ outlined in CHART B provides connrollntlA 40 and 41 as a ~Lu e. In the case where X is S, the suLfur group can be nYitli7e~ by an applop.;ate n~ i7e- such as N-methylmorpholine N-oxide and oc...i~l... tetroxide in an a,u,u-o,ul;ate solvent such as ~lul ~ of water and ~ceton~ or by NaI04 in an ap,u~vp~;ate solvent such as ~lu~ of water and m~Ol~nf l, to provide the cv.~ uV~ in~ sulfones and 8ll1fin~ e8, ~e_~e_lively. When it is desirable, the double bond in the hel~ le ring may be reduced by catalytic hyLu~,~. nt;~ n in the pr~e~c~ of an appl~p,;ate catalyst and a sllit~qhle solvent. Furthermore, in the case where X is 0, S0, or S02, the regioiRompl ic ~i,~lu~e of 4Q and 41 can be separated by cl~m~raphy as illustrated in EXA~LEs 68 and 69.
The following ~po~lnds of Fonnula ( I ) having a 5-m~mh~sred hetero~y~ lc co~tC ;~ g a sulfilr atom, osygen atom, sulfone group or slllfn~ group, for P-~mple, are L)re~ed ~ ~ ,ly by the mPt~ o~3 of CHART F:
(S) (-~N-[[3-[3-Fluoro4~di}iy~c.ll,ien-3-yl)-phenyl]-2-oxo-5-n~s-7nli~inyl]methyl]~ ts~ . . .ide;
(6S)-N-t[3-t3-Fluoro~2,5~ihydro-1-osido-3-thienyl)-phenyl]-2-oxo-5-n~ iinyl]methyl]~ t~ e;
(5S~N-[t3-t3-Fluoro-4-(4,5-dihydro- l~xido-3-thienyl~phenyl]-2-oxo-5-n S~7c~ inyl]methyl]nc ~ e;
(S~N-t[3-[3-Fluoro~2,5-dihydro- 1, 1-dioxido-3-thienyl~phenyl]-2-oxo-5-35 ~ 7nli~1inyl]methyl]~r~ ~....ide;
(S~N-[[3-[3-Fluoro-4~4,5-dihydro-1, 1-dioxido-3-thienyl~phenyl]-2-oso-5-W O 97/09328 PCT~US96/12766 oYs~7nli~1inyl]methyl]s~etslmirlP-A mPtho~l for preparing co~lpo.l..ds having a 6-mPrnhered hete~ le cont~ining a nitrogen atom, suLfur atom, oxygen atom, sulfone group or slllfi~-ide group wherein R3 and R4 are hydrogen i8 depicted in CHART G. As shown in 5 CHART G, the first step involves the con~lPn~tion of structures 42 and 43 (wherein X is 0, S, or N) to afford cu ,pou~d 44. In the case where X i8 a nitrogen atom, the s~mino group should be ~v~. ~ed with an appropriate ~ulul~ g group such as c~Lo~e..zyloxy (CBz). The protecting group is option~lly le~uved after the synthesis to give u,~pùunds 4~ or 47 (wherein X is NH), which can be used to 10 prepare the del;v~Liv~: c u~uuu~ds ~Pmon~ated in CHART A. The reaction of 42 with 43 occurs in an appropriate solvent such as 1'~, at an apl~rop.;ate tempe,~l~u- ~ such as -78~C to ~0~C, in the presence of a lit~inm base such as n-butyllit~ illm The subsequent ~limin~tirn reaction known to those skilled in the art provides compound 45. The r~m~ining synthetic steps which lead to the c~....l.u....
15 46 are similar to the procedures outlined in CHART B. When it is desirable, the double bond in the hetel~. l;c ring may be reduced to give 47 by catalytic h~ e-~t;~ n; and when X is a sulfur atom, the sulfilr group r~n be ~-~ ;-1;7~'1 to afford the c.,~.- 7~,u~.~ing sulfones and sl-lfr~ Ps as ~l~s-~ihed above for CHART F.
CHART H depicts a mP~ for prep~ing cv~po~ds having a 6-..-~ d 20 hete~ le ~ hele, sllh~ R3 and~or R4 are halo. As shown in CHART H, u. Lu~e 48 ( X is 0, S, or NR wherein R is an ~pprup.;ate pl.~tC~ g group) is ea_~èd with a protected aniline 19 in the plcaance of an ayyl~yr;ate base, such as sec-butyllithinm in an apyl~yr;ate solvent such as THF at a te-. p~,.a~u a in the range of 40~C to -78~C, followed by the ~ itinn of zinc chloride and an apy.-.y.iate 25 catalyst such as tetrakis(triphenylrhn7rhin~) p~ m with further reaction at re~us to afford co~L~yuuud 49. Optionally, in the case where X is nitrogen, structure 4~ can be reduced to the s&~ ted do.;v~ at this point and carried on, or structure 49 can be acylated by the reaction known to those skilled in the art to provide structure ~50. The r~m~ining synthetic steps which lead to cv Iyuulld 51 are 30 similar to the plWedu c~i outlined in CHART B. In the case where X is a sulfilr atom, the sulfur group of structure 61 can be o irl ~-~ to afford the co~rDyo..-ling sulfones and e~llfn~ s as ~l~srrihell above. In ~ tion where X is O, NR, or S02,tl~ru~;Lu~ il may be leluced to s~u,ated dt:.;v~lives by catalytic hyd~u~ tinn in the yrasel.ca of an appropriate catalyst and a suitable solvent to provide the 35 8al u~ated de~;v~tive 62. As ~tated above, in the case where X is a ILiLrogaIi atom, the amino group is protected during the preparation with an appropriate ~,~ule ~i~lg group. In this case, the ~urefe~d protecting group is 1,1-dimethylethyl carbamate (BOC). The ~,ùt~ ;n~ group i8 removed after the syntl eAir, and the reslllt~nt culllpou,ld can used to prepare the derivative compounds demnnctrated in CHART A.
The following cu pou~ds of Formuls ( I ) having a 6-m~mhered hete~ cle co"tS~i"i~ a nitrogen atom, sulfilr atom, oxygen atom, sulfone group or slllfnYi~3e group, for example, are prepared directly by the m~tl r~A4 of CHART A, CHART G, and CHART H:
(S)~-)-4-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oYn7oli~linyl]phenyl]-3~6-dihydr 1(2H)-pyri~lin~,~.l,u.,ylic acid phenyllllclllyl ester;
(S)-(-~N-1[2-Oso-3-[4~4-piperidinyl)phenyl]-5--A--~7A~ inyl]methyl]s~et4..~i-le (S){-~N-[[3-t4-[1-[(Benzyloxy)acetyl]-4-piperidinyl]phenyl]-2-o~co-5-n~7A~lirlinyl]methyl]~-~4mitle;
(S) (-~N-[[3-[4-[l~IIyd~o~y.~cetyl)-4-piperidinyl]phenyl]-2-oso-5-15 o--M7o~ inyl]methyl]nr~t~ . . ,i-l~;
(S) (-~N-[[3-[4-[1-[(Benzyloxy)acetyl]~-piperidinyl]-3-fluorophenyl]-2-o~co-5-n ~7Alininyl]methyl]~r~t~ e;
(S) (-~N-[[3-[4-[1~IIyd,cl..y -w~yl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-n~7AliAinyl]methyl]~r~?t 4 . . .itle (S)~-~N-[[3-[4-[1-[(Be~ylu,~y)acetyl]~-piperidinyl]-3,5-difluorophenyl]-2~xo-5 n~7Alillinyl] ~ll~yl]r~r~t~---iAe;
(S) (-~N-[[3-[4-[ 1-(IIyd~ u.~yacetyl)~-piperidinyl]-3,5 di~uorophenyl]-2-oxo-5-nYs~7r~ inyl]methyl]~r~t~
(S){-)-N-[[3-[4-[ l~Indole-2~arLonyl)4-piperidinyl]-3-~uorophenyl]-2-oxo-5-25 Q~7' 1i-linyl]methyl]~ L~i-l~;
(S)-(-~N-[[3-[4-[l~TRn-~7~1e-5 c~lvollyl~4-piyt .;dil yl]-3-fluorophenyl]-2-os~5-n ~7~ linyl]methyl]~fe~ e;
(S}(-~N-[[3-[4-[1~Methylsulfonyl)4-piperidinyl]-3-fluorophenyl]-2-oso-5-n~s~7n1itlinyl]methyl]~q~xL~ . ~-i-lP
(S) (-)4-[4-[5-[(Acetylamino)methyl]-2-oxo-3~Y~7nli~linyl]-2-nllvl~vl~henyl]
piperitlin~-~LvAylic acid methyl ester;
(S) (-)-N-[[3-[4-[l~Cy~r~ .yl)4-piperidinyl]-3-fluorophenyl]-2-oso-5-n~7nli~inyl]methyl]s~r"~4...i~
(S)~-~N-[[3-[4-[1~2-Fluo~ yl)4-piperidinyl]-3-fluorophenyU-2-oxo-5-35 n l~7r~1itlinyl]methyl]F~l-.et~...i~le (S)-(-~N-[[3-[4-[1~Formyl~4-piperidinyl]-3-~1uorophenyl]-2-o~co-5-W O 97/09328 PCTrUS96/12766 oy~7~ inyl]methyl]~ret~mi~le;
(S)~-)4-[4-t5-[t(2,2-Dichlo~oacetyl)amino~methyl]-2-oxo-3~Y~7Qlitlinyl]-2-fluorophenyl]-l-piperi-iin~ boxylic scid l, l-dimethylethyl e4ter;
(S)~-)-2 ,2-Dichloro-N-[t2-oxo-3 -[3 -fluoro4~4-piperidinyl)phenyl]-5-5 oYs~7Qli~3inyl]methyl]~retS~mitle:
~ (S)~-~-2,2-Dichloro-N-[[2-oxo-3-[3-fluoro4-[1-[(acetoxy)acetyl]4-piperidinyl]phenyl]-5~Y~7.nli-1inyl]methyl]~ret~mitl~;
(SH-)-2,2-Dichloro-N-[[2-oxo-3-[3-fluoro-4-[1 (hyd~o~y~cetyl)4-piperidinyl]phenyl]-5-oY~7Qli-linyl]methyl]~r.. lS~"~
(S)-(-)-N-[t2-Oxo-3-[3-fluoro4-[1-[(acetoxy)acetyl]4-piperidinyl]phenyl]-5-Q ~7r~ nyl~methyl]~qret~
(S)~-~N-[[3-t4~3,6-Dihydro-2H-pyran4-yl)-3-fluorophenyl]-2-o~co-5-oy5l7r~ inyl~ l~thyl]~eet~r~ e;
(S)~-~N-[[3-[4-tTetrahydro-2H-pyran4-yl]-3-fluorophenyl]-2-oxo-5-15 ~y~7r~ inyl]methyl]~r~t4~ p;
(S) (-)-N-[[3-[4-(3,6-Dihydro-2H-thiopyran4-yl)-3-fluoro.phenyl]-2-o~co-5-nYs~7Qli~linyl]met~hyl]~ret~mifle;
(S) (-~N-[[3-[4~3,6-Dihydro-2H-thiopyran4-yl~3-fluorophenyl]-2-oso-5-r~ys~7nli~linyl]~ hyl]~ .ts~ ~ S,s-~ y~
(S~ N-[[3-t3-Fluoro4~tetrahydro-2H-thiopyran4-yl~phenyl]-2-oYo-5-7r~ nyl]methyu~re~ e S~s-~inyislf?;
(S)~-)-N-[t3-[4~3,6-Dihydro-2H-pyran4yl~phenyl]-2-oYo-5-nyl]methyl]~ret~mitle;
(S)-(-)-N-[[3-[4-tTetrahydro-2H-pyran4-yl]phenyl]-2-oYo-5-25 ~ 7r~ inyl]methyl]~r~~
(S){-~N-[[3-[4~3,6-Dihydro-2H-thiopyran4-yl)phenyl]-2-os~5-o~s~7r~1itlinyl] ~ ~lyl]Ar~ t4",i~;
(S)~-)-N-[[3-[4~3,~Dihydro-2H-thiopyran4-yl)phenyU-2-oso-5-7~ inyU l~ yl]~ ~ S,S-tliny~
~S) (-~N-[[3-[4~3,6-Dihydro-2H-thiopyran4-yl~3-fluorophenyU-2-o~o-5-clY~7Qli~linyl]met~hyl]Ar~ e S-oside;
(S)~-)-N-[[3-[4~3,6-Dihydro-2H-thiopyran4-yl)phenyl]-2-oso-5-inyl]methyUA~ e S-oxide;
(S)-(-)-N-[[3-t4~Tetrahydro-2H-thiopyran4-yl~phenyl]-2-oso-5-35 ~Ysl7~ inyl]methyl]~r~etqmi~le S,S-~
(S)~-)-N-[[3-[4-[1-(4-Os~2 ~ 7~linyl)4-piperidinyl]-3-fluorophenyl]-2-oYo-B

Qysl7~ inyl]methyl3~r-pt~mi~le (S)~-)-N-t[3-[4-[1~5-Methyl-1,3,4-thi~ 7O1-2-yl)4-piperidinyl]-3-fluorophenyl]-2-ox~5~-~7oli-1inyl]methyl]~qc~t~
CHART I depicts a mPt~lo~ for preparing co~ ou~ds of intermP~ ~ 1 which 5 have a partially saturated 6-membered hetelu.;~,le cont~ining nitrogen in highly en~nffomPrically enriched form. As shown in CHART I, the first step involves theco~rling of structure ~;3 and structure 1~4 to provide comrolln~lq 55 and ~56. The triflate group of structure 53 may be at either side of the double bond, wherein both are readily prepared from the corresponding commercially available k~ton~s The 10 structure 54 may be prepared accol.li,.g to the prvcelu~es described in PCT/US92/08267 and PCT/US93/09589. The reaction occurs over a few days, e.g. 1-5days in the presence of an appropriate catalyst such as tris(dibenzyli~Pn~s-retone)~ip~ li--m(0). The amino protec~;ng group of 65 is removed by tre~t~n~nt with iodotimethylsilane and that of 56 is removed by 15 tre~tmPnt with either trifluoroacetic acid or iodoLr t~ ylsilane to give the co..~_~onding compounds 57 and 58. Compounds 67 and 68 can be used to prepare the dt ~;v~Lvt: compounds ~lem~nCl rated in CHART A.
Following the general plwelu.e as ~le~rrihed above, and m~king non-critical v~ri~ti~n~ but sl-h~ .l ;ng 7- or 8-mPmhered rings for the 6-mpmhpred ring of 20 ~ 53, copc,u~lds that have a 7- or 8-m~mhered hetelc~ lc cont~ining ~ in highly Pn~nti~merically enriched form can be prepared. Their preparations are illustrated in further detail in EXAMPLEs 75 to 79.
The following cv~upounds of Formula ( I ) for example, are prepared di~
by the mPtl~o~ of CHART A and CHART I:
(S){-~N-[[3-[4-[1{4-Oxo-2 ~ 7~linyl)-3,6 dihytro 2H-pyridin-5-yl]-3-fluorophenyl]-2-oxo-5~701i-1inyl]methyl]J~r~t~ e;
(S){-)-N-[[3-[4-[ 1~5-Methyl- 1,3 ,~ t~ l -2-yl~3 ~6~ihydro-2H-pyridin-4-yl]
3-fluorophenyl]-2-oxo-5~-~701i~1inyl]methyl]~r,PtS-mi~lP;
(S){-)-N-t[2-Oxo-3-[4{3,6-dihydro-2H-pyridin~-yl~3-fluorophenyl]-5-30 o~sl7nli~linyl]methyl]~ e (S){-)-N-[[2-Oxo-3-t3-fluoro 4-tl-t( c~ )acetyl]-3,6 dihydro-2H-pyridin-4-yl]phenyl]-5-n~ nli~inyl]methyl3r~ el ~
(S){-)-N-tt3-t4-[ 1~ ~ v,~cetyl)-3,6~ihydro-2H-pyridin4-yl]-3-fluorophenyl]-2-o~co-5~Y~701i~inyl]methyl]~-~ t~ ...i-le;
(S) (-)-N-t[3-[4-[ 1~Formyl)-3~6-dihydro-2H-pyridin-4-yl]-3-fluorophenyl]-2 5_n sl--nlirlinyl]methyl]~r~Pt~mi~

(S)~-)-4-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oY~7o~ inyl]-2-fluorophenyl]-3~6 dihydro-1(2H)-pyri~in~rbosylic acid methyl ester;
(S)-(-)-N-[[2-Oxo-3-[4~3,l;-dihydro-2H-pyridin~-yl)phenyl]-5-oY~l7~ 1inyl]methyl]s~ret~mi~P
F. (S)~-)-N-[[2-Oxo-3-[4-[1-[(acetoxy)acetyl]-3,6-dihydro-2H-pyridin~-yl]phenyl]-s~Y.~ inyl]methyl]~cet~mide (S)-(-)-N-t[3-t4-tl~Hyd~ y~cetyl)-3~6-dihydro-2H-pyridin-4-yl]phenyl]-2-oxo-5 r,Y?~7~ nyl]methyl]~et?lmi~lp;
(S)~-~N-tt3-t4-tl~Formyl)-3,6-dihydro-2H-pyridin-4-yl]phenyl]-2-oxo-5-10 o-~7oli-1inyl~methyl]~ et~3mi.1A~;
(S) (-)-4-t4-t5-[(Acetylamino)methyl]-2-oxo-3-oy~7oli~linyl]phenyl]-3~6-dihydr 1(2H)-pyri~iner~rboxylic acid methyl ester;
(S~N-[t2-Oxo-3-[3-fluoro-4-t 1-t(acetoxy)acetyl]-5,6-dihydro-2H-pyridin-3-yUphenyl]-5~Y~7nli~inyl]methyl]~r~f~mi~ie (S~N-tt3-[4-[l~Hydl~Ayacetyl~5,6-dihydro-2H-pyridin-3-yl]-3-fluorophenyl]-2 oso-5~s-7oliflinyl]methyl]s~r~t~...i.3A
(S~N-tt2-Oxo-3-[3-fluoro-4-t 1-t(acetoxy)acetyl]-2,3,4,7-tetrahydro- lH-a_epin-5-yl]phenyl]-5~y~7~ nyl]methyl]~ pt~mi~lA
(S) (-)-N-t[3-[4-tl~Hyd~u~y~cetyl)-2,3,4,7-tetrahydro-l~-azepin-5-yl]-3-20 fluorophenyl]-2-oxo-5~.~7Oli~inyl~methyl]~r,~ts.r..i-lP;
(S) (-)-N-tt2-Oxo-3-t3-fluoro-4-tl-t(scetoxy)acetyl]-2,3,6,7-tetrshydro-lH-azepin-4-yl]phenyl]-5~-~oli~linyl]met-hyl]~et ~ .. .i-le (S) (-)-N-[[3-t4-[l~Hy.l~oAy~cetyl)-2,3,6,7-tetrahydro-1~-azepin~-yl]-3-fluorophenyl]-2-oxo-5~Y~7.olitlinyl]methyl]~cehmi-1e (5S)~-)-N-[t3-t4-[l~Hy~luAy~Lcetyl)he~hydro-lH-azepin-4-yl]-3-fluorûphenyl]
2-oxo-5~7~ linyl]methyl]~qr~t~ P
A second mpth~l for preparing c~puu~ds of illteL...P-liAt~ 1 which have a partially sa~u~dted 6-membered het~ le contS~ining nitrogen in highly Pn~nti~mPrically enriched form is ~lepi~t~d in CHART J. As shown in CHART J, 30 structure 59 is reacted with a protected ~niline 19 t~ afford structure ~0. The subsequent acylation reaction provides structure 61 which is treated with an a~plu~l;ate acid to give a mi~ture of B2 and ~3. The rçgioiRomers can be sc},ar-t;ed by chrnmAlo~;.cLl.hy as described in EXA~LEs 72 and 73 and carried on. The protecting groups then are ~ Jved by Lr~AI*~pnt with iodotrimethylsilane to give35 the desired col,,pù~ ds 64 and ~7, which can be used to prepare the de- ;v~Live c--...pu-~ c dPmonRt~ated in CHART A. Use of the 4-keto isomer of structure 59 provides an alternate route t,o the 4-isomer, structure 68. Alternatively, the hydroxy group of struct~ure ffl or its 4-isomer may be replaced by a fluoro atom using an appropriate agent such a8 diethyl~minoslllfur trifluoride in sn a~vpr;ate solvent such as methylene chloride. The elimin~t;on step shown for structure ffl is not 5 conducted in this qitn~tior~- This repl~remPnt reaction is further ~et9il~-~ in EXAMPLE 74.
The following co~uullds of Formula ( I ) for PY~mrl~p are prepared di~ lly by the methods of CHART A snd CHART J.
(S)-N-[[2-Oxo-3-[3-fluoro4-[ 1-[(acetoxy)acetyl]-3 ,4-dihydro-2H-pyridin-5-10 yl]phenyl]-5-0-~701i-1inyl]methyl]~cet~mi-lP
(S) (-~N-[[3-[4-[l~Hydlu.~y~cetyl)-3,4-dihydro-2H-pyridin-5-yl]-3-flUorophenyl]-2-OXO-5~Y~ inyl]methyn~r~t~ 9 (S) (-)-N-[[3-[4-[1-Formyl4-fluoro-4-piperidinyl]-3-fluorophenyl]-2-oso-5-~Y~7~ inyl]methyl]Ar~t~...i~e.
These cc.. -pc,u.lds are useful for tre~t~nPnt of _icrobial infPction~ in hllmslnQ
and other warm hloo~ Anim~lq, under both parenteral and oral ~imini~tration.
The pharmaceutical co-..~oY;I :~n~ of this invention may be prepared by comhining the cc"L.poullds of Formula ( I ) of this invention with a solid or liquid ~h~ rjPnti~lly acceptable carrier and, ~pti~-n~lly, with pharm~ellti~lly 20 ~cept-hlP adjuvants and ~Yripi~Pntq employing st~n-l~rd and convPnt;~ns~l techniques. Solid form cu poc;l ;onq include pOWl~ d, t~hlPtq, dispersible granules, c~rs~lPs~ cachets and ~u~O~Iil~r;eq. A solid carrier can be at least one snhst~n~e which may also filn~tion as a ~ilnPnt flavoring agent, solnhili~sr, lubricant, s--qpPntling agent, binder, tablet r~iqintsgrating agent, and encapsulating agent.
26 Inert solid C~;e115 in~ P m~gnPcillm carbonate, ms~gnPcillm stearate, talc, sugar, lactose, pectin, dextrin, starch, gelatin, cpllllloqic m~t~ri~l~, low mPl~ing wa~, cocoa butter, and the like. Li~luid form comroqiti~nq include soltlt;~nR~ s~lqpPnqion~ and Pmnl~iQnq For P~mple, t-h-ere may be provided solntion~ of the co poullds of this invention dissolved in water and water-propylene glycol and water-polyethylene 30 glycol r..~8, optionnlly c~ t~;~.ine s--itshLp conv~nt;onnl coloring ~gPntR, flavoring agents, Pt~hili7~rs and thiflrPning agents.
Preferably, the pharnn~cell~ 1 cc~--l~~~ on is provided employing conv.-~.t:on~l techniques in unit dosage form ccmt~ining e~e~Live or a~ l;ate amounts of the active c~ cl~pnt~ that i8, t-h-e ~ pou~d of Formula ( I ) acco~di,lg to 35 this invention.
The quantity of active cQmr~nent, t-h-at is the compound of Formula ( I ) -1~

CA 02228647 l998-02-03 according to this invention, in the phar~nAcel~ti~Al c.J~ o~;~;on and unit dosage form thereof may be varied or adjusted widely dep~n~ling upon the particular appli-~Ati~ n the potency of the particular compound, the desired concPntration. Generally, the - quantity of active compsnpnt will range between 0.5% to 90% by weight of the 5 composition.
~ In therapeutic use for treating, or combAttin~, bacterial infectionQ in warm-bloo~lPtl AnimAlA, the compound~ or pharmAre~ Al ~jo~ oC;l ;onR thereof ~vill beAtlmini~tered orally and/or parenterally at a dosage to obtain and mAint~tin a csncentration, that is, an amount, or blood-level of active co~po~ent in the ~nimal 10 undergoing treAt~nent which will be An~fl)A~t~riAlly e~,tivt. Generally, suchAntihArterially effective ~ms~nt of doAage of active c~ por~Pnt will be in the range of about 0.1 to about 100, more preferably about 3.0 to about B0 mE~kg of body weightlday. It is to be understood that the dosages may vary depending upon the ,uents of the p~;ent the s. ~eAl~ of the bacteAal infP~;on being treated, and lB the particular compou-ld being used. Also, it is to be unde~ood that the initial dosage ~miniPtered may be inc.~&~cd beyond the above upper level in order to rapidly achieve the desired blood-level or the initial dosage may be RmAllPr than the U~ nd the daily dosage may be pro~ DDively increased dunng the course of ..t ~lepen~ling on the particular Aihl~t;~n If desired, the daily dose may also 20 be divided into mtllffrle doseD for ~-lminiRtration, e.g., 2~ four times per day.
The compounds of Formula ( I ) accc"~ g to thi~ invention are ~tlminiRtered parenterally, i.e., by injection, for example, by intravenous injection or by other parenteral route~ of ~Amini~ration. Pharm~cP~lt;c~l co...l~oY;I-~nR for parenteral ~tlmini~ration w~ll generally cont~in a pha~ s-~ c~lly acceptable a~ou~l, of the25 cu--.l-u~ acco,dillg to Formula ( I ) or a soluble salt (acid s~ lition salt or base salt) dissolved in a pharms-r~vtic~lly acc~able liquid carrier such as, for PY~mrlP, water-for-injecti~ n and a buffer to provide a suitably buJr~,l~d iRot~nic solution, for P-~mple, having a pH of about 3.5-6. Suitable b~ g agents in~hl~P, for r~....rlc, tr~ linm orthorhosE!h~te, sollillm bicarbonate, sodium citrate, N-methyl~lllr~mine, 30 L(+~lysine and L(+)-argirune to nP~ne but a few ~ el~t~tive b~g agents.
l~he ~.~ ~ou~d according to Formula ( I ) generally will be dissolved in the carrier in an ~m~ nt s~ffirient to provide a pharm~reltt~ y acceptable injec~hle co)~c~..t-,.tion in the range of about 1 mg/mL to about 400 mg/mL of solllti~-n The re~nltinE~ liquid pharmaceutical c~....po ;~ n wtll be ~ mini~t~red Elo as to obtain the 35 above-mPntion~ ntih~rter~ y effective amount of dosage. The co- puu~ds of Formula ( I ) accordi~g to this invention are adv~nt~eously ~lmini~t~red orally in solid and liquid dosage forms.
~ ntimicrobial activity was tested in vivo using the Murine Assay p~ e.Groups of female mice (six mice of 18-20 grams each) were injected intr~pPrit~P~lly with bacteria which were thawed just prior to use and suspended in brain heart 5 infusion with 4% brewers yeast (StaphylQcocc~ aureu~) or brain heart infilRinn(Streptococc~R species). ~ntihinti~ tre~t~nPnt at six dose levels per drug was ~lmini~tered one hour and five hours after inf~Ct;on by either oral lnt~h~t;~n or sl~hc--t~neous routes. Survival was obs.,l ~,d daily for six days. ED50 values bssed on mortality ratios were c~ te~l using probit analysis. The subject co~ou~ds 10 are compared a~inRt well-known ~nffmi-~robials vanc~ and U-100592 as controls. See "Upjohn OY~7~ inonA ~ntih~t~ ial Agent", posters pr~s~ntecl at the35th Interscience Conference on ~ntimi-~robial Agents and ChAmntl Arapy. The data are shown in Table 1 and Table 2.

EXAMPLE No. ED50(m~kg) Vanco ,~ . ED50(m~kg) 3 5.00 3.00 4 >20.00 3.10 3.60 1.30 6 >20.00 5.00 20.00 2.00 11 >20.00 2.90 12 20.00 2.00 13 >10.00 1.50 16 17.00 3.60 19 6.80 1.80 21 >20.00 1.80 22 2.30 2.40 23 >20.00 1.60 CA 02228647 l998-02-03 W O 97/09328 PCTrUS96/12766 24 ~20.00 1.90 28 15.30 1.90 29 5.00 1.90 33 10.60 1.60 34 6.30 1.60 37 8.70 1.80 39 3.00 1.80 1.00 1.80 44 5.00 0.90 0 47 7.10 1.90 EXAMPLE No. ED5o(mg/lcg) U-100 .592 ED5o(mg~}g) 2.80 2.10 46 7.90 2.30 48 17.50 2.10 49 2.40 2.10 2,20 2.90 51 2.80 5.20 52 ~.00 2.30 53 ~20.00 2.30 54 6.60 2.gO
5~ 2.30 2.50 56 4.40 2.70 W O 97/09328 PCT~US96/12766 57 6.20 2.70 59 4.2 4.40 3.1 4.40 61 6.10 2.70 62 12.0 2.40 63 4.90 4.60 64 4.60 2.90 67 13.3 6.0 68(a) 3.50 3.50 69(a) 10.0 7.80 71 13.4 4.40 74 10.3 4.40 76 >20 3.50 78 6.0 3.20 83 7.50 4.10 84 6.50 4.10 In order to more fully illus~ate the nature of the invention and the m~nn~r of pr~rtiring the same, the following e~ nt~l ~oY~mpla~ are present~
20 ~XAMPLE 1 (.C~)-N-rr3-r3-Fluoro~-r1-(l~rboben7~yln~y)-(3-m~th,yl) 3 ~Pti~ yll_gh~r~yll_~_n~rn_5_n~ nli~ yllm-~t~,yll-s-r~t.~mi-l~
Step 1: F~yl 1-cyano-1-(4-r~itro-~-fluorouh~r~yl)propior s-t~
A flame-dried 3-neck 1-L round bottom flask equipped with a m~ n~tir spinbar and ~ it;nn funnel was charged with 6.40 g sodium hydride (0.160 mol, 60~o oil 25 dispersion) followed by washing with p~nt~n~ (3 x 40 mL) and drying under house vacuum. The hydride was sl~pen~ in 100 mL tetrah~d.oru~n, cooled to 0~C, and treated with a sollltir.n of ethyl cyAn- ~cetDt~ (8.6 mL, 0.080 mol) in 150 mL
THF over 15 minllts~ with gas evolution. The rQslllting milky solution of enolate was stirred five m-inutes then treated with a sollltinn of 3,4-difluoronitrobenzene (I) Sl,~ i 11 ~JTE SHEET (RULE 26) W O 97/09328 PCTrUS96/12766 (8.8 mL, 0.080 mol) in 150 ml THF with immP~;~t~ orange coloration. The cooling bath was removed and the reaction llli~Lu~ was warmed to 50~C for 18 hours. The now red suspension was cooled to room tempel~t ula and succes~ive:ly treated with ~ 100 g io-3OmPth~nP (0.72 mol), 33 g pot~Rcillm carbonate (0.24 mol), and 100 mL
5 53r~t~nP The visually nn(~h~n~ed soh-ti~)n was warrned to 6Q~C for an ~fltlitir~n~l 16 ~ hours. The now tan suspension was cooled to room t~pt laLu~e, filtered through a pad of CELITE, and the filtrate was con~ ated in vacuo. The re~--ltin~ residue wa~ diluted with 500 mL water and ~ ,cled twice with ethyl acetate (500 mT,).
The comhinP~l organics were washed once with brine (300 mT-), dried over MgSO4, filtered, and con~ ~ aLed to give 21.39 g of a brown oil. This crude m~teri~l was purified by LC on 850 g (230-400) silica gel eluting with 20% ethyl ~etDte/hPYnna~3 to afford 18.14 g (100%) of the title compound as a yellow oil that spont~neously crystslli~e-l mp 56.0-57.0~C; Rf 0.34 (20% ethyl ~cetstel.hPy~nR~q); IR (neat) 1752, 1534, 1423, 1355, 1248, 1239, 1213, 1099, 811, 741 cm~1; lH NMR (300 MHz, CDC13) o 8.16 (m, lH, aromatic), 8.03 (dd, lH, J=2.3 Hz, J=10.4 Hz, aromatic), 7.80 (dd, lH, J=7.6 Hz, J=8.6 Hz, aromatic), 4.33 (m, 2H, O-CH2), 2.04 (8, 3H, CH3), 1.28 (t, 3H, J=7.2 Hz, O-CH2-~3). HRMS Calcd for C12Hl1N2O4Fl + Hl:
267.0781. Found: 267.0799.
Step 2: T~ min-~mPt~rl-1-(4-~minn-~-fluoro~haTvl)pro~ nS~tA
A solllt;nn of ethyl l-cyano-1-(4-nitro-2-fluorophenyl)prorion~te (17.9 g, 67.3 mmol) in ~hsol~lt~ eth~nol (500 mT,) was treated with Raney-Nickel (30.9 g of a 50%
slurry in water) and Rubjected to l,ydlo~ t;on in a Parr apparatus for 17 hours (25-30 psi H2, room tempe~d~ ). The reaction llliXlU~, was then filtered throughCelite (repeated EtOH w~hin~) and conce..t~ ~ted in vacuo (heat gun, Hi-vac) to 25 give the t,itle col~pc,ul~d as a golLden syrup (15.6 g, 97%). This material could be purified by chrnm;~ 3phy on silica gel using 15% mPtll~nol/ethyl acetate but wastypically carried on to the next step without further p~ fic~ti~n Rf 0.32 (15%
MeOH/EtOAc); lH NMR (CDCl3) ~ 7.00 (t, J=8.5, lH, aromatic), 6.45 (dd, Jz8.2, 2.3, lH, aromatic), 6.36 (dd, J=13.1, 2.4, aromatic), 4.18 (q, J=7.0, 3H, -CH2~3), 30 3.76 (br 8, 2H, NH2), 3.06 (dd, J=18.2, 13.8, 2H, CH2N), 1.52 (8, 3H, CCH3), 1.21 (t, J=7.1, 2H, -~2CH3); IR (liquid) 1722, 1634, 1513, 1445, 1305, 1283, 1243, 1172, 1132, 845 cm~l; HRMS: Calcd (C12H17FlN2O2) 240.1274; Found 240.1293.
Step 3: 3-~pthyl-3-(4-~qmin~-2-fluoror~hp~l)-s~pt~ n~np A solllt;nn of ethyl l-~minnmPthyl-1~4-amino-2-fluorophenyl)propionate (2.1 35 g, 8.7 mmol) in T~ (60 mL) was added slowly via syringe to a cold (0~C) g011lt;~n of methyl m~EnP~illm bromide (15 mL of a 3 M sollltion in ether, 45 mmol, diluted SlJ~lS ~ JTE SHEET (RULE 26) with 100 mL THF). When ~ i*on was complPt~, the syringe was rinsed with ition~l THF (2 x 12 mL). The cooling bath was removed and the beige s~ ltion was allowed to stir at room tell.pelaLul~ for three hours, at which point it waspoured into sa~ulal,ed ~mmnninm chloride (aq, ca. 500 mL) and volatiles were 6 removed in vacuo. The rP~ ting aqueous phase was extracted three times with t-butyl methyl ether and the comhinP~l organics were washed once with water, once with brine, dried over MgSO4, filtered, and conce~..t ated to give 1.4 g of a yellow syrup. E"L,~ -Lion of the aqueous phase with ethyl acetate provided and s~lrlit;on 190 mg crude product. The crude products thus obtained were comhinP(l and chrnm~1O~.aphed on silica gel using 60% ethyl ~(~et~t.o/hexane to give the titlecc".,~uu~ld (1.0 g, 60~o) as a pale yellow solid, mp 125-127 ~C: Rf 0.21 (50%
EtOAc/hexane); lH NMR (CDCl3) ~ 7.46 (t, J=8.3, lH, aromatic), 6.43-6.35 (m, 2H,arnm~t;~), 5.77 (br s, lH, NH), 3.75 (hr s, 2H, NH2), 3.54 (dd, J=5.5, 2.4, lH, CH2), 3.45 (d, J=5.5, lH, CH2), 1.64 (s, 3H, CH3); IR (mull) 3439, 3342, 3236, 1738, 1635, 1516, 1441, 1210, 1146, 631 cm~1; Anal. calcd for C1oHl1F1N2O2; C, 61.84, H, 5.71, N, 14.43. Found: C, 62.13, H, 5.81, N, 14.36.
Step 4: 3-(4-.Aminn-2-fluoro~h~nvl)-3-m~lvl~7P~;tlinP
A flame-dried 3-neck 2-L round bottom flask e4ui~ed with mP~h~ni~
stirrer, reflux rnn~ncer, and ~ iff-)n funnel was charged with 300 mL
tetral~d~,ru~ and 350 mL lM lit~illm ~ minnmhydride (0.35 mol) followed by cooling to 0~C. This sollltion was treated with a sol~lt;~ n of 9.85 g 3-Methyl-3~4-amino-2-fluorophenyl)-2-~7eti-linnnP (0.051 mol) in 210 mL THF with gas evolution and a yellow coloration. The cooling bath was removed and the reaction was heated to reflux with the rapid formation of a white pre. ;pi i ~tP!. After 20 hours, the visually llnrh~nged reaction l~l~u~ was cooled to room tempelaLul~ and qllRn~hPdby the succe~iv~ ~d~ ;on of 13 mL water, 12 mL 5M so-lillm h~dlv~ide~ and 47 mL water. The r~lllting thick gelatinous suspension was diluted with one L ethyl~etst,e, filtered through a pad of CELlTE;, concPntrated, and high vacuum dried to afford 9.82 g of the title compound as a light orange syrup. lH NMR (300 MHz, CDCl3) ~ 6.78 (t, lH, J=8.5 Hz, aromatic), 6.37 (m, 2H, aromatic), 4.06 (d, 2E, J=8.2 Hz, N-CH2as), 3.81 (bs, 3H, NHs), 3.58 (d, 2H, J=8.2 Hz, N-CH2bs), 1.65 (s, 3H, CH3).
Step 5: N-C~rbob~n7~ylnyy-3-(N-r~rbob~n7,ylo~v-3-fluoro~nilin-4-vl)-3-mPt.~ty!sl7.~ti~in.s A 500 mL round bottom flask equipped with a m~nPt;~ spinh~r and ~lit;on funnel wag charged with 85 mL water, 38.4 g sodium bicarbonate (0.46 SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 mol) and a sollltir.n of 9.82 g 3-(4-amino-2-fluorophenyl)-3-methyl~7et~ np~ (0.051 mol theorv) in 165 mL ~retone The ra~l11t;ng orange suspension was cooled to 0~Cand treated with 43 mL benzylchlorvr,...~t~ (0.30 mol) with gas evolution and the ~ reaction turning a light yellow color. The cooling bath was removed and the 5 reaction l~ ule was stirred at room tem~eLa~u~e for 65 hours. TLC in~ ts~
~ in~omrlPte consumption of the ~tarting ~mino~nilin.s and an ~lflit;~ln~l 12.8 g sodium bicarbonate (0.15 mol) and 14 mL benzylchlolvro~ate (0.10 mol) was added with ~ liti~n~l gas evolution. After two hours, the reaction ll~i~ u~e was diluted with 350 mL sa~u.d~ed sodium bica-l,wlate and extracted three times with ethyl acetate (300 mL). The comhinPrl organics were washed once with water (200 mL), once with brine (200 mL), dried over MgSO4, filtered, and con~ ted to give 29.86 g of a light yellow oil. This crude m~t,Pri~l was purified by LC on 850 g (230-400) silica gel eluting with 25% ethyl ~rets~te~hPY~np~ to afford 11.67 g (51~o) of the title ~.~, pC.ul d as a light yellow solid. Rf 0.18 (25% ethyl ~et~t~lheY~nes); IR
(neat) 1735, 1707, 1693, 1600, 1534, 1455, 1424, 1414, 1221, 1081 cm~1; 1H NMR
(300 MHz, CDCl3) ~ 7.35 (m, 11H, aromatic), 6.96 (m, 3H, aromatic & NH), 5.19 (8, 2H, Ph-CH2), 5.09 (s, 2H, Ph-CH2), 4.30 (d, 2H, J=8.2 Hz, N-CH2as), 4.00 (d, 2H,J=8.4 Hz, N-CH2bs), 1.59 (8, 3H, CH3); 13C NMR (75 MHz, CDCl3) 160.4 (d, JCF=245 Hz), 156.6, 153.0, 138.1 (d, JCF=11 Hz), 136.5, 135.7, 128.6, 128.4, 128.2, 127.9, 127.8, 127.5, 127.0, 126.9, 113.9, 106.6 (d, JCF=27 Hz), 67.1, 66.6, 60.8, 60.2, 36.1, 28.2; Anal. Calcd for C26H25N2O4F1: C, 69.63; H, 5.62; N, 6.25. Found: C, 69.37; H, 5.69; N, 5.87.
Step 6: (R)~-)-N-C~.bob~..7,~ Yy-3-lnPt~,yl-3-r2-fluoro4-r5-}-V.~ lpth~yl-2-oxo-3-t~ 7~n~ 7harur~ 7~ati~lin~?
A 500 mL round bottom flask cont~ining 11.48 g N-carbobenzyloxy-3~N-ca~l,obel.zyloxy-3-fluoroanilin-4-yl-3-methyl~7eti~1ine (25.6 mmol) was e~ui~ed with a m~nPti~ spinbar, charged with 100 mL tetrahy-lioru.~ (freshly ~liC~illP~), andcooled to -78~C. This light yellow hu IO~ ~:llOU8 solllffon was treated with 16.6 mL
n-butyllit~illm (26.6 mmol) with a slight .1~ g in color. The ca~bs~ t-a ion wa~ stirred 30 minllt~ at this reduced te ~e~ followed by tre~t~nPnt with 3.8 mL R-glycidylbu~ylate (26.6 mmol) with no observable change. The cooling bath was removed and the reaction was warmed to room temperature for 16 hours. The now orange opaque solnt;on was diluted with 200 mL sal,ulated ~mml nillm rhlori~l~P and extracted twice with ethyl acetate (250 mL). The comhine-l organics were washed once with st~u,a~ed sodium bicarbonate (200 mL), once with brine (300 mL), dried over MgSO4, filtered, and con~ ated to give 15.72 g of the title SIIBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 c~ oulld as an orange oil. This crude m~teri~l was purified by LC on 530 g (230-400) silica gel eluting with 80% ethyl ~et~tP~hPY~n~s to afford 6.79 g (64%) of a light yellow amorphous solid. Rf 0.28 (80% ethyl ~ et~t,~P/hpy~npR); [a]D -35~(c0.8967, mpth~n~l); IR (neat) 1754, 1708, 1516, 1454, 1429, 1415, 1358, 1228, 1194, 5 1076 cm~l; 1H NMR (300 MHz, CDCl3) ~ 7.44 (dd, lH, J=2.2 Hz, J=13.0 Hz, aromatic), 7.33 (m, 5H, aromatic), 7.19 (dd, lH, J=2.2 Hz, J=8.5 Hz, aromatic), 7.03 (t, lH, J=8.7 Hz, aromatic), 5.09 (s, 2H, Ph-CH2), 4.73 (m, lH, mPt~in~), 4.30 (d, 2H, J=8.2 Hz, Ph-C-CH2as), 3.97 (m, 5H, Ph-C-CH2bs, Ph-N-CH2s, HO-CH2a), 3.73 (m, lH, HO-C~[2b), 2.80 (t, lH, J=6.3 Hz, HO), 1.60 (s, 3H, CH3); 13C NMR (75 10 MHz, CDCl3) 160.2 (d, JCF=246 Hz), 156.5, 154.2, 138.0 (d, JcF=ll Hz), 136.3,128.2, 128.1, 127.8, 127.7, 126.9 (d, JCF=7 Hz), 113.1 (d, JCF=3Hz)~ 106.2 (JCF=27 Hz), 72.6, 66.5, 62.4, 60.1, 46.0, 35.9, 28.0; Melt solvate = 3.8% ethyl ~-etot~; Anal.
Calcd for C22H23N2~5Fl plu8 3.8~ro ethyl ~etste: C, 63.41; H 5 73; N 6 50 Found: C, 63.15; H, 5.52; N, 6.58. HRMS Calcd for C22H23N2O5F1: 415.1169.
15 Found: 415.1674.
Step 7: tR)-(-)-N-C~rbobPn7vln~v-3-~nptllyl-3-r2-fluoro-4-r5-h~y~l"-~y~ tllvl-~--3-~Y~7~ ;srl~?hp~ll~7pti~lin~ mPth~na slllfilride ester A 600 mL round bottom flask c;o~ 6.55 g (R)-(-)-N-c&~l,obeL,zyloxy-3-methyl-3-[2-fluoro-4-[5-hyd~ sylllethyl-2-oxo-3-~y~7olitlinyl]phenyl]~7pt;~lin~ (15.3 20 mmol) was e~ui~ped with a m~n~t;r~ srinh~r~ charged with 150 mL
dichloromPth~nP~ and cooled to 0~C. This light yellow homogenous solllt;~-n was treated succe~iv,aly with 3.2 mL triethylamine (23.0 mmol) and 1.4 mT-mPth~nPslllf~nyl ~hlor~ s (18.4 mmol) with no observable change. The cooling bath was removed and the reaction ~ lu~ was warmed to room tempeL~,u~ for one 25 hour. The visually lln~h~n~ed solnt;~n was diluted with 100 mL 0.5 N hydlochloric acid, Rh~kPn, layers separated and the acidic layer extracted once with dichloromPth~n~ (100 mL). The ccmhinP~l organics were washed once with brine (75 mT-), dried over MgSO4, filtered, and co..~..l -dted to give 7.68 g (lOOYo) of the title c....pou~d as a light yellow amorphous solid. Rf 0.40 (80~ ethyl 30 ~et~t~hPY~nps); IR (mull) 1758, 1703, 1516, 1418, 1358, 1337, 1230, 1176, 1075, 965 cm~l; lH NMR (300 MHz, CDCl3) ~ 7.44 (dd, lH, J=2.2 Hz, J=12.8 Hz, aromatic), 7.33 (m, 5H, aromatic), 7.17 (dd, lH, J=2.2 Hz, J=8.5 Hz, aromatic), 7.06 (t, lH, J=8.5 Hz, aromatic), 5.10 (s, 2H, Ph-CH2), 4.92 (m, lH, mPthin~), 4.50 (dd, lH, J=3.6 Hz, J=11.7 Hz, MsO-CH2a), 4.42 (dd, lH, J=4.1 Hz, J=11.7 Hz, MsO-35 CH2b), 4.31 (d, 2H, J=8.1 Hz, Ph-C-CH2as), 4.13 (t, lH, J=9.2 Hz, Ph-N-CH2a), 4.00 (d, lH, J=8.5 Hz, Ph-C-CH2bs), 3.94 (dd, lH, J=6.2 Hz, J-9.2 Hz, Ph-N-CH2b), 3.10 SUBSTITUTE SHEET ~RULE 26) (s, 3H, S-CH3), 1.62 (8, 3H, C-CH3); 13C NMR (75 MHz, CDCl3) 160.3 (d, JCF=247 Hz), 156.5, 153.3, 137.6 (d, JCF=ll Hz), 136.4, 129.0, 128.8, 128.3, 127.9, 127.8, 127.3, 127.2 (d, JCF=6 Hz), 113.3 (d, JCF=3 Hz), 106.5 (d, JCF=28 Hz), 69.4, 67.8, - 66.6, 60.4, 46.2, 37.7, 36.1, 28.1; Ansl. Calcd for C23H~jN207FlSl: C, 56.09; H, 5 5.12; N, 5.69. Found: C, 55.76; H, 5.17; N, 5.61.
Step 8: (R)-(-)-N-C~rbob~n7~yln~-3-m~t~yl-3-r~-flllnro-4-r5-~minnm~thyl-2-nYn 3-n~ ~7nli~ he~ 7.~t,itlinR
Two oven-dried 100 m~ se~l~hle tubes e~ ped with m~f~nPtiC spinh~rs were equally charged with a solllt;~ n of 7.50 g (R)-(-)-N-carbobenzyloxy-3-methyl-3-[2-fluoro-4-[5-llydlu~ylllethyl-2-oxo-3-ny~7.olirlinyl]phenyl]~7~ ine mPthnnR
sulfuride ester (15.2 mmol) in 75 mL mF.t~nol and 75 mT- tetrahy.l.uru~- (freshly ;11R~1). Thege light yellow homogenous sollltion~ were satu~ated with ga~eou~
~mmnni~ over ten minnt~s becc~...;.~g almost colorless, sealed with teflon ~ ,aps, and heated to 100~C for 64 hours. The reaction l..;Y~ules were comhin~-l and 15 cnnt.~,t- ~ted to afford the title cv pc,u~d as a crude yellow foam.
Step 9: (~)-N-rr3-r3-Fluo~-4-r l-(r~1. I,ob~. . 7~ylnyy)-(3-m~ yl)-3-Pt7~fftlirurll-~h~ 11-2--~Y~-5-n~ 7nli~linvllm~th~ smi~l~
The title co~ uu.~d was prepared as follows: (R)~-)-N-c~bobe~zyloxy-3 methyl-3-[2-fluoro-4-[5-~rninnmf~thyl-2-oxo-3-nY~7oli-1inyl]phenyl]~7~ ine was 20 diluted with 220 mT- dichlornmf*hs~n~?~ cooled to 0~C, and 8llr~FF ;vely treated with 3.7 mL pyridine (46 mmol) and 1.8 mL acetic anhydride (19 mmol) with no ob~e..,~ble change. The cooling bath was removed and the reaction ~ was warmed to room t~eld~ for 16 hours. The visually lln~h~n~ed solllt;on was conc~..t-ated to a yellow foam, re~iln~ç-l with 50 mT dichloromPt~n~, and filtered 25 to remove the rPm~inin~ in~olllhle ~l~ci~ e. The filtrate was purified by LC on 340 g (230-400) silica gel eluting with 2.5% mPt~ s~nol/ethyl acetate to afford 5.85 g (84~o) of (s)-N-t[3-[3-fluoro4-[l-(calbobellzyloxy)-(3-methyl)-3-~t;~linyl]-phenyl]-2 oxo-5-cY~oli~inyl]methyl]-~-~e~mi~le a~ a colorless glass. Rf 0.24 (2.5%
mPtl~nol/ethyl acetate); [a]D -19~(c 0.9971, m.oth~nol); IR (mull) 1754, 1706, 1676, 30 1516, 1430, 1415, 1357, 1227, 1194, 1075 cm~l; lH NMR (300 MHz, CDC13) ~ 7.42(dd, lH, J=2.1 Hz, J=12.9 Hz, aromatic), 7.33 (m, 5H, aromatic), 7.13 (dd, lH, J=2.2 Hz, J=8.5 Hz, aromatic), 7.04 (t, lH, J=8.5 Hz, aromatic), 6.56 (bt, lH, J=6.2 Hz, NH), 5.10 (8, 2H, Ph-CH2), 4.79 (m, lH, mPtllinP), 4.30 (d, 2H, J=8.2 Hz, Ph-C-CH2a8), 4.01 (m, 3H, Ph-C-CH2b8, Ph-N-CH2a), 3.78 (dd, lH, J=6.7 Hz, J=9.1 Hz, 35 Ph-N-CH2b), 3.64 (m, 2H, NH-C_28 ), 2.02 (s, 3H, O=C-CH3), 1.60, (8, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDCl3) 171.2, 160.3 (d, JCF=246 Hz), 156.6, 154.2, 137.9 a~nnnE*~Er~ULE2B) (d, JCF=11 Hz), 136.5, 128.9 (d, JCF=14 Hz), 128.4, 127.9, 127.2 (d, JCF=7 Hz), 113.2 (d, JCF=2 Hz), 106.4 (d, JCF=28 Hz), 72.0, 66.6, 60.7, 60.3, 47.3, 41.7, 36.1, 28.1, 22.9; Anal. Calcd for C24H26N3O5F1: C, 63.29; H, 5.75; N, 9.23. Found: C, 62.98; H, 5.96; N, 8.98.

~!~AMPLE 2 (~-N-rr3-r3-Fluoro-4-r3-mPt~yl-3-~7Ptif~ yll ~hQr~yll ~ o~ 5 oY~7nli~ ,yl1mPt~,yll-~rPts~mi~la A 500 mL Parr flask was charged with a ~olllt;~n of 5.83 g (S)-N-[[3-[3-fluoro-4-[l-(carbobenzyloxy)-(3-methyl)-3-~7eti~1inyl]-phenyl]-2-oxo-5-10 oY~7t)1i~1inyl]methyl] n~et.~...i~le (12.8 mmol) in 100 mT- mPth~nol and 1.17 g 10%
ps~ m on carbon. The black suspension was placed under 40 psi hy~llvg~ll with ~hs~kinf~ for four hours with the pla~ rem~inin~ con~t~nt at 28 psi. The Parr was removed from the Lydlv~ ator, the reaction l~L~U~e was filtered through a pad of CELITE, and con-~e~ 2,ted to afford 4.05 g (99~o) of an off-white amorphous 15 solid. A 1.00 g portion of this material was purified by LC on 100 g (230~00) silica gel eluting with 2: 17: 83 NH40H/m~l ~nol/dichloromPtl~n~ to afford 776 mg of the title compound as a colorless glass. Rf 0.26 (2: 17: 83 NH40H/mPt~ ~nol/dichloromPth~n~); [a~]D -23~(c 0.9015, mP~ nol); IR (mull) 1752,1662, 1630, 1554, 1515, 1483, 1435, 1412, 1227, 1194 cm~l; lH NMR (300 MHz, 20 CDCl3) ~ 7.37 (dd, lH, J=2.2 Hz, J=12.8 Hz, aromatic), 7.12 (dd, lH, J=2.2 Hz, J=8.6 Hz, aromatic), 6.99 (t, lH, J=8.6 Hz, aromatic), 6.33 (bt, lH, J=6 Hz, O=C-NH), 4.78 (m, lH, mPthinP), 4.04 (m, 3H, Ph-C-CH2as, Ph-N-CH2a), 3.78 (dd, lH, J=6.8 Hz, J=9.1 Hz, Ph-N-CH2b), 3.66 (m, 2H, NH-C~2s), 3.56 (d, 2H, J=7.8 Hz, Ph-C-CH2bs), 2.40 (bs, lH, NH), 2.02 (s, 3H, O=C-CH3), 1.67 (s, 3H, Ph-C-CH3);
25 13C NMR (75 MHz, CDCl3) 171.2, 160.0 (d, JCF=246 Hz), 154.2, 137.3 (d, JCF=11Hz), 130.8 (d, JCF=15 Hz), 126.9 (d, JCF=7 Hz), 113.2, 106.3 (d, JCF=27 Hz), 71.9, 58.0, 47.3, 41.7, 40.5, 27.3, 22.9; KF. Water = 0.89%; Anal. Calcd for C16H20N3O3F1 with 0.89% wat,er: C, 59.27; H, 6.32; N, 12.96. Found: C, 59.07;
H, 6.45; N, 12.89. HRMS Calcd for Cl6H20N3031 Hl: 322.1567. Fou~d:
30 322.1569.

F'~AMPLE 3 (S)-N-rr3-r3-Fluoro-4-r1-(-~rbo~ymathyl)-3-(3-mat~yl)-f~7Pt;~ yll-~har~yl~ ro-5-o~ 7.~ yllml~th~yll-~pt~slmi~la An oven-dried 25 mL round bottom flask equipped with m~gnPtic spinhSIr 35 was charged with 241 mg (S)-N-[[3-[3-fluoro-4-t3-methyl-3-~7eti-1inyl]-phenyl]-2-oxo-5 oY~7oli~1inyl]methyl]-~cet~miclQ (0.75 mmol), 8 mL dichloromPth~nP, and cooled to SU~;~ JTE SHEET (RULE 26) W O 97/09328 PCTrUS96/12766 0~C. The colorless but slightly opaque sollltion was treated with 0.16 mT.
triethylamine (1.1 mmol) and 70 ~L methylchlolofol~ate (0.90 mmol) with the reaction ~ becc ...;..g clear. The cooling bath was removed and the reaction e was warmed to room temperature over two hours. The visually llnrh~nge~
5 snlllt;on was diluted with 30 mL dichloromPthAnç, washed once with water (20 mL), ~ once with brine (15 mL), dried over MgSO4, filtered, and conr~.. l ated to give 267 mg of a white foam. This crude m~t4rlAl was purified by LC on 18 g (230-400) silica gel eluting with 5% mPth~nol/dichloromPth~nP to afford 219 mg (77~o) of the title C~ u~d as a white foam. Rf 0.30 (5% mPth~n- Vdichlor~m~t~n~); ta]D -21~(c 1.0194, mPth~nol); IR (mull) 1755, 1706, 1676, 1631, 1517, 1394, 1227, 1208, 1195, 1076 cm~l; lH NMR (300 MHz, CDCl3) ~ 7.43 (dd, lH, J=2.2 Hz, J=12.9 Hz, aromatic), 7.14 (dd, lH, J=2.2 Hz, J=8.5 Hz, aromatic), 7.05 (t, lH, J=8.6 Hz, aromatic), 6.35 (bt, lH, J=6 Hz, NH), 4.80 (m, lH, m~thin~), 4.28 (d, 2H, J=8.2 Hz, CO2-N-CH2as), 4.04 (t, lH, J=9.0 Hz, Ph-N-CH2a), 3.97 (d, 2H, J=8.4 Hz, CO2-N-CH2bs), 3.77 (dd, lH, J=6.7 Hz, J=9.1 Hz, Ph-N-CH2b), 3.68 (m, 5H, NH-CH2s, OCH3), 2.03 (8, 3H, O=C-CH3), 1.61 (s, 3H, Ph-C-CH3); 13C N~ (75 MHz, CDCl3) 170.9, 160.2 (d, JCF=246 Hz), 157.1, 154.0, 137.8 (d, JCF=11 Hz), 128.5 (d, JCF=l5 Hz), 127.0 (d, JCF=7 Hz), 113.1 (d, JCF=3 Hz), 106.3 (d, JCF=27 Hz), 71.8, 60.4,52.1, 47.2, 41.7, 35.9, 28.0, 22.9; KF. Water = 1.19%; Anal. Calcd for Cl8H22N3O5F1 plus 1.19%water: C, 56.31; H, 5.91; N, 10.94. Found: C, 56.27; H, 5.93; N, 10.93.

EXAMPLE 4 (0-N-rr3-r3-Fl~ ro~-rl-(m~th~ rP~yl)-3-(3-mpthyl) sl7Pti~i~vll-ghp~ vll-~ yn-5-~y~7o~ vllmpt~yll-acets~mill~
An oven-dried 25 mL round bottom flask e~ ed with m~enetic spinbar was charged with 241 mg (s)-N-[[3-[3-fluoro-4-[3-methyl-3-~7et~ nyl]-phenyl]-2-oxo-5 t~y~7~ inyl]methyl] s~ret~ (0.75 mmol)~ 8 mT~dichlorom~t~nf~ and cooled to 0~C. The colorless but slightly opaque sol~lti~n was treated with 0.16 mL
triethylamine (1.1 mmol) and 85 ~L mPth..,cy~ce:l~yl~hlori~le (0.90 mmol) with a30 smokey/haze developing. The cooling bath was removed and the reaction ~Lu~
was warmed to room temperatue over two hours. The now clear colorless solllti~n was diluted with 25 mL dichlorompth~np~ washed once with water (15 mL), once with brine (15 mT.), dried over MgSO4, filtered, and conrent~ ated to give 294 mg of a white foam. This crude material was purified by LC on 27 g (230-400) silica gel 35 eluting with 7~~0 meth~nol/dichlorompthslnp to afford 240 mg (81~o) the titlecompound as a white amorphous solid. Rf 0.23 (7% mPth~nl l/dichloromPth~nP);

CA 02228647 l998-02-03 [a]D -20~(c 0.9736, mP+hAnol); IR (mull) 1754, 1662, 1654, 1632, 1517, 1437, 1412, 1226, 1194, 1122 cm~l; lH NMR (300 MHz, CDCl3) â 7.45 (dd, lH, J=2.1 Hz, J=13.0 Hz, aromatic), 7.15 (dd, lH, J=2.1 Hz, J=8.6 Hz, aromatic), 7.07 (t, lH, J=8.5 Hz, aromatic), 6.47 (bt, lH, J=6 Hz, NH), 4.80 ~m, lH, mPthine)~ 4.51 (d, lH, 5 J=9.0 Hz, Ph-C-CH2a), 4.35 (d, lH, J=9.7 Hz, Ph-C-CH2b), 4.25 (d, lH, J=9.2 H_, Ph-C-CH2a), 4.05 (m, 4H, O=C-CH2s, Ph-C-CH2b, Ph-N-CH2a), 3.66 (m, lH, Ph-N-CH2b), 3.66 (m, 2H, NH-CH2s), 2.03 (s, 3H, O=C-CH3), 1.63 (s, 3H, Ph-C-CH3); 13CNMR (75 MHz, CDCl3) 171.2, 169.7, 160.4 (d, JCF=246 Hz), 154.2, 138.2 (d, JCF=11Hz), 128.4 (d, JCF=l4 Hz), 127.3 (d, JCF=6 Hz), 113.4, 106.6 (d, JCF=28 Hz), 72.1, 10 71.5, 62.4, 59.5, 59.2, 47.5, 41.9, 36.9, 28.3, 23.1; KF. Water = 2.03%; Anal. Calcd for C1gH24N3O5F1 plus 2.03% water: C, 56.83; H, 6.25; N, 10.47. Found: C, 56.99; H, 6.34; N, 10.49. HRMS Calcd for C1gH24N3O5F1: 394.1778. Found:
394.1784.

15 T~XAMPLE 5 (~)-N-rr3-r3-Fluoro-4-r1-(for-m~yl)-3-(3-mpt~ 7pt ~hPr~
~_n~rn 5 ~Ys~7~n~ invllmpt~urll-acet~mitla An oven-dried 25 mL round bottom flask e.~ ped with mA~neti~ spinbar was charged with 241 mg (S)-N-[[3-[3-Fluoro-4-[3-methyl-3-A7Pt;~inyl]-phenyl]-2-20 oxo-5-oYA7n~ inyl]methyl]-A~et~mi-lP (0.75 mmol), 8 mL dichloromPtl~Anp~) andcooled to 0~C. The colorless but slightly opaque sollltion was treated with 0.16 mT.
triethylamine (1.1 mmol) and 73 ~L ethyl formate (0.90 mlnol) with no observablechange. The cooling bath was removed and the reaction ~ uLa was warmed to room tempeldtula for 16 hours. TLC analysis of the now clear sollltion inr~
25 in~omrlet~ consllmption of (S)-N-[[3-[3-Fluoro-4-[3-methyl-3-A~eff~inyl]-phenyl]-2-oxo-6-nY~olirlinyl]methyl]-A-et~mi-le. The reaction lllil~lUl~ was treated with an A~it;onAl 0.14 mT, ethyl formate (1.8 mmol) and 8.0 mL lN so-lillm h~dl~ulLide with vigorous stirring for five minll+~s The reaction was diluted with 10 mL water and extracted twice with dichlorom~t~ Ane (25 mL). The cnmhinPcl organics were 30 washed once with water (20 mT-), once with brine (20 mL), dried over MgSO4, filtered, and conc~ . dted to give 253 mg of a white foam. This crude mAt,Pri~l was purified by LC on 18 g (230-400) silica gel eluting with 6%
mPt~ nnl/dichlorompth~ne to afford 145 mg (55~o) the title compound as a white amorphous solid. Rf 0.25 (7% mPt~Annl/dichlorompt~lAnp); [a]D -20~(c 0.9949, 35 mPthflnnl); IR (mull) 1754, 1666, 1631, 1548, 1516, 1478, 1433, 1414, 1227, 1195 cm~l; lH NMR (300 MHz, CDCl3) â 8.06 (s, lH, CHO), 7.47 (dd, lH, J=2.0 Hz, SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 J=13.0 Hz, aromatic), 7.16 (dd, lH,J=2.2 Hz,J=8.5 Hz, aromatic), 7.07 (t, lH, J=8.6 Hz, aromatic), 6.33 (bt, lH,J=6 Hz, NH), 4.80 (m, lH, mPthinP), 4.42(d, lH, J=8.2 Hz, Ph-C-CH2a), 4.30 (d, lH,J=9.9 Hz, Ph-C-CH2b), 4.16 (d, lH,J=8.3 Hz, Ph-C-CH2a), 4.05 (m, 2H, Ph-C-CH2b, Ph-N-CH2a), 3.79 (dd, lH, J=6.8 Hz,J=9.1 5 Hz, Ph-N-CH2b), 3.67 (m, 2H, NH-CE2~), 2.03 (s, 3H, O=C-CH3), 1.64 (8, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDC13) 171.1, 162.3, 160.3 (d, JCF=246 Hz), 164.1, 138.2 (d, JCF=11 Hz), 127.9 (d, JCF=14 Hz), 127.1(d, JCF=6 Hz), 113.3, 106.4 (d,JCF=27Hz), 71.9, 59.6, 58.2, 47.3, 41.7, 37.6, 28.0, 23.0; HRMS Calcd for C17H20N304F1:
349.1438. Found: 349.1444.
F'XAMPLE 6 (O-N-rr3-r3-Fluoro-4-rl-(~i~hl~ s~Ptyl~ 3-(3 mPt~yl) ,s.~Pti~inyll-~?hpr~yll-2-r~yn-5-oys~7.~ yllmpt~lvll-~pt-9~mi~p An oven-dried 25 mT- round bottom flask e~lui~ed with msFnPtiC spinbar was charged with 241 mg (S)-N-[[3-[3-Fluoro-4-[3-methyl-3-s7Pt~ nyu-phenyl]-2 15 oxo-5-oY-s.7o~ inyl]methyl]-s~etsmi~(0.75 m_ol), 8 mL dichloromPt~ sn~, and cooled to 0~C. The colorless but slightly opaque sollltion was treated with 0.16 mL
triethylamine (1.1 mmol) and 87 llL dichloroacetyl chloride (0.90 mmol) with a smokey/haze developing. The cooling bath was removed and the reaction ~Lul~:
was warmed to room temperature over three hours. The now clear colorless 20 solllti~n was diluted with 15 mL water and extracted twice with dichlor m~th~nP
(25 mL). The comhinP-l organic~ were washed once with brine (15 mL), dried over MgS04, filtered, and con-~ntrated to give 363 mg of a tan foam. This crude ms~t~ l was purified by LC on 25 g (230-400) silica gel eluting with 5%
mPt~s~nol/dichlorompthz~n~ to af~ord 243 mg (75%) the title compound as an off-25 white amorphous solid. Rf 0.26 (5~O mPt~l~nol/dichloromPth~ne);[a]D -18~(c 0.9862, mPth~n~l); IR (mull) 1752, 1666, 1631, 1545, 1517, 1440, 1412, 1288, 1227, 1193 cm 1; lH NMR (300 MHz, CDC13) ~ 7.48 (dd, lH, J=2.1 Hz, J=13.0 Hz, aromatic), 7.18 (dd, lH,J=2.2 Hz,J=8.6 Hz, aromatic), 7.08 (t, lH, J=8.6 Hz, aromatic), 6.52 (bt, lH, J=6.1 Hz, NH), 4.81(mS lH, mPtllin~), 4.70 (d, lH, J=8.9 Hz, Ph-C-CH2a), 30 4.48 (d, lH, J=9.1 Hz, Ph-C-CH2b), 4.41 (d, lH, J=10.1 Hz, Ph-C-CH2a), 4.13 (d, lH, J=10.0 Hz, Ph-C-CH2b), 4.06 (t, lH, J= 9.0 Hz, Ph-N-CH2a), 3. 79 (dd, lH, J 6.7 Hz,J=9.1 Hz, Ph-N-CH2b), 3.67 (m, 2H, NH-C~2s), 2.03 (s, 3H, 0=C-CH3), 1.67 (s, 3H, Ph-C-CH3); 13C NMR (76 MHz, CDC13) 171.3, 163.1, 160.3 (d, JCF=246 Hz), 154.2, 138.4 (d, JCF=11 Hz), 127.6 (d,JCF=15 Hz), 127.1 (d, JCF=6 Hz), 113.4, 36 106.6 (d, JCF=27 Hz), 72.1, 64.6, 63.1, 60.3, 47.4, 41.8, 36.9, 28.2, 23.0; KF. Water ~ al- Calcd for C18H20N3~4FlC12 plu~ 1.3% water: C, 49.36; H 4 76; N

Sl ~ rlE SHEET(RULE2~;~

W O 97/09328 PCT~US96/12766 9.60. Found: C, 48.97; H, 4.80; N, 9.53. HRMS Calcd for C18H20N304FlC12:
432.0893. Found: 432.0900.

EXAMPLE 7 (~ N-rr3-r3-Fluoro~-rl-(3-mPt~ yv~ ior~yl)-3-(3--mpth~yl) 5 A7~ti~ yl~ hPr~yll-2-o~ -5 nYzl7nli~inyllmPth~yll-acet~mi~lP
An oven-dried 10 mL round bottom flask equipped with mAEnPti~'- spinbar was charged with 241 mg (S)-N-[[3-[3-fluoro-4-[3-methyl-3-A7etirlinyl]-phenyl]-2-oxo-5 oyn7~ inyl]methyl]-~setsmi~p (0.75 mmol), 4 mL dichlorompt~np~ 81 llL 3-m~thoxy~io~ionic acid (0.83 mmol), 0.13 mL of ~ictille~l diethylcyanophosph<-nAte 10 (0.83 mmol) and cooled to 0~C. The colorl~R soll~tion was treated with 0.11 mL
triethylamine (0.78 mmol) beco~ a rinki~h color. The cooling bath was removed and the reaction ~ Lula was warmed to room tempe.r ~ over 66 hours. The now reddish brown sollltion was diluted with 20 mL dichloromPt~An~ and washed once with water (15 mL), once with brine (15 mL), dried over MgSO4, filtered, and 15 con~ dt~d to give 297 mg of a red foam. This crude mAt~riAl was purified by LC
on 18 g (230-400) silica gel eluting with 7% mPtllAnol/dichlorompth~ne to afford 216 mg of an off-white amorphous solid. lH NMR in~licA~e~ this m~t~ri~l to be cont~minAt~-l with 10% (S)-N-[[3-[3-fluoro-4-[1-(formyl)-3-(3-methyl)-~7~ot;~1inyl]-phenyl]-2-oxo-5-oY~7~ inyl]methyl]-~cl tsmi~p which was removed by catalytic 20 hydrogenolysis with 22 mg 10% pAllAtlillm on carbon in 30 mL tetrahy.liorur ln cont~inin~ 10 drops conr~ d hyd~.)cl~loric acid. The re~llltin~ crude mAt~ri~l was rechromAtographed on 13 g (230400) silica gel eluting with 7~o m.ot~nol/dichlorompt~Anp to afford 135 mg (44% overall) the title compound as anoff-white amorphous solid. Rf 0.23 (7% mpthAnol/dichlorom~t~Anp); [a]D -19~(c 25 0.8324, met~nol); IR (mull) 1755, 1644, 1630, 1548, 1516, 1440, 1410, 1226, 1192, 1115 cm~l; lH NMR (300 MHz, CDC13) ~ 7.45 (dd, lH, J=2.0 Hz, J=12.9Hz, aromatic), 7.15 (dd, lH, J=2.2 Hz, J=8.5 Hz, aromatic), 7.07 (t, lH, J=8.5 Hz, aromatic), 6.29 (bt, lH, J=6 Hz, NH), 4.80 (m, lH, m~ in~), 4.42 (d, lH, J=8.0, Ph-C-CH2a), 4.30 (d, lH, J=9.6 Hz, Ph-C-CH2b), 4.15 (d, lH, J=8.2 Hz, Ph-C-CH2a), 30 4.04 (m, 2H, Ph-C-CH2b, Ph-N-CH2a), 3.79 (dd, lH, J=6.7 Hz, J=9.1 Hz, Ph-N-CH2b), 3.67 (m, 4H, NH-C~2s, O-CH2s), 3.34 (s, 3H, OCH3), 2.36 (qrt, 2H, J=6.2 Hz, O-(CH2)-C~2s), 2.03 (s, 3H, O=C-CH3), 1.61 (s, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDCl3) 171.5, 171.1, 162.5 (d, JCF=246 Hz), 154.2, 138.1 (d, JcF=ll Hz), 128.5 (d, JCF=15 Hz), 127.3 (d, JCF=6 Hz), 113.4, 106.5 (d, JCF=28 Hz), 72.0, 68.4, 35 61.6, 58.9, 47.5, 41.9, 35.6, 32.2, 28.6, 23.1; HRMS Calcd for C20H26N305Fl:
407.1856. Found: 407.1855.

~;13t5~ 3TE SHEEr (RULf~2B) F'XAl\rPLE 8 (S)-N-rr3-r3-Fluoro4-rl-(3-~ v~ >inr~vl)-3-(3-lnp+l~vl)-~7~eti~ir~yll-ph~r~yll-2-nyn-5-nys~7nli~iinvllm~+.~yll-acets~mitlf~
A 10 mL recvv~l y flask equipped with m~Ene+ic stirrer was charged with 241 mg (s)-N-[t3-[3-fluoro4-[3-methyl-3-~7e+;~linyl]-phenyl]-2-oxo-5-oY~7nlitlinyl]methyl]-~et~mill~ (0.75 mmol) and 1.5 mL water then cooled to 0~C.The colc-rlQss but slightly opaque solll+inn was treated with 52 rUL ~-propiol~ctor e (0.75 mmol) with no observable change. The cooling bath was removed and the reaction ~ixLul~ was warmed to room te~ laLule for two hours. The visually lln~h~nEed reaction ~ ule was diluted with 10 mL brine and extracted twice with dichlorom~+h~ne (20 mL). The comhin~ organics were dried over MgSO4, filtered, and cQn~ ated to give 232 mg of an o~-white foam. This crude mntQri~l was purified by LC on 17 g (230-400) silica gel eluting with 7%
mP~hs~nnl/dichlorom~+h~ne to afford 178 mg (60~o) the title cou~uu~d as a white amorphous solid. Rf 0.30 (10% m~tl~nnl/dichloromPt~l~nP); [a]D -19~(c 0.9248, mPth~nnl); IR (mull) 3288, 1754, 1630, 1554, 1517, 1436, 1412, 1289, 1227, 1193 cm~1; lH NMR (300 MHz, CDCl3) o 7.46 (dd, lH, J=2.1 Hz, J=13.0 Hz, aromatic), 7.14 (dd, lH, J=2.2 Hz, J=8.5 Hz, aromatic), 7.07 (t, lH, J=8.6 Hz, aromatic), 6.55 (bt, lH, J=6 Hz, NH), 4.81 (m, lH, mQ~inQ), 4.41 (d, lH, J=8.3, Ph-C-CH2a), 4.32(d, lH, J=9.6 Hz, Ph-C-CH2b), 4.12 (d, lH, J=8.4 Hz, Ph-C-CH2a), 4.05 (m, 2H, Ph-C-CH2b, Ph-N-CH2a), 3.88 (bs, 2H, HO-CH2s), 3.80 (dd, lH, J=6.8 Hz, J=9.1 Hz, Ph-N-CH2b), 3.67 (m, 2H, NH-C~2s), 3.46 (bs, lH, HO), 2.37 (qrt, 2H, J=5.6 Hz, HO-(CH2)-C~2s), 2.03 (s, 3H, O=C-CH3), 1.63 (s, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDCl3) 172.8, 171.2, 160.3 (d, JCF=246 Hz), 154.1, 138.1 (d, JcF=ll Hz), 128.0 (d, JCF=14 Hz), 127.1 (d, JCF=6 Hz), 113.3, 106.5 (d, JCF=27 Hz), 72.0, 61.4, 58.8, 58.3, 47.3, 41.8, 35.7, 32.9, 28.2, 23.0; HR~IS Calcd for C19H24N305Fl:
394.1778. Found: 394.1788.

F~AMPLE 9 (0-N-rr3-r3-Fluoro-4-rl-(4-oxo~qnt~n~?,yl)-3-(3-lnPt~yl) s~7.P+;t~ henyll-2-t~yn-5-nys~7n~ yllmpt~ ce~s~mi(~
An oven-dried 10 mL round bottom flask equipped with mz3Enpti~spinh~r was charged with 241 mg (s)-N-[[3-[3-fluoro-4-[3-methyl-3-~7~tiflinyl]-phenyl]-2s-oysl7olitlinyl]methy~ cetqmicle (0.75 mmol), 4 mL dichloromQth~ne, 100 llL
levulinic acid (0.98 mmol), 216 mg EDC-HCL (1.13 mmol), 18 mg dimethylamino pyridine (0.15 mmol) and cooled to 0~C. The colorless sol~lt;nn was treated with0.31 _L triethylamine (2.25 mmol) becominE~ a pale yellow color. The cooling bath was removed and the reaction mixture was warmed to room tempela~ule over 16 SUBSTITUTE SHEET (RULE 26) hours. The visually lln~h~nged sollltion was diluted with 20 mL water and extracted twice with dichloromPt~ne (25 mL). The comhinp~ organics were washed once with sa~uidted sodium bicarbonate (20 mL), brine (15 mT ), dried over MgSO4, filtered, and concpnt~ ated to give 332 mg of a light yellow syrup. This 5 crude m~t~riAl was purified by LC on 20 g (230-400) silica gel eluting with 5%mPthAnnl/dichlorompthAnp to afford 256 mg of an off-white amorphous solid. lH
NMR intlicAt~s this m~to,riAl to be cQnt~min~te~ with 8% (S)-N-[[3-[3-fluoro~-[1-(formyl)-3-(3-methyl)-A7e~ inyl]-phenyl]-2-oxo-5-nY~7Qli~inyl]methyl]-~et~mi~le which was removed by catalytic hydro~ olysis with 26 mg 10% p~llAflinm on 10 carbon in 30 mL tetrahyllrorul~ln cv--19;--;-'g ten drops c- n~ l ated hy.l~o~hloric acid. The rP.slllting crude material was rechrom~tographed on 15 g (230-400) silica gel eluting with 5% mA~h~nnl/dichlorompth~np~ to afford 116 mg (37% overall) thetitle compound as a white amorphous solid. Rf 0.16 (5%
m~th~nn]/dichlorompthslnp); [a]D -19~(c 0.9205, mpthAnnl); IR (mull) 1754, 1716,15 1631, 1548, 1517, 1440, 1411, 1227, 1193, 1166 cm~l; lH N~ (300 MHz, CDC13) 7.46 (dd, lH, J=2.1 Hz, J=13.0 Hz, aromatic), 7.15 (dd, lH, J=2.2 Hz, J=8.5 Hz, aromatic), 7.07 (t, lH, J=8.5 Hz, aromatic), 6.32 (bt, lH, J=6 Hz, NH), 4.80 (m, lH, mPt~inP), 4.46 (d, lH, J=8.1, Ph-C-CH2a), 4.27 (d, lH, J=9.4 Hz, Ph-C-CH2b), 4.19 8.3 Hz, Ph-C-CH2a), 4.01 (m, 2H, Ph-C-CH2b, Ph-N-CH2a), 3.79 (dd lH
20 J=6.8 Hz, J=9.1 Hz, Ph-N-CH2b), 3.68 (m, 2H, NH-C~;2s), 2.80 (t, 2H, J=6.5 Hz, CH3CO-C~2s), 2.35 (m, 2H, N-CO-CH2), 2.19 (s, 3H, (CH2)-CO-C~3), 2.03 (s, 3H, NCO-CH3), 1.63 (8, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDC13) 207.3, 172.0, 170.9, 160.5 (d, JCF=246 Hz), 153.9, 137.8 (d, JcF=ll Hz), 128.2 (d, JCF=l4 Hz), 127.0 (d, JCF=6 Hz), 113.1, 106.2 (d, JCF=28 Hz), 71.7, 61.3, 58.6, 47.1, 41.6, 37.6, 35.5, 29.7, 26 28.0, 24.6, 22.8; KF. Water = 1.67%. Anal. Calcd for C21H26N3O5F1 plus 1.67%
water: C, 59.13; H, 6.33; N, 9.85. Found: C, 59.04; H, 6.38; N, 9.80. HR~IS Calcd for C21H26N3~5F1: 419.1856. Found: 419.1854.

F'XAMPLE 10 (S)-N-rr3-r3-Fluoro-4-rl-acetvl-3-(3-mPt~ t~ yll-phPTur 2-mrn-5~-r~7- 1irlir~y11mPth,yll ~Ptslmi(lP
An oven-dried 25 mL round bottom flask equipped with ms~ tic gpinhs~r was charged with 75 mg (s)-N-[[3-[3-fluoro-4-[3-met-h-yl-3-~etitlinyl]-phenyl]-2-oxo-5 ~Y~7oli~linyl]methyn-~et~mitle (0.23 mmol), 5 mL dichlorompth~ne~ and cooled to 0~C. The colorless but slightly opaque solution was treated with 49 llL
35 triethylamine (0.35 mmol) and 20 llL acetyl chloride (0.28 mmol) becoming a light yellow color. The cooling bath was removed and the reaction mixture was warmed SUBSTITUTE SHEET (RULE 26) to room tempel dl ule over three hours. The now clear yellow s~ tion was dilutedwith 10 mL wster and extracted twice with dichlorompth~ne (20 mL). The comhinPfl organics were washed once with brine (15 mL), dried over MgSO4, ~ filtered, and cnnc~ t~d to give 96 mg of an off-white foam. This crude material 5 was combined with 28900-RLH-017 and purified by LC on 10 g (230-400) silica gel ~ eluting with 7% mPt~ ~nol/dichloromPth~nQ to afford 143 mg the title compound as a white amorphous solid. Rf 0.24 (7% mP~h~nnl/dichlor~mpth~na-); [a]D -21~(c 0.9238, methAnol); IR (mull) 1754, 1646, 1631, 1562, 1517, 1435, 1413, 1288, 1227, 1193 cm~l; lH NMR (300 MHz, CDCl3) ~ 7.46 (dd, lH, J=2.1 Hz, J=13.1 Hz, 10 aromatic), 7.14 (dd, lH, J=2.2 Hz, J=8.6 Hz, aromatic), 7.07 (t, lH, J=8.6 Hz, aromatic), 6.40 (bt, lH, J=6 Hz, NH), 4.80 (m, lH, m~in~9), 4.39 (d, lH, J=7.9 Hz, Ph-C-CH2a), 4.30 (d, lH, J-9.5 Hz, Ph-C-CH2b), 4.11 (d, lH, J=8.2 Hz, Ph-C-CH2a), 4.02 (m, 2H, Ph-C-CH2b, Ph-N-CH2a), 3.79 (dd, lH, J=6.8 Hz, J=9.1 Hz, Ph-N-CH2b), 3.66 (m, 2H, NH-CH2s), 2.03 (s, 3H, HNCO-C~3), 1.90 (8, 3H, NCO-CH3), 15 1.62 (~, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDCl3) 171.0, 170.8, 160.3 (d, JCF=246 Hz), 154.0, 138.0 (d, JCF=11 Hz), 128.2 (d, JCF=14 Hz), 127.1 (d, JCF=6 Hz), 113.2, 106.3 (d, JCF=27 Hz), 71.8, 61.7, 58.7, 47.3, 41.7, 35.2, 28.1, 22.9, 18.6; KF. Wat,er = 1.83%. Anal. Calcd for C18H22N3O4Fl plus 1.83% water: C, 58.41; H, 6.20; N, 11.35. Found: C, 58.43; H, 6.45; N, 11.27. HRMS Calcd for Cl8H22N304Fl:
20 363.1594. Found: 363.1585.

F'XAlVlPLE 11 (s)-N-rr3 r3 FluOrO-4-rl (~-fluOlvt~ l)-3-(3--mpthyl) phanvl~ rn-5-~ nli~irurllmPth~vll s~r.~ ,-,;tla An oven-dried 10 mL re~;vv~l ~/ flask equipped with m~gnPffc spinh~r and 25 reflux cor rlQncçr was charged with 262 mg 2-fluoro-1-tosyl et~nrJl (1.2 mmol), 321 mg (s)-N-[[3-[3-fluoro-4-[3-met~hyl-3-~pt;~linyl]-phenyl]-2-oxo-5-ny~ inyl]met~hyl]
-t~t~ le (1.0 mmol), 7.0 mL ~re~ ;le, and 415 mg powdered pot~inm carbonat,e (3.0 mmol). The reffnlting white sl~pQncion was heated to reflux for 16 hours. The visually llnl~h~n~ed reaction ~ e was cooled to room temperature, 30 volatile~ removed in vacuo, rA81l1ting residue diluted with 20 mL water, and extracted twice with dichloromPth~ne (20 mL). The combined organics were washed once with brine (20 mL), dried over MgSO4, filtered, and conr~- I ~ ated to give 394 mg of a light brown syrup. This crude m~teri~l was purified by LC on 19g (230-400) silica gel eluting with 7% mP+h~nnl/dichloromP~ nP to afford 260 mg 35 (71~o) the title culllpou~ld as a light peach amorphous solid. Rf 0.30 (7~
meth~no]/dichlorompths~ne); [a]D -21~(c 0.95445, me~ nol); IR (mull) 1753, 1660, 8U~SrlTU~ESHEEI (RUI~Z6) W O 97/09328 PCTrUS96/12766 1630, 1550, 1515, 1481, 1435, 1411, 1225, 1195 cm~l; lH NMR (300 MHz, CDC13) 7.36 (dd, lH, J=2.2 Hz, J=12.7 Hz, aromatic), 7.11 (dd, lH, J=2.3 Hz, J=8.5 Hz, aromatic), 6.98 (t, lH, J=8.6 Hz, aromatic), 6.23 (bt, lH, J=6 Hz, NH), 4.79 (m, lH, mPthinP), 4.47 (dt, 2H, J=4.8 Hz, JHF=47.4 Hz, F-CH2), 4.04 (t, lH, J=9.0 Hz, Ph-5 N-CH2a), 3.77 (dd, lH, J=6.8 Hz, J=9.2 Hz, Ph-N-CH2b), 3.66 (m, 4H, HN-CH2s, N-CH28s), 3.34 (d, 2H, J=7.2 Hz, N-CH2bs), 2.75 (dt, 2H, J=4.9 Hz, J~ ~8 ~ Hz, F-CH2-C~2), 2.03 (8, 3H, O=C-CH3), 1.64 (s, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDCl3) 170.8, 159.9 (d, JCF=245 Hz), 153.9, 137.0 (d, JCF=11 Hz), 131.1 (d, JCF=16 Hz), 127.0 (d, JCF=7 Hz), 113.2 (d, JCF=3 Hz), 106.2 (d, JCF=28 Hz), 82.6 (d, 10 JCF=166 Hz), 71.7, 66.0, 58.5 (d, JCF=19 Hz), 47.2, 41.6, 36.8, 27.1, 22.8; KF.
Water = 1.05%; Ansl. Calcd for C18H3N3O3F2 plus 1.66% water: C, 57.87; H, 6.39;
N, 11.25. Found: C, 57.67; H, 6.43; N, 11.18. HRMS Calcd for C18H3N303F2:
368.1786. Found: 368.1789.

15 EXAMPLE 12 (~)-N-rr3-r3-Fluoro-4-rl-(cy~nnm~th,yl)-3-(3-mPthyl)-~7~ti~ yll-I?hpr~yl-2-n~rn-5-n~sl7~n~ yllmpt~ r~ mi~p An oven-dried 10 mL ~tC~Jvt:ly flask e~luiyyed with m~FnPti- spinh~r and reflux cc~n~n~er was charged with 321 mg (S)-N-t[3-[3-fluoro~-[3-methyl-3-s37.~ 1inyl] phenyl] 2-oxo-5-o~r~7o~ inyl]methy~ etslmi~le (1.0 m mol), 7.0 mL
20 ~qcek ..;1 - .le, 76 ~L chloros3cet~nit~ile (1.2 mmol), and 415 mg powdered pot~ m carbonate (3.0 mmol). The re.qnlffn~ white suspension was heated to reflux and quickly ~l~rk~n~rl to a tan color. TLC after 20 minutes in~ t,es almost complPtecnnRnmrtion of (s)-N-[[3-[3-fluoro-4-[3-methyl-3-~eti~linyl]-phenyl]-2-oxo-5 nYsl~n~ inyl]methyl]-s~l~e~mi(lp~ and the reaction was stirred at room tempe,d~u~
25 for 16 hours. The visually lln-h~n~ed reaction l~Lu~ was cooled to room tempe~ure~ volatiles removed in vacuo, resllltin~ residue diluted with 20 mL
water, and ~ c.cled twice with dichlornm~h~ne (20 mL). The comhinerl organics were washed once with brine (20 mL), dried over MgSO4, filtered, and cnn-~ent~ated to give 340 mg of a yellow foam. This crude m~ri~l was purified by LC on 24 g 30 (230-400) silica gel eluting with 5% mPth~nnl/dichloromPth~nP to afford 271 mg (75%) the title c."ll~oulld as a white amorphous solid. Rf 0.30 (5%
mPthsln~l/dichlorompthQn~); ta~D -22~(c 0.9252, mPth~nol); IR (mull) 1752, 1661,1631, 1546, 1516, 1480, 1434, 1412, 1227, 1195 cm~l; lH NMR (300 MHz, CDC13) o 7.39 (dd, lH, J=2.3 Hz, J=12.8 Hz, aromatic), 7.13 (dd, lH, J=2.2 Hz, J=8.5 Hz, 35 aromatic), 6.99 (t, lH, J=8.6 Hz, aromatic), 6.30 (bt, lH, J=6 Hz, NH), 4.79 (m, lH, mP~hin~), 4.03 (t, lH, J=9.0 Hz, Ph-N-CH2a), 3.77 (dd, lH, J=6.8 Hz, J=9.1 Hz, Ph-SUBSTITUTE SHEET (RULE 26) CA 02228647 l998-02-03 N-CH2b), 3.66 (m, 2H, HN-CH2s), 3.55 (S, 4H, N-CH2s), 3.49 (S, 2H, NC CH2), 2.02(S, 3H, O=C-CH3), 1.64 (S, 3H, Ph-C-CH3); 13C NMR (75 MHZ, CDC13); 171.1, 159.9 (d, JCF=246 HZ), 154.1, 137.4 (d, JCF=11 Hz), 129.7 (d, JCF=l5 HZ), 126.9 (d, JCF=7 Hz), 114.8, 113.3, 106.2 (d, JCF=28 Hz), 71.8, 63.3, 47.2, 43.9, 41.6, 36.5, 26.9, 22.8; KF. Water = 1.42%; Anal. Calcd for C18H2lN403Fl plus 1.42% water:
C, 59.14; H, 5.95; N, 15.33. Found: C, 58.96; H, 5.88; N, 15.33. HRMS Calcd for C18H21N4~3Fl: 360.1598. Found: 360.1610.

F.~Al\/IPLE 13 (~) N rr3-r3-F1UOrO-4-r1-(5-n;trO-2-th;~7n~1)-3-(3--mP~V1) sl7.~.t.i-1iT~rll_~hPr~yll-~-nyn-5-n~r~7n~ mptl~yll-acet~mi~la An oven-dried 10 mL round bottom flask e4uu~ped with m~npff~spinh~r was charged with 241 mg (s)-N-[[3-[3-fluoro-4-t3-methyl-3-~7~ti~inyl]-phenyu-2 5~Y~7n1;~;nY1]met-h-Y1]-~etSIm;~1e (0.75 mmol), 4 mL dimethyl~nl~y~ and 188 mg 2-bromo-5-nitro~hi~7nlP This golden homogenous soll~t;nn wa~ treated with 207 mgpowdered pot~illm carbonate (1.5 mmol) and stirred at room temperature for 16 hours. The now dark brown suspension was diluted with 40 mL dichloromP~hs-nP
and washed with water (3 X 15 mL), once with brine (15 mL), dried over MgSO4, filtered, and corc~.l ~dLed to give 280 mg of an orange foam. This crude ms~f~r was purified by LC on 18 g (230-400) silica gel eluting with 5%
mP~ noVdichlor~)mpth~nR to afford 191 mg (56%) the title compound as a yellow solid. This m~t~risll was recryst~lli7e~1 from ethyl Aret~tP/he~ane to a~ord 88 mg of a yellow solid. mp 182-185~C (dec.); Rf 0.29 (5% mPth~nO1IdiCh1OrOmPth~nP); [a]D -20~(C 0.4062, DMSO); IR (mull) 1747, 1771, 1572, 1517, 1498, 1475, 1439, 1282, 1228, 1199, cm~l; lH NMR (300 MHZ, CDC13) ~ 7.50 (dd, 1H, J=2.1 Hz, J=13.1 HZ, aromatic), 7.20 (dd, 1H, J=2.2 HZ, J=8.5 HZ, aromatic), 7.12 (t, lH, J=8.5 HZ, aromatic), 4.79 (m, 1H, meth;nP), 4.51 (d, 2H, J=8.9, Ph C CH2S), 4.24 (d, 2H, J=9.4 HZ, Ph C CH2S), 4.07 (t, lH, J=9.0 HZ, Ph N CH2a), 3.79 (dd, 1H, J=7.0 HZ, J=9.5HZ, Ph N CH2b), 3.62 (m, 2H, NH C~2S), 2.01 (S, 3H, O=C-CH3), 1.75 (S, 3H, Ph-C-CH3); 13C NMR (75 MHZ, CDC13) 201.0, 171.9, 171.8, 160.1 (d, JCF=247 HZ), 154.6,145.5, 138.4 (d, JCF=11 HZ), 127.1, 126.9 (d, JCF=6 Hz), 113.5, 106.5 (d, JCF=27HZ), 72.2, 64.0, 47.4, 41.7, 38.1, 28.0, 22.4; KF. Water = 0.59%. Anal. Calcd for C19H20N5O5F1S1 P1US 0.59% water: C, 50.48; H, 4.53; N, 15.49. Found: C, 50.26;
H, 4.69; N, 15.29.

FXAMPLE 14 (S)-N-rr3-r3-F1UOrO-4-r1-(-mPth~n~C111f~nY1)-3-(3-m~t~Y1) ; ~; ~11 -~h ~11 -2 -n~O-5-n~ n1; '1; 1V11m ~t~11 -a~t~ m;

SUBSTITUTE SHEET (RULE 26) An oven-dried 15 mL round bottom flask equipped with m~EnPt;c spinbar was charged with 241 mg (s)-N-[[3-[3-fluoro4-[3-methyl-3-~et;~inyl]-phenyl]-2-oxo-5 AYA7A~ inyl]methyl]-~r~et7~mi~l~R (0.75 mmol), 8 mL dichloromPt~nP~ and cooled to 0~C. The colorless but slightly opaque solllt;-An was treated with 0.16 mL
5 triethylamine (1.1 mmol) and 70 ~lL mPthAnpslllfo~yl chloride (0.90 mmol) with no visible change. The cooling bath was lGmovGd and the reaction ~ G was warmed to room t-Gl~e~atu~e over three hours. The now clear sol~lt;-An was c~An~Rntrated to a colrrlRRR syrup. This crude material was purified by LC on 18 g (230-400) silica gel eluting with 5% mPt~nol/ethyl acetate to afford 234 mg (78~o) 10 the title compound as a white foam. Rf 0.30 (5% met~n~AJI/ethyl acetate); [a]D -9~(c 0.9701, mPt~s3nol; IR (mull) 1753, 1664, 1631, 1517, 1436, 1412, 1333, 1228, 1194, 1151 cm~l; lH NMR, (300 MHz, CDCl3) o 7.44 (dd, lH, J=2.2 Hz, J=13.0 Hz, aromatic), 7.16 (m, lH, aromatic), 7.00 (t, lH, J=8.6 Hz, aromatic), 6.30 (bt, lH, J=6 Hz, NH), 4.80 (m, lH, mP~ine)~ 4.24 (d, 2H, J=7.4 Hz, M8-N-CH2as), 4.05 (t, lH, 15 J=9.0 Hz, Ph-N-CH2a), 3.88 (d, 2H, J=7.6 Hz, M8-N-CH2bs), 3.79 (m, lH, Ph-N-CH2b), 3.66 (m, 2H, NH-C~28), 2.87 (8, 3H, S-CH3), 2.03 (8, 3H, O=C-CH3), 1.68 (8, 3H, Ph-C-CH3); 13C NMR (75 MHz, CDCl3) 171.2, 160.2 (d, JCF=246 EIz), 154.2, 138.3 (d, JCF=11 Hz), 128.2 (d, JCF=l5 Hz), 126.9 (d, JCF=6 Hz), 113.5 (d, JCF=3Hz), 106.5 (d, JCF=28 Hz), 72.0, 60.8, 47.4, 41.8, 36.2, 35.0, 27.4, 23.1; Melt solvate 20 = 0.3% ethyl ~Aetst~A; KF. Water = 1.05%; Anal. Calcd for C17H22N305FlS1 plus0.3% ethyl Aret7~tC and 1.05% water: C, 50.59; H, 5.62; N, 10.38. Found: C, 50.50;
H, 5.81; N, 10.29. HRMS Calcd for C17H22N305F1S1: 400.1342. Found:
400.1352.

25 EXAMPLE 15 (O-N-rr3-r3-Fluoro-4-rl-(bPn7~ylAwacetyl)-3-(3-mf~t~yl) fl ~Pt; (~ yll ph PT~yll--~--A~A--5--A~r~ ~Al i (1 i lullm Pt.~lyll ace An oven-dried 26 mL round bottom flask equipped with mslgnAI;C spinh lr was charged with 313 mg (S)-N-[[3-[3-fluoro-4-[3-methyl-3-A~Pti~linyl]-phenyl]-25_AYA7Ali~inyl]methyl]-s~ret7~mi(3p (0.97 mmol), 10 mL dichloromPthAnp~ and cooled 30 to 0~C. The colorhP~ but slightly opaque soltltion was treated with 0.27 mL
triethylamine (2.0 mmol) and 0.23 mL benzyloxyacetyl chloride (1.5 mmol) with the reaction ~ LI,U~e bec~AminF clear and a pale yellow color. The cooling bath was removed and the reaction ~ U~G was warmed to room temperature over 16 hours.
The visually llnrh~nged sollltion was diluted with 15 mL satu.dted sodium 35 bicarbonate and extracted twice with dichloromPth~nP (20 mL). The c~A,mhinPclorganics were washed once with 15 mL brine, dried over MgS04, filtered, and SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 conce~ ted to give 521 mg of a light yellow foam. This crude mst~erisl was purified by LC on 27 g (230-400) silica gel eluting with 10% mPthsn~)lJethyl acetate to afford 370 mg (81%) the title ou~ uulld as a white foam. Rf 0.29 (10%
mP+l-~nl l/ethyl acetate); [a]D -17~(c 0.9516, m~t~snol);IR (mull) 1754, 1654, 1631, 1548, 1516, 1438, 1411, 1226, 1193, 1122 cm~1; lH NMR (300 MHz, CDCl3) 8 7.45 (dd, lH, J=2.2 Hz, J=13.0 Hz, aroma+ic), 7.33 (m, 5H, aromatic), 7.15 (dd, lH, J=2.2 Ez, J=8.5 Hz, aromatic), 7.04 (t, lH, J=8.6 Hz, aromatic), 6.42 (bt, lH, J=6 Hz,NH), 4.79 (m, lH, m~tl ine), 4.57 (s, 2H, Ph-CH2), 4.50 (d, lH, J=9.0 Hz, Ph-C-CH2a), 4.33 (d, lH, J=9.7 Hz, Ph-C-CH2b), 4.23 (d, lH, J=9.2 Hz, Ph-C-CH2b), 4.04 10 (m, 4H, Ph-C-CH2a, O-CH2, Ph-N-CH2a), 3.79 (dd, lH, J=6.8 Hz, J=9.0 Hz, Ph-N-CH2b), 3.66 (m, 2H, NH-CH2), 2.02 (s, 3H, O=C-CH3), 1.61 (s, 3H, Ph-C-CH3); 13C
NMR (75 MHz, CDCl3) 171.1, 169.6, 160.3 (d, JCF=246 Hz), 154.1, 138.1 (d, JCF=11Hz), 137.0, 128.4, 128.2, 128.0, 127.9, 127.2 (d, JCF=6 Hz), 113.3, 106.5 (d, JCF=26 Hz), 73.3, 71.9, 69.0, 62.4, 59.4, 47.4, 41.8, 36.7, 28.2,-23.0; HRMS Calcd for 15 C25H28N3~5F1: 470-2091. Found: 470.2101.

F'XAl\~rPLE 16 (~q)-N-rr3-r3-FluOro-4-rl-t~ yl)-3-(3-m~t~yl) ~s.7~+i~ -uh~ s~7~ irlyllm~ -ac~t.-smi~l~
A 250 mL Parr flask was charged with a solllffon of 310 mg (S)-N-t[3-t3-20 fluoro-4-[l-(benzyloxyacetyl)-~-(3-methyl)-~7~t;~1inyU-phenyU-2-oxo-5-r~Yn7~ inyl]methyl]-f~et-s~mi~ (0.66 mmol) in 30 mL m~~l nnnl and 31 mg 10~o pslls~ lm on carbon. The black suspension was placed under 40 psi hy-llùgt:ll with ~hskin~ for 16 hours with the pL~S~ rf~mginine~ conP~9nt The reaction was mnnitored by TLC analysis with several s~l~itionsl equivalents of 10 % ps~llgtlillm on carbon (300 mg total amount) and prolonged time (five dayg) to fully con~llm~ -(S)-N-[[3-[3-fluoro-4-[1-(benzyloxyacetyl)-3-(3-methyl)-s7eP~linyl]-phenyl]-2-oxo-5-nY~7~ inyl]-methyl]-s.- et-smi-lP The reaction ~ was filtered through a pad of Celite and con~ ated ta, afford 221 mg (88~o) the title compound as an off-white amorphous solid. ~?f 0.21 (15% m~t~nol/ethyl acetate); [a]D -20~(c 0.9432,m~nol); IR (mull) 1754, 1665, 1632, 1552, 1517, 1481, 1435, 1412, 1227, 1192 cm~l; lH NMR (300 MHz, CDCl3) o 7.47 (d, lH, J=2.1 Hz, J=13.0 Hz, aromatic), 7.15 (dd, lH, J=2.2 Hz, J=8.6 Hz, aromatic), 7.07 (t, lH, J=8.6 Hz, aromatic), 6.37 (bt, lH, J=6 Hz, NH), 4.80 (~, lH, mPt}lin~), 4.38 (m, 2H, Ph-C-CH2a&b), 4.01 (m, 5H~ Ph~C~CH2a&b~ HO-C~2- Ph-N-CH2a), 3.79 (dd, lH, J=6.8 Hz, J=9.1 Hz, Ph-N-CH2b), 3.68 (m, 2H, HN-C~2s), 2.03 (s, 3H, O=C-CH3), 1.65 (s, 3H, Ph-C-CH) 171.3, 170.9, 160.1 (d, JCF=246 Hz), 153.9, 138.1 (d, JCF=11 Hz), 127.6 (d, JCF=14 SUBSTITUTE SHEET (RULE 26) CA 02228647 l998-02-03 Hz), 126.9 (d, JCF=6 Hz), 113.1, 106.3 (d, JCF=28 Hz), 71.8, 60.1, 59.3, 58.5, 47.1, 41.6, 37.0, 28.0, 22.8; HRMS Calcd for C18H22N305 Fl: 379.1543. Found:
379.1542.

~.~AMPLE 17 (S~-(-)-N-rr~-OYn-3-r4-(4-j~eri(lir~ hPrurll-5-oY~7.nli~invllmP~thvll~P~s3mi~p~ ~
Step 1: 4 ~y~1rnY,y 4 r4 rr(~;~h~ ylmPthn~v)r~rbnT~ minnl~hPn p~eri~inP~rbnY~yli~ l phPr~ylmPt~yl ester To a snhlt;nn of N-(carbobenzyloxy)4-bromo~nilinp- (5.00 g) in dry lO tetrahyLvrulc n (80 mL) at -78~C under N2i8 added n-butyllit~illm (21.4 mL, 1.6M
in hPY~nP~) dropwise over five minllt~. The re~llltinF yellow solllti~n is stirred at -78~C for 30 minllt~ and is then treated with a snlnt;~n of N~carbobenzyloxy)-4-pipPridonP (3.99 g) in dry tetrahy-llvru~ (17 mL). The reaction ~i2~Lule is stirred for three hours, during which the reaction temperature is allowed to rise to 0~C, 15 and i8 q~nPn~h~tl with saturated aqueous ~mmonillm ~~hlnritle (30 mL). The mL~u~e is then diluted with water (100 mL), the layers are 81 ~ala~ed, the aqueous phase is extracted with diethyl ether, and the comhinP~1 organic pha~e is washed with saline (50 mL), dried over anhydrous so-lillm sulfate, and co..s~.l aled under reduced p~e8~ule. The residue is chromato-graphed on silica gel (230 - 400 mesh, 350 g),20 eluting with ethyl ~etDt~hexane (25/75), and those fractions with an Rf = 0.38 by TLC (ethyl ~cet~./hPY~nP, 50/50) are pooled and con-centrated under reduced ,Ule~Ule to give the title ~vlllpound, mp 156~C - 158~C.
Step 2: 3.6-nihy~ro-4-r4-rr(uhPru~lmpt~ cv)~rbnnvll~minnlI~hprlyll-l(~) pvri~inP- ~- L. .Y~ ?hPr~ylmPthvl ester A sollltion of 4-hydlv~y4-[4-t[(phenylm~tllnYy)carbonyl]amino]phenyl]-l-pireritline.~ .uAylic acid phenylmethyl ester (EXAMPLE 17, Step 1, 2.50 g) in dry methylene chloride under N2 is treated with trifluoroacetic acid (0.84 mL), stirred at ~mhipnt te~ uela~ule for three hours, diluted with sa~ulated aqueous potasgillm carbonate (25 mL) to neutralize excess trifluoroacetic acid, and the layers are 30 separated. The organic phase is washed with water (20 mL) and saline (20 mL),dried over anhydrous sodium sulfate and cQn~entrated under reduced pressure, andthe residue is chrom~tc.~ . a,uhed on silica gel (230 - 400 mesh, 300 g), eluting with a gradient of ethyl ~ et~t~/hexane (20/80 - 50/50). Pooling of fractions with an Rf =
0.69 by TLC (ethyl ~ret~tP/hp~r~ne~ 50/50) and removal of solvent under reduced 35 p~e~ULè gives the title cvlll,uound, mp 146 - 148~C.
Step 3: (R)-(-)-3.6-l)ihvlro-4-r4 r5 (h~ vl~.Ptl~vl)-~-n~rt)-3-S~;l 11 lJT~ SHEEr (RULE26) W O 97/09328 PCT~US96/12766 oYA7~ yllgh~nvll-1(2H)-DyrirlinPrArboxyli~ acid nh~r~ylmPt~yl ester A solllt;~n of 3,6-dihydro-4-t4-[[(phenylmPthn~y)carbonyl~amino]phenyl]-1(2H)-pyritlinPcA-lJu~ylic acid phenylmethyl ester (~AlVrPLE 17, Step 2, 0.500 g) in dry tetrahyllluru dn (5.7 mL) at -78~C under N2 is treated with n-butyllithillm 5 (0.73 _L, 1.6M in hPY~nes) dropwise over five minllt~.s. The rP~llltinF ~lule is stirred at -78~C for 45 minutes and is then treated with (R)~-)-glycidyl buly~ate dropwise. The reslllt;n~ sollltio~ i8 allowed to warm to AmhiP-nt te~pel~tu~e over a~U~ ;..,AtPly 45 ...i..~le~ and is stirred for an ~ itirln~l 20 hours, after which the reaction is qllPnrhe~ with salu aled aqueous Ammonillm chloride (10 _L), diluted10 with water (20 mL) and extracted with ethyl acetate (2 x 15 mL). The cQmhin organic phase is washed with saline (10 mL), dried over anhydrous mA~nPF~inm sulfate and conr~ cLled under reduced ~r~u~e to give the crude product which is chromAt~graphed on silica gel (230 - 400 mesh, 40 g), eluting with mPthAn~ .31hylene chloride (1/99). Pooling and concpnt~ation of those fractions 15 with an Rf = 0.37 by TLC (m~thAnol/chlo~ 5/95) gives the title cu ,l uu~d, mp 131.5- 133.5~C.
Step 4: (R)-(-)-3.6-nihy-lro-4-r4-r5-rr(mPt~ llf~ruTl)n~ylmPthyll ~ ro 3 ~YA~ hp~ R )-Dyri~in~f.~ l;l'. acid ~?hPrurlmPthyl ester A solllt;~n of (R)~-)-3,6-dihydro-4-t4-[5-(hy.llu~y.--ethyl)-2-oxo-3-20 r.YA~oli-3inyl]phenyl]-1(2H)-pyri~inP~Arboxylic acid phenylmethyl ester ( F'XANIPLE
17, Step 3, 970 mg) and triethylamine (0.50 mL) in dry methylene chloride (9.5 _L) at 0~C under N2 is treated with mPthAnp~ fi~nyl chloride (0.20 mL) dropwise. TherP~lllt;ng~--~ u~ei8 gtirred at 0~C for one hour, diluted with methylene ~hlori~e (40 mL), washed with water (10 mL), saturated aqueous sodium bicarbonate (10 mL) 25 and saline (10 mL), dried over anhydrous sodium sulfate and con-~e..l-~led under reduced pr~ e to give the title cun~pc,und, mp 166 - 168~C.
Step 5: (~)-(-)-4-r4-r6-r(Al~t~ylAminn)mpt~vll-2-ny~-3-oyA7~ vll~hpr~yll-3.
/lihvtlro-l(~ yr~ p~Arbt~y~ ' A~ UhPr~ylmPthVl ester A ll~ Ul~ of (R)-(-)-3,6-dihydro-4-t4-[5-[[(methylsulfonyl)oYy]methyl]-2-oxo-3-30 oY~7oliflinyl]phenyl] 1(2H) pyri~inPcA.bu~yLc acid phenylmethyl ester (~XAMpLE
17, Step 4, 935 mg) and con~P.Il -t ted aqueous Amm~ lm hydlo~ude (4 mL) in isopropanol (4 mL) and tetrahyd-ur~l (4 mL) is placed in a sealed tube and immersed in an oil bath mAintAinP-l at 95~C for 18 hours. The l~ lule is then diluted with methylene chloride (40 mL), washed with saline (20 mL), dried over 35 anhydrous sodium sulfate and con-~e~.t aled under reduced p,~ ~e to give the 5-AminomPthyl-2 I~YA7c~lirlinc~ne intermP~liAtP (Rf = 0.34 by TLC, mPthAno]lchlorofo~l", Sll~S i 11 LITE S~!E~ (Rl.ll~ 2~;~

10/90). A Pollltion of this interm~ te (783 mg) and pyridine (1.55 mL) in dry methylene chloride (19 mL) at 0~C under N2 is treated with acetic anhydride (0.90 mL), and the resulting soll-tion is allowed to warm to ~mhi~nt~ tempclal,ule with stirrinF over 1.5 hours. The llli~L~U~ iS then diluted with methylene chloride (20 5 mL), washed with water (10 mL), sa~u~dted aqueous sodium bicarbonate (2 x 10 mL) and saline (10 mL), dried over anhydrous so~lillm sulfat~ and conr~ .dted under reduced pres~ul.2 to give the crude product which is chrom~tographed on silica gel (230 - 400 mesh, 75 g), eluting with a gradient of mPth~nr~l/methylene r.hlo-ri~e (lt99 - 2t98). Pooling and con~ent~ ation of those fractions with an Rf =
10 0.26 by TLC (mPt~ ~nnltchlo~ " 5t95) gives the title cOIllpc u~d, mp 166 - 169~C.
Step 6~ )-(-)-N-rr~-O~rn-3-r4-(4-pu;~eri-linvl)~h~r~yll-6-~Y~7nli~ ,yl1mP~t~h~ylls~9t~mitl~
A ll~ U~e of (S)-(-)-4-[4-[5-[(acetylamino)methyl]-2~xo-3-oYsl7olil1inyl]phenyl]-3~6-dihydro-1(2H)-pyritlin~c~rboxylic acid phenylmethyl ester 15 (~xAMpLE 17, Step 5, 625 mg) and 10% p~llArlillm-on-carbon (300 mg) in m~th~nol (100 mL) is shaken on a Parr apparatus under a hyd~o~n ~tmo~ph~re at 40 psi for one hour and at 20 psi for 16 hours, the catalyst is removed by filtration through Celite and the filtrate is cnnc~ Lted under reduced p e~ to give the title co~puulld, mp 169 - 171~C.
FXAl\/rpLE 18 (O-(-)-N-rr3-r4-rl-r(Rf~n7~yln~ P~yll-4-~erir~ ?h~r~yll-~-nYn-5-nYsl7nlillinyllm~t~yll~ tslmi~l~
A ~ e of (S)-(-)-N-[t2-oxo-3-t4-(4-piperidinyl)phenyl]-5-~-Y~7oli~inyl]methyl]acetamide (EXAMPLE 17, 300 mg) and triethylamine (0.20 mL) 25 in dry methylene ~hloricle (19 mL) at 0~C under N2 is treated with benzyloxyacetyl ~hlori-l~q (0.18 mL), and the reslllting solllt;nn is stirred at 0~C for one hour and at f~mhif~nt tempe,,~ e for one hour. The reaction ~Lu,e is then washed with water (2 x 10 mL), s~Lu~dted aqueou~ ~o~illm bica~l,unate (10 mL) and saline (10mL), dried over anhydrous so~illm sulfate and con~e..l-ated under reduced l)re.i~u~e 30 to give the crude product which is chrom~.a~hed on silica gel (230 - 400 mesh, 45 g), eluting vwith a gradient of mPth~nnllmethylene ~hlori-l~ (1/99 - 2/98). Pooling and con~ent~ation of those fractions with an Rf = 0.28 by TLC
m~th~nol/chloruro~"~, 5/95) gives the title co-lll)oulld, NMR (CDCl3, 400 ~Iz) 7.45, 7.35, 7.18, 6.26, 4.75, 4.63, 4.22, 4.04, 3.78, 3.70, 3.60, 3.09, 2.70, 2.02, 1.85, 1.60 o.
~XAlVlPLE 19 (S)-(-)-N-rr3-r4-r1-(IIv~ tyl)-4-Di~erirlir~ Dh~lvll-2-o~n 5 SUBSTITUTE SHEET ~RULE 26) n~sl7..~,1i(1invl1mPthvl~ ptslmi(~e A L~Pi~L~LL~ of (S)-(-)-N-[[3-[4-[1-[(benzyloxy)acetyl]-4-piperidinyl]phenyl]-2-oxo-5 o~rzl7nlirlinyl]methyl]~cet~mide (EXAMPLE 18, 207 mg) and 10~o p~ m on carbon (100 mg) in mPth~nol (9 mL) i8 shaken on a Parr apparatus under a 5 hydlu~;cll ~t~n~~"~Fhere at 40 psi for 20 hours, the catalyst is removed by filtration through Celite and the filtrate i8cnn~Antrated under reduced ~lcs~ulc to give the crude product which is chrom~t~~.graphed on silica gel (230 - 400 mesh, 20 g), eluting with a gradient of mPt~n-~,l/methylene ~hl.~,ri~la (6/95 - lO/90). Pooling and cn..c~ dLion of those fractions with an Rf = 0.26 by TLC (mP~nnltchlorurv.Ll,, 10 lOt90) and lc~,ly~lli7~tion from methylene chloridetdiethyl ether gives the title compound, mp 155 - 167~C.

F'XANIPLE 20 (.O-(-)-N-rr2-O~n-3-r4-(4-giDeri~ yl)-3-fluoroghPr~yll-5 n~ 7nli~ ,vllma~l~yllsl~+s~mi~1~
Step 1: 1-(3-Fluoro~h~nyl)-2 -~~ 5.5-tAl~mpth~yl-l-~7~-~ E~-llicil~o~vclo~ant~naA solllt;nn of freshly ~ flla~ diiso~lv~ylamine (22.9 mL) in dry tetrahydl~rul~ (175 mL) at -78~C under N2 is treated with n-butyllit~ m (1.6M
in hpy~nps~ 109 mL) dropwise over 15 ~ , and the reslllt;n~ LlLil LU~ is stirred at -78~C for 45 ...i~ 19s and is then added over ten ...i....les via c~nnlll~ to a 20 solllt;~n of 3-fluoros-nilina (8.00 mL) in dry tetrahyvllrv~ (166 mL) at -78~C
under N2. The reslflt;ng reaction ~ Lur~is stirred at -78~C for 50 ~ s and is then treated with a solllt;-~~n of 1~l~4~4-tetramethyl-l~4-dichloro~ ilptllylene (18.3 g) in dry tetrahy.ll~,ruL~ (85 mL). The ~i~Luleis allowed to slowly warm to ~mhientt~lllpeldLule over four hours with stirring and is then washed with water (2 x 200 25 mL) and saline (100 mT.), dried over anhydrous so~lillm sulfate and cnno-l-dted under reduced ~ 8~ULe to give the title compound, NMR (CDC13, 400 ~Iz) 7.12, 6~65~ 6~58~ 0~86~ 0~24 5v;.
Step 2: 3.6-nih~ydro-4-rr(trifluor.~m~t~yl)slllf r~ylln~ T-T)-pyr~ np~.!
-rlimPtl ~yletll~yl ester A solllt;on of freshly ~ ;lle~l diisoplv~ylamine (8~70 mL) in dry tetrahyvllvrul~ (133 mL) at -78~C under N2 is treated with n-butyllithillm (1.6Min h~y~nps~ 41.5 mL) dropwise over ten ...il~ s, and the resulting ~.~Lu~ is stirred at -78~C for one hour and is then treated with a sollltion of 1-(1,1-dimethylethulf.yoaLlvullyl)-4-piperi(~onP (12~0 g) in dry tetrahyvllvruldn (120 mT.) 35 dropwise over 10 minutes. The resnl*ng l~Ll~ is stirred at -78~C for 40 minllt~s and is then treated with a solution of N-phellylLl;auorompth~np-slllfonimi~le (22.0 g) ~:UB51T~ S~lE~ (RIJ~ 26) W O 97/09328 PCT~US96/12766 in dry tetrahydlvr~an (62 mL) over five minutes. The reaction lnil~iUl.3 iS stirred at -78~C for 10 min~ltes and at 0~C for four hours and is then ql-~n~h~cl with water (200 mL). The layers are sepa,ated, the aqueous phase is extracted with diethyl ether (100 mL) and the combined organic phase is washed with saline (50 mL), 5 dried over anhydrous mA~ ~-e~ sulfate and concPntrated under reduced ,ule~u~e to give the title col..puulld, NMR (CDC13, 400 MHz) 5.77, 4.05, 3.64, 2.45, 1.48 ~.
Step 3: 3.6-nihy~ro~-r4-Amin--2-fluorouh~r~yll-1(~)-pyritlin~ .bu~ acid l.l ~limPth~ylPthvl ester A solllt;~ n of 1-(3-fluorophenyl)-2,2,5,5-tetramethyl-1-aza-2,5-10 disilacyclopPntqnP (F'XAlVlPLE 20, Step 1, 19.1 g) in dry tetral ydlvruld~ (150 mL) at -78~C under N2 is treated with sec-butyllithillm (1.3M in cy~lohPY~nP, 60.3 mT.) dropwise over ten minutes, and the reslll~ing mi~Lu~e is stirred at -78~C for 2.25 hours. A solllt;~n of zinc chloride (0.5M in tetrahyLvruLdn, 150 mL) is then added over 15 minllt,e~, and the Il~Lul~ is allowed to warm to Amhient 15 tempe-aLule over one hour with stirring. A solllt;~n of 3,6-dihydro-4-[[(trifluoromethyl)-sulfonyl]oxy]-1(2H)-pyri~inPcArboxylic acid l,l-dimethylethyl e~ter (~XAMPLE 20, Step 2, 20.8 g) in dry tetrahydlvru an (63 mT ) and tetrakis(t~iphenylrhosFhinp)palladium(o) (1.45 g) is added, and the ~Lule is ~iegARRell, heated up to reflux, refluxed for five mintlt~s, coûled to Amhi~Pnt 20 tempeldLule and stirred for 12 hours. The l~LuLe is then diluted with water (150 mL), the layers are separated, the aqueous phase is ~:~L~ Led with diethyl ether (2 x 100 mL) and the comhin~(~ organic phase is washed with water (100 mT-) and saline (100 mL), dried over ~nhydrûus mA~n~illm sulfate and con-~e..t.ated underreduced pre~:jule. The residue is then dissolved in mPtl~nol (630 mL) and treated 25 with anhydrous pot~inm carbonate (17.3 g), and the ~Lu-e is stirred at AmhiPnt temperature for 40 minnt,PR, cor.-~e,.l-ated under reduced pressure, diluted with water (100 mL) and extracted with diethyl ether (2 x 150 mL). The comhin~-l organic phase is washed with water (50 mL) and saline (50 mL), dried over anhydrous mAgn~Rillm sulfate and con-~l.t ~ted under reduced pressure to give the 30 crude product which is chromAtQ~ dphed on silica gel (230 -400 mesh, 1 kg), eluting with a gradient of ethyl Acet~t~hexane (15/85 - 50/50). Pooling and con-entration of those fractions with an Rf = 0.17 by TLC (ethyl Acet~ h~Y~ne~ 25/75) gives the title compound, mp 123 - 125~C.
Step 4: 4-r4-rr(Ph~r~ylm~thoxv)carbonyllAmin- -2-fluorouh~r~yll-1-35 p~eri(1inecArboxyli~ acid 1.1-~imPthyleth~yl ester A ~Lu~e of 3~6-dihydro-4-[4-amino-2-fluorophenyl]-l(2H)-pyri~lin~c~lJu~yLc E;l,w~ 111 ~TE S~!EE~ (RULE 26) acid 1,1-dimethylethyl ester (EXAMPLE 20, Step 3, 11.44 g) and 10% p~ m-on carbon (4 g) in mpth~nol (400 m1) in four Parr bottles is shaken on the Parr ap~a~us under a hydlo~n ~trno~srh~re at 40 psi for two hours, the catalyst is 5 re~lov~d by filtration through Celite, and the filtrate is concel~t~ted under reduced ,ures~ula to give the 4-[4-amino-2-fluorophenyl]-1-piper~ nP~ 1.bu~ylic acid 1,1-dimethylethyl ester intqrmP~i~t~ A ~ l ula of this interTnP~ ? (11.17 g) and sodium bicarbonate (6.57 g) in dry tetrahy-llvrul~- (390 mL) is treated with benzyl chlol.3rw~ate (5.86 m~), and the resllltinF ll~Ul~: iS stirred at ~mhient 10 t~. pt:ldtUl~ for 15 hours and washed with water (200 mL). The aqueous phase is e~Ll~ ~d with methylene ~~hlnrirle (150 mL), and the comhin~-l organic phase is washed with saline (50 mL), dried over anhydrous so~illm sulfate and concPntrated under reduced ~l~s~u~ to give the crude product which is chrnm~lo~.d,uhed on silica gel (70 - 230 mesh, 800 g), eluting with a gradient of ethyl ~cet~t~/hexane 15 (15/85 - 25/75). Pooling and concentration of those fractions with an Rf = 0.38 by TLC (ethyl ~et~t~hPY~ne, 25l75) gives the title compound, mp 96 - 98~C.
Step 5: (R)-(-)~-r4-r5-(E~ Pt~ ~n-3-ny~7nli(1iTu~ -fltlor T?Veri(~in~ acid 1 l-~limPthylPt~yl ester A sollltion of 4-[4-[[(phenylmpthnyy)carbonyl]~mino-2-fluorophenyl]-l-20 piperi~ine~.l,u~ylic acid 1,1-dimethylethyl ester (EXAMPLE 20, Step 4, 0.500 g) in dry tetrahydlvrul~l (5.7 mL) at -78~C under N2 is treated with n-butyllithillm (0.73 mL, 1.6M in hPY~nPs) dropwise over five minllt~s The resllltin~ u~a is stirred at -78~C for 45 minutes and is then treated with (R)-(-)-glycidyl bu~ylate dropwise. The reslllting solntion is allowed to warrn to ~mhiPnt tempe~ ule over25 app~ t~ly 45 minnte~ and is stirred for an ~ ition~l 20 hours, after which the reaction is qllen~hP~ with saturated aqueous ~mmonillm chloride (10 mT-), diluted with water (20 mL) and extracted with ethyl acetate (2 x 15 mL). The comhinPcl organic phase is washed with saline (10 mL), dried over anhydrous m~gnPcillm sulfate and conre..i ~ted under reduced pres~ula to give the crude product which is 30 chrom~io~.aphed on silica gel (230 - 400 mesh, 40 g), eluting with mPthz~novmethylene ~hlnr~le (1/99). Pooling and con~ntration of those fractions with an Rf = 0.37 by TLC (methanoVchlùl~rc-.--, 5/95) gives the title con-~ou~d, mp 120- 122~C.
Step 6: (R)-(-)-4-r4-r5-rr(Met~ylclllfonvl)oxylmathyll-2-n~rn-3-~ nli(1irlyll-2-35 fluorophPr~yll-1-~peri~linal~rboxvli- acid 1.l-~im~thyletllyl ester A solllt;on of (R)-(-)-4-[4-[5-(hylllu~y~ethyl)-2-ûxo-3-o~ nlir~inyl]-2 SUBSTITUTE SHEET (RULE 26) fluorophenyl]-1-piperi-linkcf..l,u"yLc acid 1,1-dimethylethyl ester (FXAMP~E 2a,Step 5, 970 mg) and triethylamine (0.50 mL) in dry methylene chloride (9.5 mL) at 0~C under N2 is treated with m~th~n~nlforlyl chloride (0.20 mL) dropwise. The reslllt;nF ~lu e is stirred at 0~C for one hour, diluted with methylene chloride (40 6 mL), washed with water (10 mL), saLulated aqueous sodium bicarbonate (10 mL) and s~line (10 mL), dried over anhydrous sodium sulfate and conr .l ated under reduced plasYu a to give the title c~pou~d, mp 163 - 165~C.
Step 7: (R)-(-)4-r4-r5-(A7i~1-m~~ Yr.-3--Y~7~ vll-~-fluoro~h~rlyll-1-p~eri~in~ ylir ~ri~ 1.1--lim~thvletllyl e~ter A ~ixLu~ of (R)-(-)-4-t4-[5-[[(methylsulfonyl)oxy]methyl]-2-oxo-3-oY~ inyl] 2-fluorophenyl]-l-piperi~lin~cA~Lu~ylic acid 1,1-dimethylethyl ester (FXAMPLE 20, Step 6, 13.83 g) and sodium azide (7.62 g) in dry (litn~LLylLul...~mi~ (117 mL) under N2 is stirred at 60~C for five hours and at slmhiPnt t~ p-~laLu-c: for 16 hours. The l~Lu~a is then diluted with ethyl acetate (200 mL), washed with water (8 x 100 mT-) and saline (100 mT-), dried over anhydrous m~ e.y;u~ll sulfate and conce~.t-dted under reduced pl~sYula to give the title compound, mp 109 - 110~C.
Step 8~ (-)4-r4-r5-(-~min~m~ yl)-2-o-y-~-3-~y-fl7nli~ -fl~ ro~h~
j~ri~linf~ rbryyli~ im~ot~ Utl ester A sollltinn of (R)4)4-[4-[5-(~ hyl)-2-oxo-3-~y~7nliflinyl]-2-luorophenyl]-l-piperi~inecA-Lu~yLc acid 1,1-dimethylethyl ester (T~XAMPLE 20, Step 7, 12.05 g) in dry tetrah~-l-vru~l (96 mL) under N2 is treated with triphenylphosphine (8.29 g) over five minlltes~ and the reslllt;ng llli~LLu~i8 stirred at ~mhiem+ tem~elature for two hours. The l~ixLu-a is then treated with water (3.1 mL), heated up to 40~C, stirred at 40~C for five hours and at ~mhi~nt temperature for 12 hours, and then con- Pnt~ated under reduced p~ u~a to give a viscous oil which i~ chromAto~. aphed on silica gel (70 - 230 mesh, 600 g), eluting with a gradient of mP+l~nnl/methylene r~hloride (2.5/97.5 - 16/86). Pooling and c-~n-~çnt~ation of those fractions with an Rf = 0.26 by TLC (m~th~nol/ch 10/90) gives the title c~lllpuulld, mp 136 - 137~C.
Step 9: (S~-(-)-4-r4-r5-r(Acetyl~min-)mPth,yll-2-o~t-3-~nr~7~ yl1-~-fl~ ro~?hprlyll-l-~Deri~linprslrbr~cyli~ acid l~ impth~yletht?r ester A s(~llltinn of (s)-(-)-4-t4-[5-(~minnmp+~yl)-2-oxo-3-~y~ inyl]-2-fluorophenyl]-1-piperi-linP~rboxylic acid 1,1-dimethylethyl ester (EXAMPLE 20, Step 8, 9.45 g) in dry methylene chloride (96 mL) under N2 is treated with pyridine (6.82 mL) and acetic anhydride (3.40 mT-), and the resulting ss~i~Luse is ~4-S~l 11 LlTESHEEr(RLlLE26) stirred at Amhi~nt temperature for four hours, diluted with methylene chloride (25 mT-), washed with water (25 mL), sdLu~led aqueou~ so~ m bicarbonate (25 mT.) and saline (25 mL), dried over anhydrous sodium sulfate and conce..l.dted under ~ reduced ple~lU~e to give the cnlde product which is then chrnTn~ ;. d~hed on silica 5 gel (230 - 400 mesh, 350 g), eluting with a gradient of mPt~n~l/chlol~ (2.~/97.5 - 7.5/92.5). Pooling and cnnr~ntration of those fractions with an Rf = 0.51 by TLC
(m~thAn~l/chl~lo~ 10/90) gives the title compound, mp 144 - 146~C.
Step 10: (S)-l-)-N-rr~-0~ n-3-r4-(4-~i~eri~iT~yl)-3-fluoro~hRnvll-5-tYs~7nli~1inyllm~t~ acet~mi~
A sollltion of (S)-(-)4-[4-[5-[(acetylamino)methyl]-2-oxo-3-nYA7nlitlinyl]-2-fluorophenyl]-l-pireri~in.=cA.l,~.~ylic acid phenylmethyl ester (EXAMPLE 20, Step 9, 10.44 g) in dry methylene chloride (100 mL) at 0~C under N2 is treated with trifluoroacetic acid (24.0 mL) over one minllte, and the rF~ tinF ~Lu~e is stirred at 0~C for 1.75 hours, cv... e-lt - ated under reduced ~ u~, diluted with water (100 15 mL), cooled in an ice bath, adjusted to pH 11 with sdLuLat~d aqueous pot~ccillm carbonate, and extracted with T~n~t~Annl/methylene chloride (5/95, 6 x 100 mL). The comhin~-l organic phase is dried over anhydrous sodium sulfate and cor.c~--t ~ dted under reduced ~ Ule to give the title c~ poulld, mp 163 - 164~C.

20 EXAMPLE 21 (~)-(-)-N-rr3-r4-rl-r(RPn~yln~y)acetyll-4-jiDeritlir~yll-3-flllnro~?hRr~yll-2-l~n-5-ny~nl~ yllmf!t~ R
Following the general ~loce-lu. e of EXAMPLE 18, and nns~kin~ non-critical variations but 8llhg~ g (S)-(-)-N-[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyl]-5-nYsl7~ inyl]methyl]-s~et~micle (EXAMPLE 20,) for (S)~-)-N-[[2-oxo-3-[4~4-25 piperidinyl)phenyl]-5-nY~oli~inyl]-methyl]~ret~mi~R and p~;ryillg the crude product by L~,Lu-dLion with chlorvrc,~ll./diethyl ether and filtration, the title cu~pousld is obtained, mp 147 - 149~C.

F'XANIPLE 22 (s)-(-)-N-rr3-r4-rl-(IIy~ y~r-p~ Deri~ ll-3 30 fluoro~hPnvll-~-o~n-5-mr~nlitlirwllmPthvllacetslmi~l~
A ~Lula of (S)-(-)-N-[[3-[4-[1-[(benzyloxy)acetyU-4-piperidinyl]-3-fluorophenyU-2-oxo-5-nY~7nli-1inyl]methyl]~ret~mi-ie (EXAMPLE 21, 5.00 g) and 20% p~ lm hydlv~de on carbon (2.80 g) in mPth~nol (500 mT ) is stirred under a llylllv~ tTnosphçre (balloon) for four hours, the catalyst is removed by filtration 35 through Celite and the filtrate is con~el.l-dted under reduced pl~s~ula, triturated with methylene chloride/diethyl ether and filtered to give the title compound, mp SU~.S 111 UTE SHEET (RULE 26) 182- 183~C.

Ti~AMpLE 23 (~;)-(-)-N-rr3-r4-rl-(Intl~ 2-~rb~ ?eridinvll-3-fluoro~h~r~yll-2-o~n 5~r~7~ yllm~tl~vllacets3mi~1e A ~ollltion of indole-2-ca~l.uAylic acid (79 mg) and 1,1~-carbonyl~liimi~lsl7ol~(80 mg) in dry tetrahyd~uruLan (2.0 mL) is stirred at s~mhient te~pelaLul.2 for one hour, and a sollltion of (S)-(-)-N-[[2-oxo-3-[4~4-piperidinyl)-3-fluorophenyl]-5-oY~7oli-1inyl]methyl]~ce~ 1e (T~'xAMpLE 20, 150 mg) in dry tetrah~L~ru~ (6.0 mT~ 3 added. The ~ UL~3 is then stirred at ~mhieT~t. telupt~ tuLe for 19 hours, cl n~çnt- ~ted under reduced ~r~s~u, e, diluted with methylene chloride (20 mT.), washed with satllL~Lted aqueous sodium bicarbonate (10 mT ), water (10 mL) and saline (10 mL), dried over anhydrous sodium sulfate and conce~ ted under reduced p~ ul~: to give the crude product which is chromagraphed on silica gel (70 - 230 mesh, 10 g), eluting with m~th~nnl/methylene chloride (7.5/92.5). Pooling and cc-n-~ntration of tho~e fractions with an Rf = 0.67 by TLC (mpth~nr~l/chlolvru~ "
10/90) and le~ ti~ n from chlo~ufo-~/diethyl ether gives the title co~pouL,d, mp 223 - 225~C.

F:~AMpLE 24 f$0-t-)-N-rr3-r4-rl-(I~ -5-~rbnnyl)-4-~weri~ vll-3 fluorouh~ -s-~~y~ invllmf~t~vllslrPtslmi~P
A sohltion of i~ny~7olp-5-c~l~u~ylic acid (79 mg) and l,l'-carbonyltliimi~ 7rlP
(80 mg) in dry tetrallyLvruldn (2.0 mL) is stirred at ~mhipnt t~lllpeldtll~,a for one hour, and a solllt;c.n of (S)~-)-N-[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyl]-5-oY~7olir~inyl]methyl]acetamide (EXAMPLE 20, 150 mg) in dry tetrahydloruLdn (6.0 mT-) is added. The J~ LUL~ is then stirred at ~mhipnt tempel~tule for 19 hours, cnnc~.~t. dted under reduced ~ ULe~ diluted with methylene chloride (20 mL), washed with salu~a~ed aqueous sodium bicarbonate (10 mL), water (10 mT-) and saline (10 mT.), dried over ~nhydrous so~lillm sulfate and conc~ d~ed under reduced ple~ul~ to give the crude product which is chromagraphed on silica gel (70 - 230 mesh, 10 g), eluting with mPth~nnl/methylene chloride (7.5/92.5). Pooling and c- ncPnt~ation of those fractions with an Rf = 0.67 by TLC (mpth~nol/chlolvfc,l~10/90) and l~cly~ i7~t;on from chlolvfollll/diethyl ether gives the title colllpoulld, mp 290 - 292~C.

~ANIPLE 25 (s)-(-)-N-rr3-r4-rl-(~pt~v~ lf r~yl)-4-17iperi-1invll-3 fluorophPnyll-~ rn 5 ~Y~7nli~ yllmPtll,vllacet~mitle ~6-SUBSTITUTE SHEET (RULE 26) A solllti~m of (S)-(-)-N-[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyl]-5-~Y~7~ inyl]methyl]~et~mide (EXAMPLE 20, 125 mg) and pyridine (60 IlL) in dry methylene chloride (1.9 mL) at 0~C i6 treated with m~th~na~ulfonyl chloride (32 ~lL), and the re~llltinF LllixLule was stirred at 0~C for one hour and at ~mhi~nt 5 tempe~dLule for 16 hours. The reaction l,~LuLe is then diluted with methylene chloride (30 mL), washed with water (10 mL) and s~line (10 mT,), dried over anhydrous sodium sulfate and con~enl-dted under reduced ~eE~u~e, and the residue is ~ DI ~lli7e~l from methylene rhlori~p~/diethyl ether to give the title cuLu,uuuud, mp 240 - 242~C.
T~AlvlpLE 26 (S)-(-)~-r4-r5-r(Acetyl~minn)mPth~yll-2-nyn-3-oxazo~ irlyll-2 flllnrophar~yll-1-p~geriflin~rbnY~ acid mPth~yl ester A mixture of (S)-(-)-N~[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyl] -5-nYsl7nli~1inyl]methyl]~cet~mifle (T~xAl\lrpLE 20, 160 mg) and sodium bicarbonate (75 15 mg) in dry tetrahyd.urw~ul (6 mT ) at 0~C under N2 is treated with methyl chlc.roru~Luate (38 IlL), and the r~lllt;ng L."~Lule is stirred at 0~C for one hour. The reaction is then diluted with ethyl acetate (20 mL), washed with water (10 mL) and saline (10 mL), dried over anhydrous m~nP~ium sulfate and cor.ce..lr~ted under reduced ,uleb~we, and the residue is l~ L~lli7erl from methylene ~~hlnri(l~/diethyl 20 ether to give the title cu~,uuuud, mp 165 - 166~C.

T~'XANIPLE 27 (S)-(-)-N-rr3-r4-rl-(Cy~nnm~th~yl)-4-3;~ eridinyll-3-fluorophP
2-nYn-5-nYsl7nli~ lm~t~yllacet~slmi~l~
A u~ l,ulè of (S)-(-)-N-[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyl]-6-26 ny~7oli~linyl]methyl]~et~mifle (Ti~Al\/lPLE 20, 160 mg), chloro~-etonit~ (31 ~lL) and anhydrous potassium carbonate (124 mg) in dry ~retonitrile (4 mL) under N2 was stirred at ~mhie~nt temperature for 20 hours, diluted with methylene chloride (20 mL), washed with water (10 mL) and saline (10 mL), dried over anhydrous sodium sulfate and con~..t-dtêd under reduced pressure, and the residue is 30 le~ ~y~ 1 from methylene chlnrirl~/diethyl ether to give the title compound, mp 166- 167~C.

EXAMPLE 28 (o-(-)-N-rr3-r4-rl-(2-Fluo~ l)-4-~?er~ yll-3-fluorol~h~r~
2-~Yn-6-n~ n~ yllm~thyllacet~m~
36 Following the general plocedu~e of EXAMPLE 27, and mslking non-critical lTE SHEEr (Rlll~26) W O 97/09328 PCT~US96/12766 v~ri~tinnR but 8llh~ F 2-flouroethyl 4-toluenesulfonic acid ester for chloro~-etonitrile and pul;ryi.lg the crude product by chrom~ aphy on silica gel(70 - 230 mesh, 30 g), eluting with m~t~ ~nnl/methylene chloride, the title comrollnd is obtsine-l, mp 155 - 157~C.

EXA~LE 29 (S)-(-)-N-rr3-r4-r1-(Formyl)-4-piperi-liTv11-3-flll-ro~h.or~vll 2 n Ysl7~1i(3invllm~t.1~ ots~mi~1~
A ~il~Lula of (S)-(-)-3-[[2-oxo-3-[4~4-pip~ri~linyl)-3-fluorophenyl]-5-~Y~ inyl]methyl]~ ~t~...i~le (EXAMPLE 20, 150 mg), 1-(3-dimethylaminopropyl)-10 3-ethylcarbo~iimi~ y-llo- hl~ P (171 mg) and formic acid (34 ~lL) in dry tetrahydlurul~n (6 mL) is stirred at ~mhiPnt t~ ,u~.dLula for one hour, diluted with methylene chloride (10 mT-), washed with water (10 mL) and saline (10 mL), driedover anhydrous sodium sulfate and c()nr~ ~l a~d under reduced ~las~ul~ and the re~idue is ~ y~ from methylene chloride/diethyl ether to give the title 15 cu. puulld, mp 186 -187~C.

EXAMPLE 30 (~)-(-)-4-r4-r5-rr(~ ~-T)ir.hl-rn~ min~-lm~+.~ .-n~rn 3 7nlil1ir~yll_~_flllr~ro~h~rlyll-l-DiDeri~linp~ .b~ r.i~ mf~t~ vlpt~yl e~ter A solllt;~ n of (S)-(-)-4-[4-[5-(Ar. .; . ..~ ~hyl)-2-oxo-3-oY~7 nli~inyl]-2-20 fluorophenyl]-1-piperillinP~ArLu~ylic acid l,l-dimethylethyl ester (FXANIPLE 20, Step 8, 400 mg) in dry methylene ~.hlor~ (4.1 mL) at 0~C under N2 is treated with triethylamine (0.21 mT.) and dichloroacetyl chloride (0.11 mT,), and the re~nlting ~i~Lul~ is stirred at 0~C for three hours, diluted with methylene chloride (10 mT.), washed with water (10 mL), saturated aqueous sodium bicarbonate (10 mL) and 25 saline (10 mL), dried over anhydrous sodium sulfate and cc~ce~ dted under reduced L)~ u~e to give the crude product which is then chrom~t~S~.aphed on silica gel (70 - 230 mesh, 50 g), eluting with mPth~nol/chlolofo~ (5/95). Pooling and conr~..l~~Lion ofthose fractions with an Rf = 0.53 by TLC (m~nol/chlo,urol....
10/90), ~l;Lu~lion with methylene chloride/diethyl ether and filtration gives the 30 title co ,uound, mp 168 - 170~C.

F:~AM PLE 31 (~O-(-)-~ ~-Di- hlr~ro-N-rr2-r~-~-3-r3-fluoro-4-(4-yl)Dh~ yll 5 ~ 7~nli~1inyl1mf~th~yl1ace~lmi~
Following the general procedure of EXAMPLE 20, Step 10), and ms~king non-35 critical variations but ~llh-~;t.lt;ng (S)-(-)-4-[4-[5-[[(2,2-dichloroacetyl)amino]methyl]-~8-SlJlb~ 111 UTE SHEET (RULE 26) 2-oxo-3-nYA7oli-1inyl]-2-fluorophenyl]-l-piperi~linPcArboxylic acid l,l-dimethylethyl ester (FXAMPLE 30) for (s)-(-)4-[4-[5-[(acetylamino)methyl]-2-oxo-3-ny7l7olitlinyl]-2 fluorophenyl]-l-piperi-linPcArbo~ylic acid phenylmethyl ester, the title compound is obtained, NMR (CDCl3, 400 MHz) 7.37, 7.22, 7.10, 5.99, 5.29, 4.83, 4.07, 3.78, 3.71, 5 3.30, 2.98, 2.83, 2.09, 1.81 o.
>

EXAMPLE 32 (~ -r)i rhlnro-N-rr~-~yn-3-r3-fluoro4-rl-r(acetny~y~acetyll-4vi,~P-ri~ ylll~hp-r~yll-5-l~rA7~nli~ yllmpt~yllA~ G~ p, Following the general pr~cedure of EXAMPLE 18, and mnkinF non-critical 10 vAriAt;~nR but snh~L;~ g (S)~-)-2,2-dichloro-N-[[2-oxo-3-[3-fluoro4-(4-piperidinyl~phenyl]-5-nY~7nlitlinyl]methyl]nc~tG...itlP (EXAMPLE 31) for (S)-(-)-3-N-[4~4-pirPritiinyl)phenyl]-5-A~etslmitlomptllyl-2-nyA7~oli~inonp and aca~u~y~cetyl chloride for benzyloxyacetyl chloride, the title co pound i8 obt~inP-l N~ (CDC13, 400 ~z) 7.42, 7.15, 6.24, 4.77, 4.04, 3.77, 3.68, 3.20, 3.07, 2.71, 2.20, 2.02, 1.88, 15 1.68 ~.

F'XAl\/IPLE 33 (~q)-(-)-~ ~ni~hlnro-N-rr~ n-3-r3-flll-ro4-rl-(~ cetyl)-4-yllDhPr~yll-5-nYA7~n~ yllmpt~yllA~ s....itlP
A ~u~a of (S)-(-)-2,2-dichloro-N-[[2-oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-4-20 pip.~ . ;.l; .. yl]phenyl]-5-nYn7nli-1inyl]methyl]nc~~ .. i~P (FXAMPLE 32, 110 mg) and anhydrous pot~RRillm carbonate (60 mg) in mP~l Anol (8.8 mL) is stirred under N2at Amhient. te,ll~eldture for one hour and then c~ r~ dted under reduced p~ a and chromA~graphed on silica gel (70 - 230 mesh, 10 g), eluting with mP~nnol/chlororo~ (10/90). Pooling and con~ dLion of those fractions with an 25 Rf = 0.41 by TLC (mp~hAnnl/chlolofol~l7 10/90), L~u~ ;cAt;~n by radial chromAt~graphy (2000~ silica gel plate) eluting with m~l Anol/methylene chl~ri~le~
and Ll;Lu~lLion with chloroform/diethyl ether give~. the title compound, NMR
(CDC13, 400 MHz) 7.46, 7.39, 7.15, 5.99, 4.84, 4.74, 4.22, 4.09, 3.77, 3.61, 3.10, 2.79, 1.89, 1.66 ~.
EXAMPLE 34 (s)-(-)-N-rr2-oxo-3-r3-fluoro4-rl-r(~pt~y)Ar~p~vll-4 pi,~eri-linvll~?halv11-5-~ ~rA7~ irlyllmPtlurllA~pt~mi(la Following the general procedu~e of F~AlvlpLE 18, and mAkinF non-critical variations but sllh~ (S)~-)-N-[t2-oxo-3-[4{4-piperidinyl)-3-fluorophenyl]-5-35 o~A~oli~linyl]methyl]acetamide (EXAMPLE 20,) for (S)-(-)-N-[[2-oxo-3-[4~4-SUBSTITUTE SHEET (RULE 26) W O 97t09328 PCT~US96/12766 piperidinyl)phenyl]-5-nY~oli~inyl]methyl]~ret~mi~e and acetvAy~c~yl chloride forbenzyloAyacetyl chloride, the title compound i8 obtained, NMR (CDCl3, 400 MHz) 7.42, 7.15, 6.24, 4.77, 4.04, 3.77, 3.68, 3.20, 3.07, 2.71, 2.20, 2.02, 1.88, 1.68 o.

F~ANIPLE 35 (S)~-)-N-rr2-O~rn-3-r4-(4-gigeri~ 3.5--lifll-nro~hPT~ 5 n~ nli~ yllmP+l~,yllacetslmi~a Step 1: 1~3.5-n;fluoro~har~yl)-~ ~ 5.5-tetrPmPtl~yl-1-A~A-2 fi-tliRil~r~yclovant~na Following the general procedure of Step 1 of EXA~LE 20, and m~kinF non-critical v~ri~t;~n~ but sllh~L;~ F 3,5-difluorv~nilinP for 3-fluoro~nilina, the title c.,~uulld i8 obtained, NMR (CDC13, 400 ~Iz) 6.38, 6.31, 0.87, 0.17 ~.
Step 2: 3.6-nihy~ro-4-r4-~minn-~. 6-~ifluorol;?har~yll-1(~)-Dyri-linP~ ylir.
3~r.i~11.1-~limPth~ylPt~yl ester Following the general pl'uCe dule of Step 3 of ~AMPLE 20, and m~king non-critical variations but sllh~L:4~ F 1-(3,5-difluorophenyl)-2,2,5,5-tetramethyl-1-aza-2,5-disila~ ~ kjpantD.na(li'XAlVlPLE 35, Step 1) for 1~3-fluorophenyl)-2,2,5,5-tetramethyl-1-aza-2,5-disilacyclopent~ne, the title compound i8 obt~ina-l, mp 134 -135~C.
Step 3: 4 r4 rr(phPr~ylmPthn~ rslrbnr~yll~minn-2.6-tlifl rirari~linPr.ArL.-~ylirslri~ imP.+~,ylPt~yl ester Following the general ,Ul~J~,e.lUl~, of Step 4 of EXA~LE 20, and m~kinF non-critical v~ri~ti~n~ but ~illh~L;~ g 3,6-dihydro-4-[4-amino-2,6-difluorophenyl]-1(2H)-pyr;-linPcA.bul~ylic acid l,l-dimethylethyl ester (~XAMPLE 35, Step 2) for 3,6-dihydro4-[4-amino-2-fluorophenyl]-1(2H)-pyri~inacA.l,u~ylic acid 1,1-dimethylethyl ester and ~ul;ryi..g the crude product by Ll;LuiaLion with ethyl ~cet~tP~hexane and 25 filtration, the title c~ ~,uuul.d is obt~inP-l, mp 153 -155~C.
Step 4: (R)-(-)4-r4-r5-(I~ vl)-2~rn-3-nY~7n~ yll-~ 6-rliflllnrophPnvll-l-~gerirlin~ b~xvlic ~ im~'t~ylet~url ester Following the generel l.l.,cedu~e of Step 3 of EXAMPLE 17, and ms~king non-critical v~ri~t;~n~ but sllh~ g 4-[4-[[(phellyl..-P~ Yy)calllu~yl]amino-2,6-30 difluorophenyl]-1-piperir~inacA-1Ju,-ylic acid l,l-dimethylethyl ester (EXAA~LE 35, Step 3) for 3~6-dihydro4-[4-[[(phenylmpthnyy)calbollyl]amino]phenyl]-l(2H)-pyri~inPc~rboxylic acid phenylmethyl ester, the title co~llpuuud is obtained, NMR
(CDC13, 400 MHz) 7.11, 4.75, 4.22, 3.96, 3.75, 3.06, 2.76, 2.50, 1.98, 1.65, 1.48 ~.
Step 5: (R)-(-)4-r4-r5-rr(MPt~ fnr~yl)n~ylmpt~y~ -nyn-3-ny~7nli~irtyll-~ 6-35 ~lifluoro~h~rlyll-l-pi~eriflinpl~A . IJO~ acid 1. l-~im~thylet~yl e~ter Following the general ~urûcellule of Step 4 of EXAMPLE 17, and mslkin~ non-~l~lTrUrESttEEI (RUlE2~

CA 02228647 l998-02-03 W O 97/09328 PCT~US96/12766 critical v_riations but sllhstihlting (R)-(-)-4-[4-[5-(hy(llu~y~l~ethyl)-2-oxo-3-~~YA7~ inyl]-2~6-difluorophenyl]-l-piperitlinpçArboxylic acid 1,1-dimethylethyl ester (~XAMPLE 35, Step 4) for (R)-(-)-3,6-dihydro-4-[4-[6~hydro~y--lethyl)-2-oxo-3-~YA7nli(1inyl]phenyl]-l(2H)-pyri~linecArboxylic acid phenylmethyl ester, the title 5 compound is obt~inP-l, mp 125 - 126~C.
Step 6: (R)-(-)-4-r4-r5-(A7irl-~mPt.~yl)-2-n~n-3-n~rA7.nli~ir~yll-~ 6-rliflllnrophPn 1-piI~eri-linPrArbn~cvlir Ari-l l 1-~limPt~ylethvl ester Following the general procevu~~ of step 7 of EXAMPLE 20, and mAking non-critical variations but sllhr l~ g (R)-(-)-4-[4-[5-[[(methylsulfonyl)oxy]methyl]-2-10 oxo-3-nYsl7oli-linyl]-2,6-difluorophenyl]-1-piperi~1inec~ ~ bu~ylic acid 1,1-dimethylethyl ester (F:~AMpLE 35, Step 5) for (R)-(-)-4-[4-[5-[[(methylsulfonyl)oxy]methyl]-2-oxo-3_9YA7nli~inyn 2 fluorophenyl]-1-pirPri~in~Albu~ylic acid 1,1-dimethylethyl ester, the title cv~ vulld is obtained, mp 125 - 127~C.
Step 7: (.O-(-)-4-r4-r5-r(AcetylAminl-)met~yll-?.-f~Yn-3-nYD~7n~ ll-? 6-15 ~1ifluorophPr~yll-l-~i~;l;?eri(lin~rArbn~ylir 1 1-t7imPt~urlet~yl ester A ~Lu.~ of (R)-(-)-4-[4-[5-(A7i~onnpt~yl)-2-oxo-3-nyA7~ inyl]-2~6-difluorophenyU-1-pirP.ri~inPcArboxylic acid 1,1-dimethylethyl ester ((EXAMPLE 35, Step 6, 1.51 g) and 10% pAllA~illm on carbon (367 mg) in mPthAn~l (35 mL) is stirred under a hy~v~ AtrnnsphPre (balloon) for 18 hours, the catalyst is removed 20 by filtration through Celite and the filtrate i8C~ r,c~ Led under reduced pl~~
to give the 5-AminnmPthyl-2-~yA7~ inonp intermP-liAt~ (Rf = 0.10 by TLC, mPt~Annvchlol~rv~ 5/95). A solllt;nn of this interm~liAte- (1.28 g) and pyridine(2.51 mL) in dry methylene o.hlsri(lr- (31 mL) at 0~C under N2 is treated with acetic Anhydride (1.47 mL), and the rPclllt;ng sslnt;nn is allowed to warm to AmhjPnt 25 tempe~dLu ~ with stirring over 1.5 hours. The ...ixLu-~ is then diluted with methylene chloride (15 mL), washed with water (10 mT~)~ saLuldted aqueous sodiurn bic~l,ûnate (2 x 10 mT-) and saline (10 mL), dried over anhydrous so~lillm sulfate and conce..l-dted under reduced pL~~u~~ to give the crude product which is chrom~ . dphed on silica gel (70 - 230 mesh, 150 g), eluting with a gradient of30 mp~h~nnl/methylene chloride (1/99 - 4/96). Pooling and con~ntration of those fractions with an Rf = 0.31 by TLC (m~t)~nnl/chlolù~o~ , 5/95), L.;Lu~dLion withdiethyl ether and filtration gives the title cu~ )c ulld, NMR (CDCl3, 400 ~Iz) 7.06, 6.56, 4.78, 4.22, 4.00, 3.74, 3.65, 3.05, 2.75, 2.02, 1.96, 1.64, 1.47 ~.
Step 8: (~S)~ ) N-rr2-Oy-n-3-r4-(4-~?iDe~ yl)-3~5-~lifluoro~h~r~yll-5 35 ~y~7n~ invllm~t~yll~ t~mi~le A ~Lu. ~ of (s)-(-)-4-[4-[5-[(acetyla-m-ino)methyl]-2-oxo-3-ny~oli~inyl]-2~6 SUB5TITUTE SHEET (RULE 26) difluorophenyU-1-pipRri-iinPrsrboxylic 1,1-dimethylethyl e~ter ((EXAMPLE 35, Step 7, 847 mg) and trifluoroacetic acid (12 rrlT,) m~s~intsiner~ at 0~C under N2i8 stirred for two hours and then conc~ ~t~a~ed under reduced ~8~ to remove excess trifluoroacetic acid. The residue is diluted with salu~ated aqueous potsRcinm 6 carbonate (70 mL) and methylene chloride (50 mL), and the layers are separated.
The aqueous phase is extracted with methylene chloride (2 x 50 mL), and the comhin~l organic phase is dried over anhydrous sodium sulfate, conrentrated under reduced ~ Ul~, h;lu~ated with diethyl ether and ~ li7e~ from ethyl acetate to give the title cc .pou~d, NMR (CDC13, 400 MHz) 7.08, 6.10, 4.78, 4.00, 3.74, 10 3.64, 3.19, 3.07, 2.72, 2.03, 1.99, 1.68 o.

F~AlVrPLE 36 (~c~)-(-)-N-rr3-r4-rl-r(RRn7~ s~p~ -4-~er~ -3~6 ~lifl~ ros?hp~ oxo-6-~ys37~nli~ mpt.~ pt~mitl~
Following the general ~.~cedu~a of F!~AMPLE 18, and m~king non-critical 15 v~ri~ti~nR but 8l~h~ F (S)-(-)-N-[[2-oxo-3-[4~4-pireri~linyl)-3~5-difluorophenyl]-6 ~Y5~ inyl]methyl]~cehmi-l~ (EXAMPLE 35) for (S)-(-)-N-[[2-oxo-3-[4-(4-piperidinyl)phenyl]-6~Y~ inyl]methyl]~e~~ P, the title compound is obtPined, mp 169~C- 171~C.

20 F~xAlvlpLE 37 (~q)-(-)-N-rr3-r4-r1-(I~ p~yl)-4-pi~I?erit~ yll-3.6-~iflllnrophPTu~ -n~rn-5-ny~7nli~ ,yllmpt~,yll~ pt~mi~lp~
A~ . of(S)~-)-N-[t3-t4-t1-t(benzyloxy)acetyl]4-pirPritiinyl]-3~6-difluorophenyl]-2-oxo 5 oy~7olitlinyl]methyl]~ et~mitlp (EXAMPLE 36, 207 mg) and10% p~ illm-on-carbon (100 mg) in mPth~nol (9 mL) is shaken on a Parr 25 apparatus under a hyd~ tmosrhpre at 40 psi for 20 hours, the catalyst i6 removed by filtration through Celite and the filtrate is co..~ dted under reduced ~lèS~u~e to give the crude product which is chromAlo~ hed on silica gel (230 -400 mesh, 20 g), eluting with a gradient of mPth~nr)]/methylene ~hlnri~e (5/95 -10/90). Pooling and concpntration of those fractions with an Rf = 0.26 by TLC
30 (mpth:~nnl/chlo~ofc~ 10/90) and le~ lli7~t;nn from methylene chloride/diethyl ether gives the title compou~d, NMR (CDCl3, 400 MHz) 7.07, 6.80, 4.78, 4.69, 4.18, 3.99, 3.74, 3.63, 3.60, 3.16, 3.06, 2.90, 2.72, 2.00, 1.97, 1.75 o.

li'XAl\/lPLE 38 (S)-(-)-N-rr~-O~r~-3-r4-(3.6-~ y~ro-2~-~yri~lin-4-yl)-3 35 flllnro~h~ -5-ny~7nli~lir~vllmpthvll~t~pt~
Step 1: (S)-(-)-4-r4-r5-r(Ace~ minn)mPt~ rn-3-n~7nli~ yll-2 SUBSTITUTE SHEET(RULE26) fluoro~hPr,yll-3.6--lihylro-1(~T-T)-vyri~inPr~rboxyli~~ acid 1.1-rlimPt~ylP+hvl ester A ~u~e of (S)~-)-N-t[3-[4-trin~~~llylstc nnyl-3-fluorophenyl]-2-oxo-5-nYs~7nli~inyl]methyl]~ret~mille (690 mg), 3,6-dihydro~-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyri-linP~- rboxylic acid l,l-dimethylethyl 5 ester (step 2 of Ti~xA~ pLE 20, 500 mg), tAs(dibenzyli~enP~.~etonP)-lir~ m(0 (14 mg) and triphenylarsine (37 mg) in N-methyl-2-pyrroli~lin~AJne (7.5 mT-) is ~lçg~Re~3, stirred under N2 at ~mhiant ~ ~p~,.a~l--e for 4.5 days, diluted with ethyl , o,et~te, washed with water (3 x 40 mT~) and saline (20 mT-), dried over anhydrous mn~nPcillm sulfate and c.~Jn.~a~.l aled under l~e.lucad ~ ule. The residue is 10 chrom~ . dphed on silica gel (230 - 400 mesh, 120 g), eluting with a gradient of mP~hslnr~l/methylene chloride (1/99 - 2/98), and those fraction having an Rf = 0.27 by TLC (mP~7 ~nol/chlo-~ , 2 x 5/95) are pooled and con~u ~-aled to give the title compound, lH NMR (CDCl3, 400 MHz) 7.39, 7.22, 7.13, 7.01, 5.92, 4.82, 4.06, 3.80, 3.67, 3.61, 2.47, 2.03, 1.49 o.
Step 2: (S)-(-)-N-rr2-O~ -3-r4-(3.6--lihvl1ro-?~T-gyIi~lin-4-yl)-3-flllnrol~hPnvll-5-~Y~7~ yllmPt.hy~ .t~...i~a A solllt;~n of (s)~-)4-[4-t5-[(acetylamino)methyl]-2-oxo-3~y~ inyl]-2-fluorophenyl]-3,6-dihydro-1(2H)-pyri-line~--.l,u.~ylic acid l,l-dimethylethyl ester (Ti~xAMpLE 38, Step 1, l.OOg) in dry methylene chloride (9.2 mL) at 0~C under N220 i8 treated with trifluoloa_~l~ acid (2.3 mL) over one minll~q, and the maRlllt;ng ~Lu~e is stirred at 0~C for three hours and added slowly to sa~u~ d aqueous pot"RRillm carbonate (30 mT.) to neutralize excess trifluo~ac~Lic acid. The rpBllltslnt BlU~Ty iB filtered and the pre~ g is chrom~to~ phed on silica gel (70 -230 mesh, 60 g), eluting with gmmnnillm hydroxide/mP~ nol/methylene chl-~ri~e 25 (0.26/19.75/80). Those fractions with an Rf = 0.08 by TLC (mP+~An- l/chlolûfo,,l., 20/80) are pooled and conc~ ated under reduced pre8~e to give the title cu~pc und, lH NMR (MeOH~4, 400 MHz) 7.47, 7.33, 7.25, 6.02, 4.80, 4.15, 3.83, 3.58, 3.47, 3.04, 2.46, 1.98 o.

30 ~XAl\~PLE 39 (S)-(-)-N-rr2-OY~--3-r3-fluoro-4-rl-r(~c,~ A~Pt~T11-3.6-~ lro-vritlin-4-yll,~hPr~yll-5--~YA7~ ,,vllmPt~,vllA~.P+-9mi~
Following the general p.~,cedule of F'XAlVlPLE 18, and mAking non-critical variations but snhs+it~lting (S)~-)-N-[[2-oxo-3-[4-(3,6-dihydro-2H-pyridin-4-yl)-3-fluorophenyl]-5-oYs701i~1inyl]methyl]A~et-smifle (~XAl\/IPLE 38) for (S)~-)-N-[[2-oxo-35 3-[4-(4-piperidinyl)phenyl]-5-oY-s7oli-linyl]methyl]A~et-s~ and acetv~y~cetyl chloride for benzyloxyacetyl chloride, the title cul-l~uulld is obtsinP~, mp 188 -SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCTrUS96/12766 191~C.

PLE 40 (~ )-N-rr3-r4-rl-(ITvlllv~y~tatyl)-3~6-~lih~y~ro-~H-vyri~lin~
3-fll~nro~harlyll-2-oyn-5-~-y-~nli~invllm~t~lvll~c~t~r~ a A ~Lul~ of (S)-(-)-N-[t2-oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-3,6-dihydro-2H-pyridin-4-yl]phenyl]-5-oY~:nli-linyl]methyl]~et~mi~e (F'XAlVrPLE 39, 475 mg) andanhydrous poto~ lm carbonate (303 mg) in m~t~nnl (44 mL) is stirred under N2 at ~mhient te~ el~LuLa for 1.5 hours and then adjusted to pH 7 with aqueous LyLocl~loric acid (1~) and cnncf ~ dted under reduced pl~ iUl~. The residue is chrom~ hed on silica gel (230 - 400 mesh, 40 g), eluting with a gradient of m~th~nnl/chlolufc,~ (5/95 - 10/90), and those fractions with an Rf = 0.21 by TLC(m~tll~no]/chlolu~u,,ll, 10/90) are pooled and conce~ Led under l~:du~,~d ple~ul~.
The ra~lllt;n~ foam is then L;Lul~Led with methylene ~.hlnri~/diethyl ether and the ~ filtered to give the title cc.lll,uu~lud, Anal. calcd for ClgH22N305F C, 58.31; H, 5.67; N, 10.~4. Found: C, 58.15; H, 5.64; N, 10.72.

FxAlvrPLE 41 (5-C:)-N-rr3-r3-Fluoro-4-rl-(uhalulmat~yl)-3-~vrr~ ?h~Tu~ll ~ nYn ~; nYs~nlitlirlyllmat.~ylln/ ~ a Step 1: r.C~)-(-)-N-rr3-r4-li',t~anvl-3-flllnrophalull ~ nYn 5 20 ny~7nli~irlyllm~ot~ t~mitl~-A ~Lul~, of (s)-(-)-N-[[3-[4-iodo-3-fluorophenyl]-2-oxo-5-Qy~7olitlinyumethyl]
s~r,e~ la (5.45 g), villylL;~uLylLi~l (5.48 g) and bis(t~iphanylrhosrhine)pS~ illm(II) ~hlnri~P (303 mg) in 1,4--linY~n~ (72 mL) under N2 is ~lpF~e~l~ heated up to reflux, lenu~ed for seven hours, cooled to 26 ~mhiPnt. te p~.dtUl~ and stirred for 12 hours. The ~xLulais then diluted withethyl acetate (40 mL) and water (50 mL) and the layers are separated. The aqueous phase is extracted with ethyl acetate (2 x 30 mL), and the comhin~cl organic phase is washed with saline (40 mL), dried over anhydrous mslgnP~illm sulfate, cQn~ dLed under reduced ~ ula and Lr;Lu~aled with diethyl ether.
30 The re~nlt~nt. yla-~ e is filtered to give the title cu~pound, mp 165 - 166~C.
Step 2: (5.~)-N-rr3-r3-Flnnro~-rl-(DhPru~lmpt~yl)-3-Dyrroli~ yll~hp~ -2 5~Y~7:n~ lmpthvllace~ ,i(la A snhlt;nn of (S)-(-)-N-[[3-[4-vinyl-3-fluorophenyl]-2-oxo-5-nYsl7~ inyl]methyl]~et~mi~a (EXAMPLE 41, Stap 1, 3.50 g) and trifluoroacetic 35 acid (0.23 mL) in dry methylene chloride under N2 is treated with a sollltinn of N-benzyl-N-(mPtl nYymethyl) trimethylsilylmethylamine (6.10 g) in dry methylene SUBSrlT~ SHEl~T ~RULE26) W O 97/09328 PCT~US96/12766 chloride (50 m L) dropwise over 4.5 hours, and the re~sllltinF sollltion was stirred at AmhiPnt te"~peL~,lul~ for 17 hours. The reaction ~ lule is then washed with sa~ul~ted aqueous sotium bicarbonate (30 mL), water (30 mL) ant sPline (30 mL), dried over anhydrous sodium sulfate and conc~ dted under reduced pL'~eDDula to 5 give a residue which is chrom~toFraphed on silica gel (230 - 400 mesh, 350 g),~ eluting with a gradient of mPtl~novmethylene chloride (1/99 - 10/90). Pooling and cnn- ~.t - ~l ion of tho~e fractions with an Rf = 0.19 by TLC (mPth~n~ l/chloro~l~, 10/90) and l~;lul~Lion with mPth~nnl/diethyl ether gives the title co~puulld, NMR
(CDC13, 400 MHz) 7.35, 7.25, 7.13, 6.08, 4.78, 4.03, 3.76, 3.69, 3.62, 2.97, 2.78, 2.56, 10 2.33, 2.02, 1.85 ~.

F'XAMPLE 42 (5.0-N-rr3-r3-Fluoro-4-(3-Dvrrnli~ vl)phPr~ . nYn 5 ~Ys~7r~ yl1mPt.~ Pt.slmiria A ~lule of (5S)-N-[[3-[3-fluoro-4-[l~phenylmethyl)-3-pyrrolidinyl]phenyl]-15 2-oxo-5-oY~7oli~ inyl]methyl]~~t *. ..i~ie (EXAMPLE 41, 1.09 g) and 20% ps~ lm hydlv~de on carbon (545 mg) in mPth~nnl (30 mL) is shaken on the Parr a~palalus under a hy-llv~ t nosFh~re at 40 psi for 1.5 hours and at 10 psi for 18 hours.The catalyst is then removed by filtration through Celite, and the filtrate is c~...r~ aled under reduced ~e.~Dule to give the title ~ oulld, NMR (CDC13, 400 ~Iz) 7.39, 7.24, 7.11, 6.35, 4.78, 4.04, 3.77, 3.67, 3.44, 3.37, 3.18, 3.11, 2.88, 2.21 2.02, 1.86 ~.

hXAMPLE 43 (5S)-N-rr3-r3-Fluoro-4-rl-r(13Pn7~ Yy)acet~vll-3-pyrrrliriir~vll,l~hPrvll-~ Y -5 nys~ nliri~ mpth~yll~ at~mi~ip Following the general ~l~ce1ule of F'XAMPLE 18, and mslking non-critical vslriS~ n~ but snh~ g (5S)-N-[[3-[3-fluoro-4-(3-pyrrolidinyl)phenyl]-2-oxo-5-nY~7~ inyl]methyl],lr~t~ (~XAlvlpLE 42) for (S)-(-)-N-t[2-oxo-3-[4~4-piperidinyl)phenyll-5-nY~oli~inyllmethyU~et~mi(le~ the title w ~uu~d is ohtsina~HRMS c~l~nll~t~l for C25H28N305F: 470.2091. Found: 470.2106.
EXAMPLE 44 (5~)-N-rr3-r3-Fluoro-4-rl-(1-v~ cetyl)-3-~ Tnli~invl~ har~r Yn_5_~Yz3~ mf~t~ c~ a Following the general plC~ e of EXAMPLE 22, and m~kinE non-critical v~riS~tinn~ but sllh~L;I~~ g (5S)-N-[[3-[3-fluoro-4-[1-[(benzyloxy)acetyU-3-pyrrolidinyl]phenyl]-2-oxo-5-nY~7nli~inyl]methyl]~et~mi~l~ (EXA~LE 43) for SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 (S)-(-)-N-[[3-t4-[1-[(benzyloxy)acetyl]-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-nY~7o~ inyl]methyl]~r~et~micle~ the title co---pc u.ld i8 obtained, FAB-HR~S
c~lr~ t~tl for C18H22N3~sF + H: 380.1622. Found: 380.1625.

6 F~AlVIPLE 45 (6~q)-N-rr3-r3-Fluoro4-r1-(formvl)-3-Dyrrnli~ yl~h~ 2-- Y-.-~; oY~7n~ vllm~t~lvll~rf~tslmitl~ .
Follovring the general pl~cedul~ of ~XAMPLE 29, and mAking non-critical v~ri5~tion~ but sl~h~ g (5S)-N-[[3-[3-fluoro-4-(3-pyrrolidinyl)phenyl]-2-oxo-5-nYs~nli~linyl]methyl]~~tG~ e (FXAMPLE 44) for (S)-(-)-N-[[2-oxo-3-[4~4-10 piperidinyl)-3-fluorophenyl]-ij-nYn~ inyl]methyl]Acet~mitl~, the title a~mrolln~
~t~in.q-~, HRMS c~lrlll~t~cl for Cl7H20FN304: 349.1438. Found: 349.1444.

h'XAlVIPLE 46 (5~q)-3-r4-r~;-r(Acetyl~min~)m~t~yll-~ y~-3-~y~7~ ,yll-2 flllnrophf~r~yll-l-~;>yrrt)li-lin-b- A - l~n~l;r ~ri~ mf~t.l~,yl e~ter Following t~e general ~l~ce~lul~, of ~XA~ pLE 26, and mAkinE non-critical v~ris~t;~m~ but ~llh- l: l . i: ..g (5S)-N-[[3-[3-fluoro4-(3-pyrrolidinyl)phenyl]-2-oxo-5-nY~nli~inyl]methyl]~ e (~XAlvlpLE 44) for (S)~-)-N-[[2-oxo-3-[4~4-pireri-1inyl)-3-fluorophenyl]-~ Y~7nli~inyl]methyl]A(~et~...i~a, the title COI~ pùuud i8 obtained, HRMS c~lrlll~t~l for C18H22FN30~: 379.1543. Found: 379.1546.
FXAMPLE 47 (~)~-)-N-rr3-r4-(3.6-nihy~ro-~ yr~n-4-yl)-3-flnnrol7hpr~
oY--5-ny~7nli~ yllmptllyllnr.1~,..i(la Step 1: 3.6-ni~y lro-~ vr~n-4-vl trifluornmatl~np~ f~ni~ acid ester Following the general p~cedulc of Step 2 of FXANrPLE 20, and m~kinE non-25 critical v~ri~tinn~ but sllh~ l:l .l :-.~ tetrahyd-ùpy-~-4-one for 1-(1,1-dimethylethoxycarbonyl)-4-pireri-lon~, the title cc.~pou~d is obtsinP-i, lH NMR
(CDC13, 400 MHz) 5.82, 4.27, 3.90, 2.47 o.
Step 2: 3-Fluoro-4-(3.6-~lih~y-lro-~-gyrzin-4-yl)ban~Pn~mina Following the general pl~ccdul~ of Step 3 of F'XANrPLE 20, and m~king non-30 critical variations but sllhstitntin~ 3,6-dihydro-2H-pyran-4-yl trifluoromPt~ ~npslllfonic acid ester (FXAlVlPLE 47, Stepl) for 3,6-dihydro~-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyri-linP- A- bu~ylic acid l, l-dimethylethyl ester, the title compound is obtained, mp 86~C- 88~C.
Step 3: 3-Fluoro-4-(3.6-~ y-lro-~ yr~n-4-yl)ban7an~mina-~.1,.,~1i~ s 35 pha-~ylmat~yl ester A ~--; X~u~e of 3-fluoro~-(3,6-dihydro-2H-pyran-4-yl)ben~Pn~min~(F~A MPLE

SU~; 111 ~J I t SHE~ (RIJLE 26) 47, Step 2, 2.28 g) and so~linm bicarbonate (1.98 g) in tetrahyllruru dn (69 mL)i8 treated with benzyl ChloLoro~ 1;e (1.85 mL), and the reRlllt;nE slurry is stirred at ~mhiPnt tempelatul2 for six hours. The ll~Ule is then washed with water (50 mL), the aqueous phase is t~ t~d with methylene chloride (50 mT ), and the 5 comhinPtl organic phase is washed with saline (25 mL), dried over anhydrous sodium sulfate and cv.-~ r ..1- dted under leduced ~r~ule. The residue is then chrom~t,o~. dphed on silica gel (70 - 230 mesh, 80 g), eluting with ethyl ~e+~t~lheYane (15/85), and those fractions with an Rf = 0.45 by TLC (ethyl ~et~t~/hPy~np~ 25/75) are pooled and a~nr~ led to give the title cu~puu~ld, mp 75 - 76~C.
Step 4: (R)-(-)-3-r3-Fluoro4-(3.6--lih~y lro-~-vyr~n-4-yl)phpTurll-5 }~ ,vl~ ~pthyl-~ ys~7~ non~
Following the general pr~cedu e of Step 3 of EXAMPLE 17, and m~kinF non-critical variations but sllh~ l; 1- .1 . .g 3-fluoro-4-(3,6-dihydro-2H-pyran-4-yl)bçn~Pn~minP~-boxylic acid phenylmethyl ester (FXAMPLE 47, Step 3) for 3,6-dihydro-4-[4-[[(phenylmPth- Yy)calLu~yl]amino]phenyl]-l(2H)-pyr~ npc~ . bu~ylic acid phenylmethyl ester, the title c~.~pou Ld is obtained, mp 127 - 130~C.
Step 5: (R)~-)-3-r3-Flll- ro~-(3~6-~lihydro-~-gvr~n-4-yl)~hPr~yll-5-rr(mP~,ylRlllf~tlyl)~Y~ylmp+l~yll-~ y~7~ in~np Following the general ~ cé~luLe of Step 4 of EXAMPLE 17, and m~king non-critical v~ri~t;onR but 8 lh--l:l ~.1 :..g (R)~-)-3-[3-fluoro4-(3,6-dihydro-2H-pyran4-yl)phenyl]-5-hy-lr~y lethyl-2-~Ysl7c~ inonp- (EXAMPLE 47, Step 4) for (R)-(-)-3,6-dihydro4-[4-[6-(l~y.l.uAy.llethyl)-2-oxo-3-rY~7oli-linyl]phenyU-1(2H)-pyritiinPc~bu~ylic acid phenylmethyl ester, the title cu~ )uu ld is obtained, mp166 - 169~C (ClPcQmr.).
Step 6: (S)-(-)-N-rr3-r4-(3.6-ni~y~ro-?~-~yr~n4-yl)-3-fluoroghPnvll-2--Y -5-nY~7~ yllmf~t~ylls~pts~m~
Following the general ploce.lul~ of Step 5 of F'XAlVlPLE 17, and m~king non-critical variations but 8llh~ g (R)~-)-3-[3-fluoro4~3,6-dihydro-2H-pyran4-yl)phenyl]-5-[[(methylsulfonyl)oay]methyl]-2-/~y~7oli(linonp (~XAMPLE 47, Step 5) for (R)~-)-3,6-dihydro4-[4-[5-[[(methylsulfonyl)oYy]methyl]-2-oxo-3-nyl]phenyl]-l(2H)-pyri~in~rboxylic acid phenylmethyl ester, the title col~.puundi8 obtained, mp 148 - 151~C.

EXAMPLE 48 (~O-(-)-N-rr3-r4-lTPtr~hy~ro-?~-~yr~n-4-vll-3-fluoroghPrlyll-2-5-~y~7nli~ yllmpt~h~ t~mide S~ ITE SHE~ (Rlll~26 W O 97/09328 PCT~US96/12766 A llLib~u~e of (S)~ N-[[3-[4-(3,6-dihydro-2H-pyran4-yl)-3-fluorophenyl3-2-oxo-5-nY~oli~linyl]methyl]~et~mi-le (EXAMPLE 47, l.OOg) and 10% p~ m on-carbon (637 mg) in mPth~n~l (60 mL) i~ sh~ken on a Parr apparatus under a llyd~ n ~nosphPre at 40 psi for three hours, the catalyst is l~:L~-uved by filtration 5 through Celite and the filtrate is con~ t~d under reduced ~r~.~C.ure to give the title compound, mp 191- 192~C.

EXA~LE 49 (~)-(-)-N-rr3-r4-(3.6-T)ih,y~lro-~-thinDyr~n-4-yl)-3-fluorol?hPr~
~. r~Yn 5 oYsl~nli~ yllm~t.hvllslr~ts~mill~
10 Step 1: 3.6-ni~y1ro-~ hir~;vyr~n-4-yl trifluoromPtl~n.ocnlfnni~ acid ester Following the general prûce,lu~e of Step 2 ûf ~AMPLE 20, and ms~kinE
non-critical variations but Pllh l;l~ F tetrahydL~ iopyran-4-one for 1~1,1-dimethylethoxycarbonyl)-4-pipPri-lonç, the title ~,~JLupoulldi8 obt~in~, NMR
(CDC13, 400 MHz) 6.01, 3.30, 2.86, 2.62 ~.
16 Step 2: 3-Fluoro-4-(3.6-1lih,y~lro-~-thi~yr~n4-yl)bPn~n~minP
Following the general procedure of Step 3 of FXAMPLE 20, and mnking non-critical variations but sllh~ F 3,6-dihydro-2H-thiopyran~-yl trifluorQmPth~nP~lllfoni~ acid ester (liXAMPLE 49, Step 1) for 3,6-dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyri~inP~rboxylic acid l,l-dimethylethyl 20 eater, the title cc,~uulld is obtained, NMR (CDC13, 400 ~Iz) 6.98, 6.40, 6.35, 5.94, 3.73, 3.31, 2.84, 2.62 ~.
Step 3: 3-Flnnro~-(3.6-~ y lro-?~l-thi~vran~-yl)b~n7~n~ninP~rbn~yli~ acid phPr~ylmPtllyl ester Following the general procedure of Step 3 of F~AMPLE 47, and mslking non-25 critical variations but snh~ ll ;llg 3-fluoro4-(3,6-dihydro-2H-thiopyran4-yl)bPn7Pn~mine (FXAlVlPLE 49, Step 2) for 3-fluoro4-(3,6-dihydro-2H-pyran4-yl)bPn7Pn~minP~ the title o vlll~uuulld is obtained, mp 99 - 101~C.
Step 4: (R)~-)-3-r3-Fluoro-4-(3.6-~i~ytlro-~-thin~yr~n4-ylb~hP~rurll-5 ~l..Pt.~ nYs~7:nli~in~nP
Following the general ,ulvcedule of Step 3 of FXANIPLE 17, and ms~king non-critical variation~ but snhstitnting 3-fluoro4-(3,6-dihydro-2H-thiopyran4-yl)bPn7Pn~minP~A~l~u~ylic acid phenylmethyl ester (EXAMPLE 49, Step 3) for 3,6-dihydro4-[4-[[(phenylmPtl~nyy)c~l,ollyl]amino]phenyl]-l(2H)-pyritlinfc~Lo~ylic acid phenylmethyl ester, the title culllpuul~d is obtained, mp 119 - 122~C.
Step 5: (R)-(-)-3-r3-Fl~oro4-(3.6-rlillylro-~I-thio~pyr~n4-yl)l?hp~ -5 rr(mp~yl~lllf~rlyl)oy~ylmpt~yll-2-n~r~7nliflinnnp SU~ 111 ~ITE SHEET (RULE 26) W O 97/09328 PCTrUS96/12766 Following the general ~u.oce~ e of Step 4 of ~A~ PLE 17, and mgking non-critical vsris-t;nn~ but s-lh~ ;..g (R)-(-)-3-[3-fluoro4-(3,6-dihydro-2H-thiopyran~-yl)phenyl]-5-hydlu~y~ethyl-2-oYs7nli linon~ (EXAMPLE 49, Step 4) for (R)-(-)-3,6-dihydro-4-[4-[5-(hydlu~y...ethyl)-2-oxo-3-nY-s.7.olieiinyl]phenyl]-1(2H)-5 pyri- inf~c~ . bu~ylic acid phenylmethyl ester, the title coll.,uuund is obtained, mp 138 ~ - 141~C.
Step 6~ )-(-)-N-rr3-r4-(3.6-nihy~-iro-~ ~vrs~n4-yl)-3-fllloro~hQr~yll-~-nyn 5_~Y~s~7n~ yllm~tt~vl~
Following the general p~UI GdUl.G of Step 5 of ~XAMPLE 17, and mskinF non-10 critical vsrisffon~ but 8~ 1 ..g (R)-(-)-3-[3-fluoro4-(3,6-dihydro-2H-thiopyran4-yl)phenyl]-5-[[(methylsulfonyl)oxy]methyl]-2-oY-s7oli iinone (EXAMPLE 49, Step 5) for (R)-(-)-3,6-dihydro4-[4-[5-[[(methylsulfonyl)oxy]methyl]-2-oxo-3-nYs7o~ inyl]phenyl]-l(2H)-pyri~lin~c~ o~ylic acid phenylmethyl ester, t,he titlecompound i8 obtsin-~-l, mp 187 - 189~C.
~xAlvrpLE 50 (S)~-)-N-rr3-r4-(3.6-l~ihytlro-~-thi- Dyr~n-4-yl)-3-fluoro~?h~-lyll-~_nYn-6-ny~s~7n~ yllm~thvll~ le~ linYi-lQ
A soll-t;on of (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran4-yl)-3-fluorophenyU-2_oxo_5_oYs~7oli~inyl]methyl]s~etsmi~1Q (F'~AlVIPLE 49, 300 mg) in wate~ et~na 20 (25%, 17 mL) i8 treated with N-mel~lyl,.lu-~holine N-oxide (301 mg) followed by o~...i.~... tetroxide (2.~; wt~o in t-butanol, 0.54 mL), and the r~ ltinE ~ u~e is stirred at gmhianttelll~e~aLula ovçrnight The lllix~ule is then qnenrhP~l with saturated aqueous sodil~m bi~--lfit~ (10 mL) and extracted with methylene chloride (2 x 20 mL). The comhinecl organic phase is washed with saline (10 mL), dried over 26 sodium sulfatQ and conc.~-~t-ated under reduced p~ u a to give the crude p.~-lu~.
which is then chrnm~.al)hed on silica gel (70 - 230 mesh, 30 g), eluting with a gradient of mpt~nnvmethylene c-hloride (3t97 - 5t95). Pooling of fractions with an E~f = 0.49 by TLC (mpth~nnltchlol~ro~ 10/90) and L-;~u-c-~ion with methylene ~~hl-)riclP/diethyl ether gives the title compound, mp 181 - 182~C.
F~AlVlPLE 51 (S)~-)-N-rr3-r3-Fluoro-4~tet~ ~h~y lro-~-thio~yr~n-4-yl)phPr~yll-rn_5_n~ 7nli~ ,yllmat~ylls~Pt~mifla~q.S--lin~ a Following the general ~ e.lul~ of F~AMPLE 48, and m~kinF non-critical v~ri~;nn~ but 8~h~ E (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran-4-yl)-3-35 fluorophenyl]-2-oxo-5-nY~7olitlinyl]methyl]~ret~mi-1a S,S-dioxide (~AMpLE 50) for (S)~-)-N-[[3-[4-(3,6-dihydro-2H-pyran-4-yl) 3-fluorophenyU-2-oxo-5-SUlBSrll~lrE SHEEr lRULE21~) nYsl7Q~ nyl]methyl]s~ret~mitle and ~e~ L~lli7inE the product from methylênê
chloride/diêthyl ether, the title compound is obtained, mp 199 - 200~C.

FXAl\/rPLE 52 (S)-(-)-N-rr3-r4-(3.6-TIihyl1ro-2H-~yr~n-4-vl)Dhf~r~yll 2 nYn 5 5 nY~7nlitlir~yllmeth~y~ Ptslmi~
Step 1: 4-r4-(E~y~rnYv)tetr~hv~lro-2~-~yr~n-4-yllbPn7Pn~minp~rbny~y~ acid phenylmPth~yl ester Following the general procedure of Step 1 of EXAMPLE 17, and m~kinE non-critical v~ri~tionR but snh~ti~lt;nF tetrallydlvpy. ~-4-one for N-tcarbobenzyloxy)-4-10 pipPri(lon~P, the title c.~ll~vu~d is obtained, mp 143 - 145~C.
Step 2: 4-(3.6-T)ih~y~ro-~ vran4-yl)bPn7an~min~-~l1.,..~1it~ sl~itl hpr~ylmpt~vl ester Following the general procedure of Step 2 of EXAMPLE 17, and m~kinE non-critical variations but 8--h~ L~ F 4-[4-(hy~ v~y)tetrahydro-2H-pyran4-15 yl]bçn7Pn~mine.~.l.vAylic acid phenylmethyl ester (EXAMPLE 52, Step 1) for 4- hyd~ y-4-[4-[[(phenylmPthnYy)carbonyl]
amino]phenyl]-l-piperi~linec~rboxylic acid phenylmethyl ester and ~:,;,y2j~lli7.inF
the crude product from ethyl ~cet~t~/hpy~np~ the title compound is obtained, mp 145- 148~C.
20 Step 3: (R)-(-)-3-r4-(3.6n;h"ylro-2~-pyrs-n-4-yl)~hPrlyll-5-l~y.l...~..Pt~yl-2-c~Ysl7nli~innn~
Following the general procedure of Step 3 of EXAMPLE 17, and m~kinE non-critical v~ri~ff-)nR but s--h~ E 4-(3,6-dihydro-2H-pyran4-yl)bPn7Pn~minec~.l,."~ylic acid phenylmethyl ester (FXAlVlPLE 52, Step 2) for 3,6-25 dihydro4-[4-[[(phenylmpthnyy)ca~llullyl]amino~phenyl]-l(2H)-pyr~ n~c~. bu~ylic acid phenylmethyl ester and triturating the crude product with ethyl ~ret~t~/heYane (50/50), the title cclllpc.ulldi6 obtained, Anal. Calcd for C15H17N04: C: 65.44; H, 6.22; N, 5.09. Found: C: 65.05; H, 6.04; N, 4.91.
Step 4: (R)~-)-3-r4-(3.6-T)i~y lro-~-Dyr~n4-yl)~h~r~yll-5-30 rr(~n~thyl~ fnr~vl)~ m~tl~yll-2-n~r~7oli~innnp Following the general procedure of Step 4 of EXAMPLE 17, and m~kinE non-critical variations but snhsL~ F (R)-(-)-3-[4-(3,6-dihydro-2H-pyran-4-yl)phenyl]-~-hyLvAylllethyl-2-nY~7nli-1innnP (EXA~LE 52, Step 3) for (R)-(-)-3,6-dihydro-4-[4-[5-(hylll'v~ylllethyl)-2-oxo-3-nY~7oli-1inyl]phenyl]-1(2H)-py~liner~rboxylic acid 35 phenylmethyl ester, the title compound is obtained, mp 182 - 184~C.
Step 5: (S)-(-)-N-rr3-r4-(3.6-Dihy~ro-~ vr~n-4-yl)~?hPnvll 2 ~n 5 SIJ~ 111 ulTE SHEET (RULE 263 t~ys~ yllmpth~yll~t~ptslmide Following the general procedure of Step 5 of EXAMPLE 17, and ms-kinE~ non-critical v~riAtion.q but sub2~ u~ing (R)-(-)-3-[4-(3,6-dihydro-2H-pyran-4-yl)phenyl]-5-[[(methylsulfonyl)oxy]methyl]-2-o~ itiinonP (EXAMPLE 52, Step 4) for (R)-(-)-3,6-5 dihydro-4-[4-[5-[[(methylsulfonyl)oxy]methyl]-2-oxo-3-~Y~7~ nyl]phenyl]-l(2H)-pyri~lint c~ ".ylic acid phenylmethyl ester, the title compound i8 obt~in-.-l, NMR
(CDC13, 400 MHz) 7.45, 7.36, 6.63, 6.09, 4.77, 4.31, 4.05, 3.92, 3.80, 3.65, 2.48, 2.01 ~.

10 EXAMPLE 53 (S)-(-)-N-rr3-r4-rTetr~hvdro-2~-Dvr~n-4-yll~hPrlyll ~ r~Yn 5 t~ 7.~ ,yllmtt.~l,yll~tPt.~mitit.
Following the general ~locedule of FXAlVlPLE 48, and m~kin~ non-critical vs~riz-t;~n~ but 8nh~ (S)-(-)-N-t[3-[4~3,6-dihydro-2H-pyran 1 yl)phenyl]-2-oxo-5 ~Ys~7~ tlinyumethyl]s3t~et~mi~p (F:~AlvlpLE 52) for (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-15 pyran-4-yl)-3-fluorophenyl]-2-oxo-5-oY~7oli-iinyl]methyl]~ ~~ , the title cc"l.pou~d is obt~inPcl, mp 185~C - 187~C.

liXAlVlPLE 54 (.~:)-(-)-N-rr3-r4-(3.6-n;h,y lro-~-thi- pyr~n-4-yl)~hPnvll-2-~Y~-5-r~Ys~ t~lirlir~,yllmPt.hvll~r~
20 Step 1: 4-r4-(IIy.h..~)tetr~hv~lro-~ ~hitu~yr~n-4-yllbenzpn~min ?hPr~y]mPt~yl ester Following the general pl~cedu~G of Step 1 of EXAMPLE 17, and m~king non-critical VAri~tion~ but snhsL;~ F tetrahyd.vl~liopy-ran-4-one for N-(carbobenzyloYy)-4-pireri~lonP and lG~;ly~ lli7inF the product from ethyl 25 Acet~t~/hPY~n~ the title compound is obtained, mp 152 - 154~C.
Step 2: 4-(3.6-n;h,yl1ro-2~-thiltDyr~n-4-yl)bpn7pn~minp~A~l~u~ylir acid ~hPl~ylmPt~yl ester Following the general procedure of Step 2 of EXAMPLE 17, and mAkinF non-critical v~riflt;on~ but snh~ F 4-[4-(hy-ll u~y)tetrahyL~L~iopyran-4-30 yl]hen7Pn~minPc~rboYylic acid phenylmethyl ester (EXAMPLE 54, Step 1) for 4-hy~Lu~Ly-4-[4-[[(phenylmPt~c)yy)carbonyl]amino]phenyl]-l-piperi(linpc~rbo-y-ylic acid phenylmethyl ester and ll;luldlillg the crude product with diethyl ether or rG.,Ly~L~lli7inE~ from ethyl A~et~teJhPY~nP~ the title compound i~ obt~inetl mp 150 -152~C.
35 Step 3: (R)-(-)-3-r4-(3.6-l);l~y1ro-2~-thi~Dyr~n-4-yl)~hPrlyll-5-by.l~ yl~th~yl-~-SU~S 111 ~JTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 n l~7.- litlinnne Following the general procedure of Step 3 of EXAMPLE 17, and m~kinF non-critical variations but ~llh,~ E 4-(3,6-dihydro-2H-thiopyran-4-yl)bPn7.~n~Tnincc~lLu~ylic acid phenylmethyl ester (EXAMPLE 54, Step 2) for 3,6-6 dihydro4-[4-[[(phenylmPth- Yy)call,u~lyl]amino]phenyl]-1(2H)-pyritlin~c~ r bu~ylic acid phenylmethyl ester and ~ u.,Llillg the crude product with mPtl~nol/methylene .hlnride, the title compound is obtained, mp 182 - 184~C (~lPcomr.).
Step 4: (R)-(-)-3-r4-(3.6-n;h~y~lro-?~-thio~yr~n4-yl)DhQr~yll-5-rr(m~t~yl~lllfflnvl~ mQt~yll-2-~ 7~ in~nQ
Following the general ,ul~ced~ of Step 4 of EXAMPLE 17, and m~king non-critical variations but sllh~ F (R)-(-)-3-[4-(3,6-&ydro-2H-thiopyran-4-yl)phenyl]-5-hy~llc.~ylllethyl-2--)Y~7nlitlinollQ (EXAMPLE 54, Step 3) for (R)-(-)-3,6-&ydro4-[4-[5-(hyL~yl~ethyl)-2-oxo-3-ny~7~ inyl]phenyl]-l(2H)-pyri-iinec~.bu~ylic acid phenylmethyl ester and ~iLu~ g the crude product with 15 methylene chl-ri~P/diethyl ether (25/75), the title co Ipou~d is obt~ine-l mp 171 - 174~C (-lPcc~mr.).
Step 5: (S)-(-)-N-rr3-r4-(3.6-T)il~y~ro-~-t.hir?Dyran-4 yl)phPT~yll ~ mrr 5 oY~7~ iTu~llm~tl~vll~tslmitlp Following the general ploceduie of Step 5 of FXAMPLE 17, and m~king non-20 criticalvariationsbutEllh~ l .l ..g(R)-(-)-3-[4-(3,6-dihydro-2H-thiopyran-4-yl)phenyl]-5-[[(methyl~ulfonyl)oxy]methyl]-2--Y~7nli-1inonQ (F'XAMPLE 54, Step 4) for (R)-(-)-3,6-&ydro-4-[4-[5-[[(methylsulfonyl)oxy]methyl]-2-oxo-3-oY~7.nl inyl]phenyl]-l(2H)-pyri-linpc~rboxylic acid phenylmethyl ester and ~cet~nitrile for isopropanol, the title compound is obtained, mp 169~C - 173~C
25 (~lecomp ).

FXANIPLE 55 (~)-(-)-N-rr3-r4-(3.6-nih,y(1ro-2~-t.hi- pyr~n-4-yl)~hQr~yll-2-ox -5-yllmpt~ pt~mi~Q ~ Xi-l~
Following the general ~ucedu~ of ~XAMPLE 50, and m~king non-critical 30 v~ri~t;~n~ but sllh~ (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-~Y~olitlinyl]methyl]~cet~mi~P (EXAMPLE 54) for (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran~-yl)-3-fluorophenyl]-2-oxo-5-~Y~7:oli~inyl]methyl]~cet~mi-lQ and ll;Lu~ g the product with ethyl ~cet~t~/methylene chloride, the title cu Ipuulld i~
obtained, mp 185 -187~C.
F~AMPLE 56 (~)-(-)-N-rr3-r4-rl-(Forr~w1)-3.6-~ vtiro-~ yrif~in-4-yll-3 SI~IT~E SHEET (RULE2t~l W O 97/09328 PCT~US96/12766 fl~ ro~hPr~v~ -oY~-5-~x~ invllmp+h~vllacets3mi~lp Following the general procedure of FXANIPLE 29, and mAkin~ non-critical variations but snhsl; 4 ~ F (S)-t-)-N-[[2-oxo-3-[4~3,6-dihydro-2H-pyridin-4-yl)-3-fluorophenyl]-5-oY~7oli~linyl]methyl]~cet~mitle (EXAMPLE 38) for (S)~-)-N-[t2-oxo-5 3-t4{4-piperidinyl)-3-fluorophenyl]-5-nY~7o~ inyumethyl]Acet~mi~e~ the title uu~d i8 obtained, mp 148 - 151 ~C.

EXAMPLE 57 (~C~)-(-)-4-r4-r6-r(A P~ylAminn)mPt~vll-2--Y~-3 flllnroghar~yll-3.6-rlihydro-1(~ linP~A . l~ acid mPthvl ester Following the general procedure of EXAMPLE 26, and mAkinF non-critical v~riAtil n~ but sllh~ E (S)~-)-N-t[2-oxo-3-[4-(3,6-dihydro-2H-pyridin-4-yl)-3-fluorophenyl]-5--.Y~oli-linyl]methyl]~cet~mida (EXAMPLE 38) for (S)~-)-N-tt2-oxo-3-t4-(4-piperidinyl)-3-fluorophenyl]-5-oY~7oli~inyl]methyl]Acet~mid~p~ the titlecompound is obt~inP-l, NMR (CDCl3, 400 MHz) 7.36, 7.18, 7.10, 6.85, 6.89, 4.78, 15 4.08, 4.02, 3.78, 3.71, 3.64, 2.45, 2.00 ~.

F~xAl\lrpLE 58 (~)~-)-N-rr~-Ox ~-3-r4-(3.6-~ y~lro-2~-~yri~in-4-yl)~h~r~yll-~;-I~Y~ ,yllm~t~l,y~ t~mi~1Q
Step 1~ -)-4-r4-r~-r(~ yl~min-)matl~yll~)nY -3-- Y~ yllphQr~yll3.6 20 (lihytlro-1(~)-pyri-linQcaIb..~vli~ im~t~lyletl~yl e~ter Following the general procedure of step 1 of F~A~ pLE 38, and m~kin~ non-critical variations but snh~ F (S)-(-)-N-t[3-t4-(t~im~t~ylstannyl)phenyl]-2-oxo-5-7Oli~inyl]methyl]~etqmi-le for (S)-(-)-N-t[3-t4-(trimethylstannyl)-3-fluorophenyl]-2-oxo-5--Y~7oli-linyl]methyl]Acet~ e, the title ~;o~-l,uuulld is obtained, 25 NMR (CDC13, 400 MHz) 7.45, 7.35, 6.55,6.00,4.77, 4.05, 3.80, 3.63, 2.49, 2.01, 1.48 ~.
Step 2: (.5)-(-)-N-rr2-OY~ -3-r4-(3.6--lih~yrlro-~-pyri-lin-4-Yl)l7h~Tw11-5-7nliflirwl1m~th~ ts~mi~o A solllti~n of (s)-(-)-4-[4-[6-t(acetyla-m--ino)methyl]-2-oxo-3-30 r~ 7r~ inynphenyl] 3,6-dihydro 1(2H) pyrillinPc~ uAylic acid 1,1-dimethylethyl ester (EXAMPLE 58, step 1, 0.92g) in dry methylene chloride (8.8 mL) at 0~C under N2 is treated with trifiuoroacetic acid (2.2 mL) over one minllte, and the resulting llli2~l,Ule is stirred at 0~C for four hours and added slowly to saturated aqueous pot~ lm carbonate (30 mL) at 0~C to neutralize excess trifluoroacetic acid. The 35 ~Lul~ is then diluted with water (50 _L) and saline (50 mL), extracted with SUBSTITUTE SHEET (RULE 26) slnol/methylene chloride (3 x 150 mL, 25/75), and the combined organic phase iB dried over anhydrous sodium sulfate and con~entrated under reduced ple ~u~e to give the title c~ puuL,d, mp 164 - 166~C (decomp.).

li.~AlvrPLE 59 (S)-(-)-N-rr~-o~n-3-r4-rl-r(~ptn~rv~ yll-3~6-~lih~y~ro-?~
pyri-lin-4-yll~h~r~yll-5-nY~7nli-1invllm.qth,yll~. a~ a Following the general procedure of EXAMPLE 18, and m~king non-critical v~rint;onR but sllh~ (S)-(-)-N-[[2-oxo-3-[4-(3,6-dihydro-2H-pyridin-4-yl)phenyl]-5-nY~ linyl]methyl]ncet~mi(1e (EXAMPLE 58) for (SH-)-N-[[2-oxo-3-[4-(4-piperidinyl)phenyl]-5-oY~7o~ inyl]methyl]n~ .s and act,~o~y~cetyl chloride for benzyloxyacetyl chloride, the title c., .pc~u~d i8 obtSIin~ HR,MS calcd for C21H25N3~6: 415-1743. Found: 415.1752.

EXAMPLE 60 (S)-(-)-N-rr3-r4-rl-(IIv.l I ox vacetvl)-3.6-~ihv~ro-~-Dyri~in-4-vllDhar~yll-~--n~n-5-nYS~7nli~ yllma+h~vl~ at~mi~la Following the general procedure of ~XAlVlPLE 40, and mnking non-critical v~ri~t;nn.~ but sllh~t;t~lting (S)-(-)-N-[[2-oxo-3-[4-[1-[(nc~ Lu~y)acetyU-3~6-dihydro-2H
pyridin-4-yl]phenyl]-5-nY~7olitlinyl]methyl]~r~etsmi~1a (EXAMPLE 59) for (S)-(-)-N-[[2-oxo-3-[3-fluoro 4-[l-[(~cdLu~y)acetyl]-3~6-dihydro-2 H-pyridin-4-yl]phenyl]-5-oY~7oli.linyl]methyll~t~et~mi~le~ the title cun~uulld is obtained, HR~IS (FAB) calcd for Cl9H23N3~s + H: 374.1716. Found: 374.1713.

~:~AlVIPLE 61 (S)-(-)-N-rr3-r4-rl-(For~yl)-3.6-~lih~ ro-~ vri~in-4-yllDhar~yll-2-n~r ~-5-ny~7nli~ yllm~tllyllacetslmi~la Following the general pruce.lu,~ of EXAME~LE 29, and m~king non-critical v~ri~t;on~ but snh~ ..g (S)-(-)-N-[[2-oxo-3-[4-(3,6-dihydro-2H-pyridin4-yl)phenyl]-5-c.Y~7nli~inyl]methyl]~et~mi-1e (EXAME~LE 58) for (S)-(-)-N-[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyl]-5-nYn7olirlinyl]methyl]~ et~mi~e, the title compound i8 obt~in~l mp 149 - 152~C.
EXAMPLE 62 (S)-(-)-4-r4-r5-r(Acety!~minl~)ml~th~yll ~ ~nrn 3 ~nyll-3.6-~ h~y(lro-~ vri~linpr~rbox~vlir ~ l m~t~vl ester Following the general procedure of EXAMFLE 26, and m~king non-critical variations but sllhstitllting (S)-(-)-N-[[2-oxo-3-t4-(3,6-dihydro-2H-pyridin4-35 yl)phenyl]-5---r~7oliflinyl]methyl]~oet~mi(1~ (EXAMPLE 58) for (S)-(-)-N-[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyl]-F,-rY~o~ inyl]methyl]~et~mi~leT the title compound SUBSTITUTE "11_~1 (RULE 26) W O 97/09328 PCT~US96/12766 is obtained, mp 142 - 14~;~C.

PLE 63 (~q)-(-)-N-rr3-r4-(3.6-Dih~y~ro-~-thin~vyr~n4-yl)-3-fluorol;?ha~
2-oxo-5-n~ nli~linyllmath,yllace1~.l.;~la S-~ a A sollltion of so-lillm perin~te (192 mg) in water at 0~C is treated with a slurry of (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-5-~y~7n~ inyl]methyl]~r~et-mi~le (EXAMPLE 49, 300 mg) in m~h~nol (10 mL), and the r9sll1ting llli~l,Ule iS allowed to slowly warm to ~mhiant t~ e~d~ulc over app~ t,ely one hour and is stirred overnight. The ~ix~ult: is then cnn~..t. ated10 to remove mP~nol, diluted with water (20 mL) and ~ ed with m~t~nnl/chlol~fol~l (3 x 30 mL, 5/95). The comhina~ organic phase is washed withsaline (20 mL), dried over anhydrous sodium sulfate and con~ l - c.led under ~:ducad ~ul~slSul.3 to give the crude product which is then chr~m~t4~.dphed on silica gel (30 g, 70-230 mesh), eluting with mpth~nol/methylene chloride (5/95). Those 15 fractions an Rf = 0.39 by TLC (math~nol/chlulv~l~ 10/90) were pooled and cnnra..l~ated and the residue was l~ y~lli7erl from methylene ~hlori~la/diethyl ether to give the title colll,uuulld, mp 150 - 151~C.

~XAl\~PLE 64 (S)-(-)-N-rr3-r4-(3.6 l)ihytlro-~-thinDyrs~n-4 yl)nhar~yll-2 mrn 5 20 n~ 7n~ yllmpth~ylls~r~ la S-n~i~la Following the gener~ e.lule of EXAMPLE 63, and m~king non-critical variations but Ellh~ F (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-nYs~:o~ inyl]methyl]Atetsmi-lP (EXAMPLE 54) for (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-5-nY517o~ inyl]methyl]A~et9milla~
25 the title col~pc,u,ld is obtained, mp 158 -162~C (~ecomr.).

F'XAl\/rPLE 65 (S)-(-)-N-rr3-r4-(TetrAl~y~ro-2~-thi~pyrAn-4-yl)phar~yll ~ I~Yn 5 nY~7:nli~ llmPt.hyllA~PtAmi~la ~.C3_~i~Yi~a A llli~Lul~ of (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran-4-yl)phenyU-2-oxo-5-30 oYA7oli~linyl]methyl]A~et~mi~le S,S-dioxide (EXAMPLE 55, 75 mg) and 10%
pAllA~ lm-on carbon (44 mg) in tetrahy.lluruld~l (20 mL) is stirred under a hydrogen Atmo~phare (balloon) for one hour, the catalyst is removed by filtration through Celite, the filtrate i8conl~.e..1 ated under reduced ple~ U~e and the residue iS ~ a~l from methylene chloride/diethyl ether to give the title compound,35 mp 190 -192~C (tlecomr.).

~ S~EFl (R~ 26) W O 97/09328 PCT~US96/12766 T~x A~rPLE 66 3-t4-~minn-7.-fluoro~hanvl)pyrr~ in~

Step 1: 2-(~-fluoro-4-~itro~har~yl)-~limathylm~ tQ
A flame-dried 500 mL round bottom flask e~ ed with ~pinhs~r and it;or~ funnel was charged with sodium hydride (4.0 g, 0.10 mol). This oil 5 dispersion was washed three times with pentsna (30 mL), dried under house va~ diluted with 50 mL of freshly tli~;lled tetrahydloruldnt and cooled to 0~C.
The grey suspension was drop-wise treated with a 100 mL THF solution of dimethylm~lnn~t~ (5.7 mL, 50 mmol) with copious gas evnllltin~ The r~slllting thick suspension was treated with a 100 mL THF solllt;on of 3,4 10 difluoronitroben~ne~ quickly turning golden in color and was warmed to 50~C for 16 hours. At this time, the deep red wine hom~gPnous solllt;~n was cooled to RT,qll~n-~hP~l with 300 mL lM hydlocl~loric acid, and volatiles removed in vacuo. The rç~lllting aqueous acidic residue was extracted three time with ethyl acetate (200 mT-) with the combined organics washed once with brine (200 mL), dried over Mg 15 SO4, filtered and conc~ ated to give 13.58 g of a brown solid. l~is m~tQri~l was L;~ d with a ~Lu~a of ethyl ~- etste/hPy~npldichlorompth~np- to afford 7.60 g of the title cu~uu~d as a light yellow solid. The filtrate was co~c~ ted and purified by Prep 500 HPLC on a single silica gel cartridge eluting with 25% ethyl ~rel qt~hpy~ne to afford and ~Ait;~n~l 3.95 g of the title c~ >oulld. Total yield 20 10.60 g (78Yo), mp 108-109. mp 108-109~C; Rf 0.38 (25% ethyl ~cet~t~Jhexane); IR
(mull) 1744, 1736, 1532, 1438, 1357, 1345, 1273, 1243, 1232, 812 cm~l; lH NMR
(300 MHz, CDC13) ~ 8.09 (dt, lH, J=2.2 & J=7.8 Hz, aromatic), 7.99 (ddd, lH, Jz2.3 & 9.4 Hz, aromatic), 7.74 (dd, lH, J=7.1 & J=8.6 Hz, aromatic), 5.08 (8, lH, mPthin~), 3.81 (s, 6H, methyls); Anal. Calcd for CllHloNlO6F1: C, 48.74; H, 3.72;
25 N, 5.17. Found: C, 48.74; H, 3.84; N, 5.14.
Step 2: ~ -fluoro~-~itro~hPr~yl)-2-(cy:~n-.mPthyl)--limPth~vlms~lnnsltA
An oven-dried 100 mT- round bottom flask equipped with spinh~r and refluY..
conflenAer was charged with 2-(2-fluoro-4-nitrophenyl)-dimethylm~lon~qtP
(T~XANrpLE 66, Step 1, 3.25 g, 12.0 mmol) and 60 mL ~etonp~ This yellow 30 homogenous solllt;nn was treated with a single portion of powdered pot~AAillmcarbonate (4.98 g, 36 mmol) inAt~ntly turning red in color. This suspension was added to by br~mo~etonitrile (1.3 m~L, 18 mmol) and heated to reflux for 16 hours. At this time, the now brown suspension was cooled to RT, diluted with 100m~ lM hyu.ocllloric acid, and extracted twice with ethyl acetate (150 ml). The 35 c~mhinPtl organics were washed once with brine (100 mL), dried over MgSO4, filtered, and con-~e..t-dted to give 4.10 g of a crude brown foam. This material was ;HEEr (RUl E 26 purified by Prep 500 HPLC on a single silica gel cartridge eluting with 30% ethyl ~etstelhf~Y~nP to afford 3.60 g of an off-white solid. This material was r~ y~ erl from ethyl ~et~tp~hpy~ne~ to give 3.14 g (84%) of the title cù~uulld as white n~e~llps. mp 137-138~C; Rf 0.26 (30% ethyl ~ et~tP/hpy~nps); IR (mull) 5 1749, 1730, 1527, 1355, 1290, 1276, 1262, 1234, 812, 739 cm~1; 1H NMR (300 MHz, CDCl3) 8.12 (ddd, lH, JHF=0.8, J=2.2, J=8.6 Hz, aromatic), 8.01 (dd, lH, J=2.3 &10.8 Hz, aromatic), 7.48 (dd, lH, J=7.5 & J=8.7 Hz, aromatic), 3.92 (B, 6H, methyls), 3.34 (s, 2H, mPthin~); 13C NMR (75 MHz,CDCl3) 166.5, 159.5 (JCF=253 Hz), 148.7, CF z), 129.9 (JCF=13 Hz), 119.4 (JCF=3 Hz), 11.9 (JCF=28 Hz) 58 0 10 54.1, 24.2; Anal. Calcd for C13H11N2O6F1: C, 50.33; H, 3.57; N, 9.03. Found: C, 50.23; H, 3.73; N, 9.06.

Step 3: ~-(4-~min~ -fluorol~hpr~l)-2-~rbompth~yvy~ linonP
A 500 mT- Parr flask was charged with a soll)t;~n of 2-(2-fluoro-4-15 nitrophenyl)-2-(cy~nomPthyl)-dimLethylm~l- n~t~ (EXAMPLE 66, Step 2, 1.236 g, 4.0 mmol) in 100 mT- m~t~zlnf~l and 1.17 g 10% p~ lm on carbon. The black sll~pen~ion was placed under 40 psi hy~v~ with Shs-kinE~ for 64 hours. The Parr was l~ ~uv~d from the hy-l-v~;entaor, the reaction ~ was filtered through a pad of CELITE and c~nr,,--l dted to afford 1.02 g of a white foam. This mslt,eri~l 20 was purified by LC on 70 g (230-400) silica gel eluting with ethyl ~et~te to afford 824 mg (82%) of the compound as a white amorphous solid. Rf 0.20 (75% ethyl ~et~h~hPY~nPS); IR (mull) 3359, 3233, 1738, 1695, 1694, 1634, 1515, 1254, 1276, 1128, cm~l; lH NMR (300 MHz, CDC13) ~ 7.15 (t, lH, J=9.0 Hz, aromatic), 6.58 (bs, lH, O=C-NH), 6.41 (m, 2H, aromatic), 3.80 (bs, 2H, NH2), 3.77 (s, 3H, CH3),25 3.49 (m, lH, N-CH2a), 3.26 (m, 2H, C-CH2s), 2.28 (m, lH, N-CH2b); 13C N~ (75 MHz, CDC13) 173.6, 170.9, 161.4 (JCF=245 Hz), 147.7 (JCF=ll Hz), 128.9 (JCF=5 Hz), 115.7 (JCF=14 Hz), 110.2, 102.5, (JCF=25 Hz), 56.9, 53.2, 39.4, 34.3; KF.
Water = 0.87%; Anal. Calcd for C12H13N2O3F1 with 0.87% water: C, 56.64; H, 5.25;N, 11.01. Found: C, 56.78; H, 5.34; N, 11.01. HRMS Calcd for Cl2Hl3N2O3F1:
30 252.0910. Found: 252.0902.
Step 4: ~-(4-~min~l-2-fluoro~?h~r~yl)-2-~rbl~mpt~ y~ linl~nP
A 100 mL recvv~ flask contS~ining 2-(4-amino-2-fluorophenyl)-2-carbomPt~..xy~y~ inone (EXAMPLE 66, Step 3, 930 mg, 3.7 mmol) was charged with 26 mL DMSO and sodium cyanide (542 mg, 11.1 mmol). This rose colored 35 suspension was heated to 150~C for 30 minlltes becoming reddish/brown in color with some gas ev~ lnt;~ n At this time, the reaction was cooled to RT, DMSO

SUBSiTITUTE SHEET (RULE 26) W O 97/09328 PCTrUS96/12766 removed under reduced pressure (approx. 60~C, 0.1 mm Hg), with the rPs-11t;nF
residue diluted with 30 mL brine and extracted three times with dichloromPt~n~
(30 mL). The comhinP~l organics were washed once with brine (15 mL), dried over MgSO4, filtered, and conrentrated to give 521 m g of a red/brown oil. TLC
5 intlir~te~l rPm~ining product in the brine layers and they were comhinP~3 and e~ lèd three times with ethyl acetate (30 mL). These ctmhin~-l organics were washed once with brine (15 mL), dried over MgSO4, filtered, and con~ -ated to give an ~it;r~nsll 230 m g of a red/brown oil. These crude extracts were purified by LC on 49 g (230-400) silica gel eluting with 5% mPt~nol/ethyl acetate to afford 10 628 mg (88%) of the title compound as a light yellow solid. mp 157-160~C; Rf 0.24 (ethyl acetate); IR (mull) 3465, 3363, 1680, 1630, 1614, 1515, 1447, 1285, 830, 828 cm~l; lH NMR (300 MHz, CDCl3) o 7.73 (bs, lH, O=C-NH), 6.85 (t, lH, J=8.4 Hz, aromatic), 6.31 (m, 2H, aromatic), 5.28 (bs, 2H, NH2), 3.48 (t, lH, J=9.4 Hz, Ph-CH), 3.24 (m, 2H, C-CH2s), 2.35 (m, lH, N-CH2a), 1.95 (m, lH, N-CH2b); 13C NMR
15 (75 MHz, CDC13) 178.8, 161.9 (JCF=244 HZ), 147.5 (JCF=11 Hz), 130.4 (JCF=6 Hz), 115.7 (JCF=15 Hz), 111.1 (JCF=2 Hz), 102.3 (JCF=25 Hz), 41.5, 40.5, Calcd for ClOH1lN2OlFl + H: 195.0134. Found: 195.0937.
Step 5: 3 (4 s3min~ -fllltro~?hpru~ vrr~ n~9 100 mL round bottom flask equipped with spinh~r and ref~ux c~n-lPncer was 20 charged with 2-(4-amino-2-fluorophenyl)-2-carbompth~y~ylloli~in~n~ (FXAMPLE
66, Step 4, 430 mg, 2.2 mmol) and 22 mL freshly ~iqffllPcl THF followed by cooling to 0~C. This light yellow homogeneous solllt;on was treated with a lM solllt;on of lithillm ~lllminllmhydride (11 mL, 11 mmol) in~t~ntly becoming an opaque light rose color with copious gas evolution. The reaction was warmed to RT then heated25 to reflux with the formation of a gelatinous pl~ e. After 20 hours, the now green/yellow thick sll~pPn.qion was sll~c~,i~;vèly qllPnrhP~ by the ~ lit;r~n of 0.42 mT.
water, 0.38 mL 5N so-lillm hydroxide, and 1.5 mT water. The r~slllt;ng thick gelatinous sllqpenqion was diluted with ethyl ~cet~te, filtered through a pad ofCelite, and c~n- ~..l - ated to give 392 mg of a yellow oil. This m~t~ri~l was purified 30 by LC on 25 g (230-400) silica gel eluting with 2:17:81 sat.
NH40T-T mPth~nol ~lirhloromet~n-p to afford 295 mg (74%) of the title compound as a light yellow oil. This material was dissolved in a ,.~Lu,a of mPth~nol/ethyls~rets~tp and treated with gaseous HCl with no observable change.
This solllt;on was coT-centrated to afford a peach colored foam that failed to 35 .e~ allize from many diÇrelèmt solvent comhin~tinn~ Rf 0.20 (2:17:81 sat NH40~ mPth~nol ~ hlorom~th~ne); IR (mull) 3139, 3042, 3016, 2766, 2562, 1514, SU~ 1111 ITE SHEET (RUl~2~) CA 02228647 l998-02-03 W O 97/09328 PCT~US96/12766 1485,1444, 1266, 1108 cm~l;lH N~CR (300 M Hz, CDCl3)o 6.99 (t,lH, J=8.2 Hz, aromatic), 6.39 (m, 2H, aromatic), 3.70 (bs, 2H, Ph NH2S),3.27 (m, 2H, mPthinP, N-C~I2a-CH),3.11 (m, 2H, N-C~I28-CH2),2.80 (dd, lH, J=6.2 & 8.9 Hz, N-CE2b-CH), 2.30 (bs, lH, N H), 2.14 (m, lH, N-CH2-C~I2a), 1.81 (m, lH, N-CH2-CH2b); 13C
5 N~IR (75 ~DHZ~ CDCl3) 161.4 (JCF=243 Hz), 146.0 (JcF=ll Hz), 128.4 (JCF=7 HZ),119.9 (JCF=152 HZ), 110.5 (JCF=2 HZ), 102.1 (JCF=26 HZ)~ 53.6,47.0,38.1,32-9;
Anal. Calcd for CloH13N2F1: C, 47.45; H, B.93; N, 11.07. Found: C, 47.10; H, 6.10;
N, 10.74. HRU~S Calcd for CloHl3N2Fl: 180.1063. Found: 180.1060.

10 FXAhrPLE 67 (S)-(-)-N-rr3-r3-F1UOrO4-(~;~Y~1~V~ n-3-V1)-~hP~Y11-2-nYn-5 l~Yn7nl~ yllmptl~vl~ pt.s~mi~lQ
Step 1: 3-Flllnro-4-r3-(~ y)tetr~l~y~ i~hpn 3-yllhPn7Pn~mina~.L.,,~yl;~ id uhQrlylmPtll,yl ester A solllt;~n of 1-(3-fluorophenyl)-2,2,5,5-tetramethyl-1-aza-2,5-15 disilacyclopçnt~nP (F~Al\lrpLE 20, Step 1, 1.00 g) in dry tetrallydLvruldn (16 m L) at -78~C under N2 iB treated with 8ec-butyllithillm (1.3 M in cy~l~hPY~nP, 3.30 _IL) dropwise over 2 mins~ and the rPRllltinF ~ e is stirred at -78~C for 2 hrs. The ~ixLurai8 then treated with a ~nlllt;~n of tetrahyvlvU,iophen-3-one (423 mg) in dry tetrally-l.vrulan (4.1 mT-) dropwise over 2 mins and is stirred at -78~C, allowing 20 the cooling bath to expire over 4 hrs. The l~ Lul~is then qllQn-he-l with saLuldted aqueous s~mmnnillm rhlori~ (25 mT-), diluted with water (25 mL), the layers are se~a.aled, and the comhinp~l organic phase is washed with saline (20 mL), dried over anhydrous sorlillm sulfate and cnnc~ dled under reduced ~l~Y~ule. The residue is dissolved in mpt~l~nol (16 mL) and treated with anhydrous potoRRillm 25 carbonate (1.09 g), and the ~ixLura is stirred at ambient temptldLula for 30 mins, ccn-~Pntrated under reduced pl~:S u.~, diluted with water (20 mL) and extracted with diethyl ether (2 x 20 mL). The cnmhinP-l organic phase is washed with saline (10 mL), dried over anhydrous m~gnPRillm sulfate and concentrated under reduced ~lesYul-: to give the crude 3-fluoro~-[3-(hydl.,Ay)tetrahyl1lo1~1iophen-3-30 Y1]bPn7Pn~m;nP intermP~;~t~ (R~ = 0.37 by TLC, ethyl ~etst~/hexane (50/50)). As-)ltlff~n of this int"~srmP~ te in tetrahy-ll.,~ld~l (16 mT ) and water (8 mL) is then treated with sodium bicarbonate (662 mg) and benzyl chloro~ll..ate (0.56 mL), and the resllltinF ~iA~ula is stirred at ambient tempelatula for 4 hrs, diluted withwater (8 mT ), the layers dre separated, and the organic phase i8 washed with saline 35 (10 mL), dried over anhydrous m~gnPRillm sulfate and con-çntrated under reduced ~esr~ula. The residue is chrom~tographed on silica gel (230 - 400 mesh, 150 g), SlJt~ ITE SHEET (RULE 26) eluting with ethyl A-et~ttP~hexane (25/75), and those fractions with an Rf = 0.1g by TLC (ethyl Acetst~/hPYAnP-~ 25/75) are pooled and conce..l-dted to give the title cc,~ ound, mp 134 - 135~C.
Step 2: 3-Fluoro-4-(~ y~ ,lhiPn-3-yl)bpn7pnstminp~Ar 5 ~?her~ylmetl ~yl ester Following the general procedure of EXAMPLE 17, Step 2, and mAking non-critical vztriAti- n~ but sllh~l ;L~ F 3-fluoro-4-[3-(hyd~ y)tetrallyd~ iophPn-3-yl]bPn7~n~tminPcA.l,~,~ylic acid phenylmethyl ester (EXAMPLE 67, Step 1) for 4-hyd~ y-4-[4-[[(phellyh~ hnYy)c~l,ullyUamino]phenyl]-1-piperirlinPçArboxylic acid10 phenylmethyl ester, the title cc lll~ou~d is obtained as a ~ule of the 2,5- and 4,5-dihydro regioi~omPrs. NMR (CDC13, 400 MHz) 7.40, 7.21, 7.14, 7.02, 6.73, 6.69, 6.31, 5.21, 4.10, 3.94, 3.33 and 3.15 o.
Step 3: (R)-3-r3-Flllnro4-(~ hiPn 3-yl~uhPrlyll-5-}~.v.1t~ yl..Pt~yl-2-r-Ysl7:nli~innnP
Following the general procedure of EXAMPLE 17, Step 3, and m~tking non-critical variations but sllh~ ..g 3-fluoro4-(dihy-l~olllien-3-yl)hen~PnStminPcA~ ylic acid phenylmethyl ester (p!~AMpLE 67, Step 2, ~Lulc:
of the 2,5- and 4,B-dihydro reEioi~omprs) for 3,6-dihydro4-[4-[[(phenylmP~ nYy)carbonyl] amino]phenyl]-l(2H)-pyrillinpc~rboxylic acid phenylmethyl ester, the title c.".,po~ d is obtained as a ~L~e of the 2,5- and 4,5-dihydro regioi~omPrs. HR~IS cAlclllAt~cl for C14H14NlF103Sl: 295.0678. Found:
295.0676.
Step 4: (R)-3-r3-Flnnro-4-(tlil~y~ h if~n-3-yl)pha~yll-5 -rr(mPt~yl~lllfnr~yl~n~ylmPt?l~vll-2-~ n~ in~np~
Following the general procedure of EXAMPLE 17, Step 4, and mAkin~ non-critical variations but sllhsL:I .I;..F (R)-3-[3-fluoro-4-(dihy-Lo~lien-3-yl)phenyl]-5-hydlu~yl~lethyl-2-nYA7nliflinonP (EXAMPLE 67, Step 3, ~,~e of the 2,5- and 4,5-~lihydro regini~nmers) for (R)-(-)-3,6-dihydro-4-[4-[5-(hydlu~ylnethyl)-2-oxo-3-nYA7olitlinyl]phenyl] 1(2H) pyritline~ bu.~ylic acid phenylmethyl ester, the title 30 co ~pou~ld is obtained as a ll~ of the 2,5- and 4,5-dihydro regi~ i~omPrs. HR~S
nlAtel1 for Cl5Hl6NlFlOss2: 373-0454- Fo Step 5: 6~)-N-rr3-r3-Flllnrû-4-(~ v.llolhiPn-3-yl~hPnvll-~ rn-s-oYA7nli~ yllmPtl~yll~pt~millp~
Following the general procedure of EXAMPLE 17, Step 5, and mAkin~ non-35 critical variations but sllh ~ g (R)-3-[3-fluoro-4-(dihydlul~lien-3-yl)phenyl]-5-SUBSTITUTE SHEET (RULE 26) [[(methylsulfonyl)oxy]methyl]-2-s~Y~70litlinonP (EXAMPLE 67, Step 4, n~i~ e of the 2,5- and 4,5-dihydro reginiqom~srs) for (R)-(-)-3,6-dihydro4-[4-[6-[[(methylsulfonyl)oxy]methyl]-2-oxo-3 -nY5l7r~ inyuphenyl]-l(2H)-pyri~lina~ .Lu~ylic acid phenylmethyl ester, the title compound is obtained as a ~ix~ule of the 2,5- and 4,5-dihydro reEioicomars. Anal. c~lr~ fe~l for C16H17FlN203Sl: C, 57.13; H, 5.09;
N, 8.33. Found: C, 56.89; H, 5.18; N, 8.24.

FAMLE 68 (5~:)-N-rr3-r3-Fluoro4-(~ 5 ~lihv~ro 1 I~Yi~lo 3 thia~ haru~
~Y--~-6-nY~7nli~ yllmPtllyllacet~mi~le (68a) and (50-N-rr3-r3-Flll-~ro-4-(4.6-tli~ydro-1-~ Yi~ -3 ~hiarlyl)uha~ -nY--5-nY~7--litliTwllmathvllacet~mi-la (68b) Following the general pl~ce-lu ~ of F~AMPLE 63, and mAking non-critical variations but sllh~ F (S)-N-[[3-[3-fluoro4-(dihydluLllien-3-yl)phenyl]-2-oxû-5-nY~nli~inyl]methyl]Acet~ a (EXAMPLE 67, Step 5, ~ u~e of the 2,5- and 4,5-dihydro rP~ioi~omPrs) for (S)~-)-N-[[3-[4-(3,6-dihydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-5-oy~7nli~linyl]methyl]~l~et~mi~e and separating the regini~cm.sr~ by chromAkJ~;.d~hy on ~ilica gel (230 - 400 me~h, m~h~nnl/methylene ~-hlnri-le (4/96) eluent), the title c~ ou~lds are obtained. mp (68a) 208 - 210~C
ccmp.); NMR (68b) (CDCl3, 400 MHz) 7.55, 7.46, 7.27, 7.13, 6.11, 4.82, 4.07, 3.82 - 3.62, 3.43, 3.23, 3.10 and 2.03 o.
EXAMPLE 69 (S)-N-rr3-r3-Fluoro-4-(~ h-~ 1ro-~ y~
3 l~ iPr~vl)-1~hP-vll-2-~-Yn-5-nyf~7inli~ yllmpthyllsl~-pt~mi~la (69a) and (-c;)-N-rr3-r3-Fl~ rO4-(4~5-~ y~ro-~ n-~ 1~ iall,yl)-uhPr~yll-2~ -5-n~ 7~litlir~yllma~hyll~rPt~mitla (69b) Following the general procedure of EXAMPLE 50~ and m~kin~ non-critical v~r~ nC but sllh~-L:I .I;..g (S)-N-[[3-[3-fluoro4-(dihydl~lhien-3-yl)phenyl]-2-oxo-5-ny~7~ inyl]methyl]sl~et~micle (EXAMPLE 67, Step 5~ of the 2~5- and 4~5-dihydro regi- i~omars) for (s)-(-)-N-[[3-[4-(3~6-di-h-ydro-2H-thiopyran-4-yl)-3 fluorophenyl]-2-oxo-5-oY~7Qli-linyl]methyl]~t~et~mi~le and separdLi~g t,he 30 regioi~omars by HPLC (Chiralpak AD, 10% isopropanol/mP~n~ l (0.05%
diethylamine), 0.5 mL/min), the title compounds are obtained. mp (69a) 183 -185~C (~Pcomp.); (69b) 238 - 239~C (decomp.).

EXA~LE 70 (S)-N-rr2-Oxo-3-r3-fl uoro-4-r l-r(arptn~y)acet~yll -35 5.6-~ y~ro-2H-Dyriflin-3-yll~hen,yll-5-- Y~7-1itlirlyll-SUBSTrlU~E SH Er (RUI~26 W O 97/09328 PCT~US96/12766 m~t~lvllncet.~...irl~
Step 1: 5.6-nih~y~lro-3-rr(trifluorom~thvl)slllf~ oxyl-~ yri(linR~ ~.bu~li~
im~thvleth~yl ester Following the general procedure of EXAMPLE 20, Step 2, and m~kinF non-5 critical variations but s-lh~ 1-(1,1-dimethylethw,y. ~lJollyl)-3-pirRri~lone for l-(l,l-dimethylethu~y~ a,L.onyl)-4-piperidone and iR~ tin~ the desired reginiRomer by chrom~t~graphy on silica gel (70 - 230 mesh, ethyl &l~et~te/heYane (10/90) eluent), the title compound is obtained, NMR (CDC13, 400 MHz) 5.92, 4.04, 3.49, 2.30 and 1.47 o.
Step 2: (~q)-3-r4-r5-r(~cetyl~minn~m~t~yll-2-~yf--3-l Y~7~liflir~yll ~ flll0ro~hR~y 5.6-~ ytlro-1(~)-pyri(lin~ .lJn,~ lim~th~ylethvl ester Following the general procedure of F~AMPLE 38, Step 1, and m~kin~ non-critical variations but snh8l;4~ 5,6-dihydro-3-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyri-linPc~.Lu~ylic acid l,l-dimethylethyl ester (EXAMPLE 70, Step 1) for 3~6-dihydro4-[[(trifluoromethyl)sulfonyl]oxy]-l(2H)-pyri~in~ .b~ ylic acid 1,1-dimethylethyl ester, the title compound is obtained, NMR (CDC13, 400 MHz) 7.41, 7.25, 7.17, 6.06, 4.79, 4.19, 4.06, 3.78, 3.75 - 3.59, 3.57, 2.32, 2.03 and 1.49 ~.
Step 3: (~)-N-rr~-Oxn-3-r3-flll-ro-4-rl-r(~r.s~ v)ace~yll-5.6--lih~ylro-~ yrillin 3-yl~h~nvll-5-~yn~ yllmptllyllaf~ts~
A snlllt;~ n of (s)-3-[4-[5-[(acetylamino)methyl]-2-oxo-3-oy~oli~inyl]-2-fluorophenyl]-5,6-dihydro-1(2H)-pyri-lin~c~rboxylic acid l,l-dimethylethyl ester(T1'xA~ pLE 70, Step 2, 158 mg) in dry ~cetonitrile under N2 is treated with iodotrimr~thylsilane (62 IlL) dropwise, and the rq~lll*n~ solllt;~r is stirred at ~mhiçnt te~,ueLdLul~ for 50 mins, during which ~tltliffon~l iodotrimethylsilane (25 ~IL) is added. The reaction is then treated with mP+h~nnl (59 IlL), stirred for 5 mins and conre~l - aLed under reduced ~las~u a to give the dt:plvte~:ted intermP~ t~. A
~iALul~ of this intermr~rli~te and triethylamine (0.122 mT-) in dry methylene rhloritle (3.6 mL) at 0~C under N2 is treated with ac~LuAydcetyl chloride (47 ~L), and the rr~sllltinF ~uALu~a is stirred at 0~C for 2 hrs and at ~mhient te~pe~dLu,c, for 2 hrs and then diluted with methylene chloride (20 mL), washed with water (10 mL), ~aLuldted aqueous sodium bicarbonate (10 m L) and saline (10 mL), dried over anhydrous sodium sulfate and concent~ated under reduced pla~u~a. The residue is chrom~toFraphed on silica gel (70- 230 mesh, 15 g), eluting with mPt~ ~n- l/methylene chloride (5/95), and those fractions with an Rf = 0.5 by TLC
(mPth~no]/chloloro~n, 10/90) are pooled and conrent~ated to give the title SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCTrUS96/12766 compound, HRMS ç~ llAt~d for C21H24N3F106 + Hl: 434.1727. Fou 434.1741.

EXAMPLE 71 (S)-N-rr3-r4-rl-(Hy.l / . .~yacetyl)-5.6-~1ihy~lro-?T-T-vyri~in-3-yll-3 5 fln.~rovhPr~yll-?.-o~r~~.-5-.~Q .7~ mpthyllncets~ ~ ~ .ifle A ~x~ e of (S)-N-[[2-oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-5,6-dihydro-2H-pyridin-3-yl]phenyl]-5-.~Y~7oli-1inyl]methyl]A-~ehmir~P (~XAl\lrpLE 70, Step 3, 105 mg) and anhydrous pot~c~illm carbonate (67 mg) in m~lhAnol (4.8 mL) is stirred under N2 at ,~mhient t~ tu~ for 2 hrs and is then neutrAli~ed with 10 hydrochloric acid (1 M), diluted with water (10 mT) and methylene chloride (40 mL), and the layers are s~ ted. The organic phase is washed with saline (10 mL), dried over ~nhydrous sodi~Lm sulfate and conr- ..1 -~ted under reduced pleP_~a to give the crude product, which is then chromA~ hed on silica gel (70 - 230 mesh, 15 g), eluting with mPthAn-~Vmethylene chl~)ri-le (5/95). Pooling and 15 conc~ ~r-lion of those fractions with an Rf = 0.30 by TLC (mPt~Anovchloloru~ 1, 10/90) gives the title cuLu~uulld, mp 188 - 190~C.

F'XAMPLE 72 (.~-N-rr~-oxO-3-r3-fluOro-4-rl-r(Al~Pt~ y)A~ptyll-3.4-~lih~y~1ro-2H
gyri~in-5-yl~hP.rl,yll-5-mrA7nli~inyllmPth,ylli~r~ P.
20 Step 1: 3-Ily~ y-3-r4-rr(uh~ n~y)~ yll~min~ -fl~ rol~hpr~yll-l-9ineril~inPf~ A~ hPnylmPt.h~yl ester Following the general procedure of ~XAlvlPLE 67, Step 1, and mAking non-criticl v_riations but snh~ F N~c~ubobenzyloxy)-3-pippri~lonp- for tetrahydl~Lhiophen-3-one~ the title cul..pou~d is obt~inP~, mp 137 - 139~C.
Step 2: 3.4nil~yrlro-5-r4-rr(gh~r~ylmpthn~yh~lbu~ minnl-~-fluorophpr l(~)-Dyri-lin~ArlJ..,~ylir Ari~l phP~ylmPth,;yl ester Following the gener~ procedure of P'XAlvlPLE 17, Step 2, and mAkinE non-cntical vAriAt;nnR but Bllh~ F 3-hy~l~v~y-3-[4-[t(phenylmP~nYy)carbonyl]~mino]-2-fluorophenyl]-l-pirpri-linpc~ G~ylic acid 30 phenylmethyl ester (lixA~ pLE 72, Step 1) for 4-hy~l~v~Ly-4-[4-[[(phenylmPt}-n~y)ca~l,ollyl]amino]phenyl]-l-piperitlinPcArboxylic acid phenylmethyl ester, the title compound iB obtained, mp 138 - 139~C.
Step 3: (R) 3.4 nihy~ro-5-r4-r6-(llyil..."yl.,Pth~yl)-2-r~rn-3-~ A7nlir~ yll-2 fluorophPrurll-1(~)-pyri~linP~ At'i~1 phP~vlmPt~yl ester Following the general procedure of ~ANIPLE 17, Step 3, and m~king non-critical v~riAtion~ but snh~ :..g 3,4-Dihydro-~-[4-SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 Il(phenylmpth~ y)carbonyl]amino] -2-fluorophenyl]-1(2H)-py~ineç~rboxylic acid phenylmethyl e~ter (F'XAlVlPLE 72, Step 2) for 3,6-dihydro-4-[4-t[(phenylmPtl~nyy3csrbonyl]smino]phenyl]-l(2H)-pyri~linr~ç~LoAylic acid phenylmethyl ester, the title compound is obt~inPrl, HRMS c~ te~ for 5 C23H23N2F1o5 426-1591- Found: 426.1594.
Step 4: (R) 3.4 nihv-1ro-5-r4-r5-rr(mPt~y~ f~ yl)ny~ylmr~t~v~ xr~-3-r Y~7r 1i~invll ~-fluorouhprlyll-l(~)-gyri~inr~ . L. ~ hr~nvlmethvl esterFollowing the general pl~cadu~ of EXAMPLE 17, Step 4, snd m~kinE non-critical variations but 8n~ F (R)-3,4-Dihydro-5-[4-[5-(hydlu~y~ethyl)-2-oxo-3 10 ~y~7~ inyu-2-fluorophenyl]-l(2H)-pyri~linr~ LuAylic acid phenylmethyl ester (~XA~ pLE 72, Step 3) for (R)-(-)-3,6-dihydro-4-[4-[5-(lly~ yLuethyl)-2-oxo-3-~ 1irlinyl]phenyl]-1(2H)-pyri~inPc~Lu~ylic scid phenylmethyl ester, the title~;u~uul~d is obtsined, NMR (CDC13, 400 MHz) 7.39, 7.27, 7.18, 5.23, 4.93, 4.47, 4.15, 3.95, 3.71, 3.11, 2.44 snd 1.97 ~.
15 Step 5; (~:)-(-)-5-r4-r5-r(Acel~ minn)mr~tl~yll-2-rY---3---Y~7r-1i~1ir~yll-~-flllr rol;?hr~rvll-3.4-~lihyrlro-l(~)-Dyrirlinhr~l b~ hPrlylmPt~yl ester Following the general ~rocedu~e of EXAMPLE 17, Step 5, and m~kin~ non-criticsl vSIri~t;~m~ but sllh~ g (R)-3,4-Dihydro-5-t4-[5-[[(methylsulfûnyl)oxy]
methyll-2-oxo-3-rY~7olirlinyu-2-fluorophenyl]-l(2H)-pyrirlinpç~rboxylic acid 20 phenylmethyl ester (~XAMPLE 72, Step 4) for (R)~-)-3,6-dihydro-4-[4-[5-[[(methylsulfonyl)oxy]methyn-2-oxo-3-nYn7olirlinyl]phenyl]-1(2H)-pyri~in.5c ..Lu~yLc acid phenylmethyl ester, the title compound i8 obt~in~ IS .~ ~d for C25H26F1N3O5: 467.1856. Found: 467.1862.
Step 6: (S)-N-rr2-Ox-~-3-r3-fluoro-4-rl-r(acetoxy)~-~Ptvll-3.4-~i~y-lro-2~-gyri~in 5-yllDhPrlyll-5-~Y~7~ yllmPtllv~ Pt~mil1P
Following the general procedure of ~XANIPLE 70, Step 3, and m~kinF non-critical v~ri~tif~n~ but sl~hsl;l ~1;,,~ (S)~-)-5-[4-[5-[(Acetylamino)methyl]-2-oxo-3-~Yfl7~ inyl]-2-fluorophenyl]-374-dihydro-l(2H)-pyritlinp~rboxylic acid phenylmethyl ester (EXAMPLE 72, Step 5) for ($)-(-)-5-t4-[5-t(acetylamino)methyl]-2-oxo-3-- Y~ inyl]-2-fluorophenyl]-3~6-dihydro-l(2H)-pyri~linpc~rboxylic acid 1,1-dimethylethyl ester, the title coll~uu,ld i80btSIinP~ mp 146 - 148~C.

FXAlVlPLE 73 (S)~-)-N-rr3-r4-r1-(~ u~yace~l)-3.4-tlih~y~ro-~ yri-lin-5-yll-3-fluoro-ohpr~yll-2-o~-5-r~y~ ir1inyllmatkyllacet~mitle A ll~Lure of (S)-N-t[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyU-3,4-dihydro-2H-Sl.~ 1 l l UTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 pyridin-5-yl]phenyl]-5-rY~7oli-1inyl]methyl]~ret~mi-1e (EXAMPLE 72, Step 6, 238 mg) and anhydrous pot~Rillm carbonate (151 mg) in m~th~nl l (27 _L) is stirred under N2 at ~mhient tempe,d~ for 2 hrs and is then neutralized with hyd~vchloric acid (1 M) and conre..t-ated under reduced l.res,iula. The residue i8 5 then diluted with methylene chloride (100 _L) and saline (~0 mL) and the reRlllt~nt. inRolllhle product is removed by filtration and dried under reduced ple__uu~. The layers in the filtrate are separated and t~e organic phase is dried over anhydrous sodium sulfate and conc~..l-ated under reduced ~r~.,.,~ to give s-Mitir~nsll qns~nt;t;~3 of the title ~v..~ ,u~d, mp 171 - 173~C.
Ti'XAlVIPLE 74 (S)~-)-N-rr3-r4-rl-Formyl4-fluoro-4-piDeritlinvll-3-flllnro~h~ -5-n~ m~thyllnl ~t~
Step 1: 4-ITy~ ..,v4-r~.-fluoro4-rr(~h~ vlm~th~ lJol~yll~min~l Dh~nvll l ~i~erillin~r~rb- ~ylir ~ri~1 ~;?h~r~ylm~t~yl ester A solllt;on of 1-(3-fluorophenyl)-2,2,5,5-tetramethyl-1-aza-2,5-disilacyclo~ G..~ (T~XAl\/IPLE 20, Step 1, 1.00 g) in dry tetrah~,-lr~,ru-~u (9.8 mT-) at -78~C under N2 is treated with sec-butyllit~-illm (1.3 M in cyr.l~h~YSIn~, 3.64 dropwise over 3 mins, and the r~snltin~ a is stirred at -78~C for 2 hrs. Theu~a is then treated with a sollltion of N-(carbobenzyloxy)-4-pireri~lon~ (919 mg) 20 in dry tetrahydroru~ (3.9 mT-) dropwise over 2 _ins and is stirred at -78~C for 2 hrs. The ~ Ul~ iS then warmed to -20~C over 1 hr and qllPnrh~l with saLu~a~ed aqueous Ammonillm rhlr~ (5 mL), diluted with water (20 mT-), the layers are separated, the aqueous phase is extracted with diethyl ether (20 mT-), and the c~mhin~-l organic phase is washed with saline (10 m~L), dried over anhydrous sodium sulfate and c~nre--l-ated under reduced pla~u~. The residue is dissolved in m~thAnol(15 mL) and treated with anhydrous pot~illm carbonate (544 mg, 3.94 mmol), and the ~lula is stirred at Amhiant t~ ~e~dLu~a for 30 mins, concc~l~t ated under reduced ~ ula, diluted with diethyl ether (30 _ L), washed with water (20 mL) and saline (10 ~), dried over anhydrous mAEn~ m sulfate 30 and con~ ~ated under reduced ples,,u~e to give the crude 4-(hydlv~y)piperidinyl bçn7~nAmin.q interm~-iiAt~ (Rf = 0.25 by TLC, ethyl Al~et~t~hexane(50/50)). A
lu.~ of this intermf~tliAte and N,N-dimethylAnilin~ (1.00 mL) in tetrahydl~,ru~l(20 mL) is cooled to -20~C and treated with benzyl chlororu~ate(0.59 mT-), and the r~qnlting ~-2f.Lu~: is stirred at -20~C for 1 hr. The lllL~ Ule~ iS then diluted with 35 saturated aqueous potassium carbonate (5 mL), water (25 mL) and diethyl ether (25 mL), the layers are separated, and the organic phase is washed with water (20 mL) -7~-Sl~ ~E ~E~ ~RULE 2 W O 97/09328 PCT~US96/12766 and saline (20 mL), dried over anhydrous sodium sulfate and conrent-dled under reduced p~ t:h~uLe. The residue is chrom~t~graphed on silica gel (230 - 400 mesh, 150 g), eluting with a gradient of ethyl Aret~t~lhexane (2B/76 - 50/50), and those fractions with an Rf = 0.47 by TLC (ethyl Aret~tP~lh~y~ne~ 50/50) are pooled and5 conr~ ted to give the title compound, NMR (400 MHz, CDCl3) 7.36, 7.00, 6.92,5.20, 5.16, 4.10, 3.32, 2.15 and 1.79 o and Anal. cAlr~ t~d for C27H27FN2O5: C, 67.77; H, 5.69; N, 5.85. Found: C, 67.44; H, 5.83; N, 5.65.
Step 2: 4-Fl~ ro-4-r4-rr(uhanvlm~t)yY)l~A~l~n~ minol-~-fll-~ ro~hanvll-l-pi~ri~in~ A-L--~yl;t~ ~rifl l~har~ylmF~t.hyl ester To a sslntion of diethylAminoslllfilr ~ iflll- ri~le (DAST, 0.65 mL) in dry methylene chloride (49 mL) at -78~C under N2 is added a solllt;~ n of 4-hydrv~y-4-[4-[[(phenylm~~ nYy)c~lul~yl]amino]-2-fluorophenyl]-l-~i~t7L;tl ;n-~cArboxylic acid phenyl...eLLyl ester (EXAMPLE 74, Step 1, 2.26 g) in dry methylene chloride (47 mL) over 2 mins. The reslllffng ~-~I,u e is stirred at -78~C for 1 hr and at Amhient 15 t,e~llp.,.dLule for 30 mins and is then adjusted to pH 8 with sa~ulated aqueous sodium bicarbonate (50 mL), diluted with water (50 mL), and the layers are separated. The organic phase is washed with water (25 mL) and saline (25 mL), dried over anhydrous sodium sulfate and conr~ dted under leduccd pr~ul~:~ and the residue is chrom~lo~;.d~hed on silica gel (230 - 400 mesh, 150 g), eluting with 20 m~thAn~l/methylene rhloricle (0.5/99.5). Those fractions with an Rf = 0.27 by TLC
(ethyl ~cet~tq/ht~YAna, 26/76) are pooled and conce..l-dted to give the title cc. ~uu~ d 4~ ted with approx. 15% of the ~liminAt;~)n side product). An analytical sample is ~ c~aled by radial chrom~lo~.d~uhy (1000~1 silica gel rotor, ethyl ~etst~hexane (20/80) eluent), mp 116 - 118~C.
Step 3: (R)-4-Fl~ ro-4-r4-r5-(l~ thyl)-2-nYn-3--flnnro~h~r~yll l-pi,;~eri(1in~ A~b~ acid ph~?rurlm~t~yl ester A sollltion of 4-fluoro-4-[4-[[(phenylm~thnyy)carLullyuamino]-2-fluorophenyl]
l-piperi~in~ .1Ju~ylic acid phenylmethyl ester (EXA~LE 74, Step 2, 2.03 g, c....tq...i..Atg~l with the eliminAti~n side product) in dry tetrahydluru~dn (21 mL) at 30 -78~C under N2 is treated with n-butyllithillm (2.80 mL, 1.6 M in h~Y~n~8) dropwise over 5 Inins. The rç~lllt~ng s~ Lul~ is stirred at -78~C for 1.25 hrs and is then treated with (R)-(-)-glycidyl buLylate (0.63 mL) dropwise. The r~3lllting sollltinn is stirred at -78~C for 1 hr, warmed to ambient tempeldLu-~ and stirred for an Arl~ition~l 20 hrs, after which the reaction is qll~n~h~rl with saLu~dted aqueous 35 ~mmonillm chloride (10 mL), diluted with water (10 mL), and the layers are Sl,~S 111 ~JTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 separated. The organic phase is washed with saline (10 mT), dried over anhydrousmagne~ m sulfate and co~ dted under reduced ~ a to give the crude product which is chrom~lc.~.d~hed on silica gel (230 - 400 mesh, 250 g), elutingwith m~th~nnl/methylene ~hlorjrl~ (3/97). Pooling and con~ tion of those 5 fractions with an Rf = 0.51 by TLC (m~tl~nnl/chlo~vro~ 10/90) and re:~u~ s~t;~m by silica gel chrom~t~graphy (230 - 400 mesh, 100 g, m~tl~nnVmethylene chloride (4/96) eluent) gives the title ~ )uulld (Cont~min~e(3 with the çlimin~tion side product from the starting m~t~ri~l). An analytical s~mple is prepared by radial chrom~t~ hy (2000~1 silica gel rotor, ethyl ~ret~te/hexane (60/40) eluent), NMR
10 (400 MHz, CDCl3) 7.45, 7.34, 7.18, 5.16, 4.74, 4.17, 3.97, 3.72, 3.22, 2.25 and 1.90 o and HRMS calculated for C23H24F2N205: 446.1653. Found: 446.1660.
Step 4: (R)4-Fll-nro4-r4-r5-rr(mPthvl~ fnr~yl~n~ m~thyll-~-n~rn-3-n~ n l-~-fluorogh~ru~ll-l-l~i,;~eri- in~A - ~ ;O acid uh~r~ylm~.+~yl ester A 80llltinn of (R)-4-fluoro-[4-t5-(hy.l~.,.ylllethyl)-2-oxo-3-QY~7nlifiinyll-2-15 fluorophenyl]-l-piperi~iin~c~rboxylic acid phenylmethyl ester (EXAMPLE 74, Step 3, 0.17 g) and triethylamine (0.080 mT.) in dry methylene chloride (2 mL) at 0~C
under N2 is treated with m~t~ ~n~lllfnnyl chloride (0.031 mL) dropwise. The res--lt;nE ~ is stirred at 0~C for 12 hrs and at Amhient tempelf tu~. for 1.6 hrs, diluted with methylene chloride (10 mL), washed with water (5 mL), s2~Lu~ted 20 aqueous so~ lm bicarbonate (5 mL) and saline (5 mL), dried over anhydrous sodium sulfate and c....~ ted under reduced ~ s~u~a to give the title c~ oulld, S c ~'i for C24H26F2N2O7S~Hl: 525-1507. Found: 525.1522.
Step 5: (1::)-N-rr~-Oxn-3-r4-(4-fluoro-4-uiDeri lir~yl)-3-fiuorouh~ ll-5-~ys~7nli~ yllmpt~ p~qmide 26 A llliX Lulc: of (R)-4-fluoro-4-[4-[5-[[(methylsulfonyl)oxy]methyl]-2-oxo-3-oY~7olitlinyl]-2-fluorophenyl]-l-piperirline-,~rboxylic acid phenylmethyl ester (F~Al\/lPLE 74, Step 4, 0.190 g) and con~ t~ ~d aqueous ~mmonillm hydroxide (2 mT-) in isopropanol (1 mL) and ~etonit~ile (2 mL) is placed in a sealed tube andimmersed in an oil bath m~intqinPcl at 95~C for 18 hrs. The ~u~e is then diluted with methylene chloride (20 _L), washed with water (10 mL) and saline (10 mT-), dried over anhydrous sodium sulfate and conl~çnt~ated under reduced pressure to give the crude 5-~minnmPthyl-2-nY~7oli~1inorlP intermP~ te (Rf = 0.13 by TLC,mPthslnnllchlorofo~ 5/9~). A solll*on of this intermp~i~te and pyridine (0.088 mL) in dry methylene chloride (3.6 _L) under N2 is treated with acetic anhydride (0.051 mT.), and the regl~lt;ne so~lltinn is stirred at slmhiPnt temperature for 18 hrs. The SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 Lurais then diluted with methylene chloride (10 mT-), washed with water (5 mL), sal~ ed aqueous sodium bicarbonate (5 mL) and s~line (6 mL), dried over anhydrous so~ m sulfate and con~e~ ted under reduced ~la~-iula to give the crude ~et~mi-lP intArmP~i~tA which, after being comhinP~l with approx. 1.5 g of 6 crude product from previous reaction wulLu~s, is chrom~t~.dl~hed on silica gel(230 - 400 mesh, 150 g), eluting with a gradient of mP~nnl/methylene chloride (1/99 - 2/98). Pooling and con~entration of those fractions with an Rf = 0.18 by TLC
(mPthslnnl/chlo~ru~ 5/95) gives 0.80 g (approx. 70% from the mesylate) of the product (cont~min~e~l with the çlimin~tion side product) as an amorphous, white 10 solid which is used without further pllrific~t;-n A ~LIule of this in~:~...P~ tP
(0.75 g) and 20~o p~ tlinm hyd.u~ide on carbon (200 mg) in mPth~nol (30 mL) is shaken on a Parr apparatus under a hyLo~en ~qt nosphPre at 40 psi for 1 hr, the catalyst i8 removed by filtration through Celite and the filtrate is conc~..t- aL~d under reduced ~l~~;Sula. The residue is chrom~J~.al,hed on silica gel (230 - 40015 mesh, 45 g), eluting with a gradient of triethylamine/mptl~n~l/methylene chloride (119/90 - 1/4/95), and those fractions having an Rf = 0.19 by TLC
(triethylamine/mPt)~nol/chlo-~rc,.~, 1/9/90) are pooled and co..cr..t-ated to give the title c.,~pou-ld, mp 163 - 165~C.
Step 6~ -)-N-rr3-r4-r1-Fornlyl-4-fluoro-4-ju~eritlir~yll-3-fluoro~hP.r~yll 2 ~Y~
20 5~Ys~7"li~inyllmPt~yll~r.~ "~
A ~i~lu~ of (S)-3-N-[[2-oYo-3-[4-(4-fluoro-4-piph~ yl)-3-fluorophenyl]-6-nyl]methyl]sl~etc~m~ (~AMPLE 74, Step 5, 205 mg), 1~3-dimethylaminopl~yl)-3-ethylcarborliimirl~s hydlocllloride (145 mg) and formic acid (28 IIL) in dry tetrahyd~ru~n (11.6 mL) is diluted with water to solllhili7P all25 ~ t~ and stirred at slmhiPnt tempe-dlu~e for 6 hrs. The reaction is then diluted with methylene chloride (30 mL), washed with water (20 mL) and saline (20 m L), dried over anhydrous sodium sulfate and csn~ dted under reduced pr~E_~e, and the residue is chr)m~o~.d~hed on silica gel (230 - 400 mesh, 40 g),eluting with a gradient of mPth~nol/methylene chloride (3/97 - 5/95). Those 30 fractions with an Rf = 0.40 by TLC (mpth~nnl/chlolorol~l~ 10/90) are pooled and cor.~ aled and the residue is recryst~ from chlororc.-~/diethyl ether to give the title compound, mp 180 - 181~C (~eComr.).

~I~AMPLE 75 (0-N-r~2-O~rn-3-r3-flllnro-4-r1-r(acet.n~v)~l~Pt~yl~ .4.7-tetrsl~y~lro-l ~-5~7:P.Din-5-yllphPr~yll-6-n~s~7:nli~ Vllm~th~yll~Pt~mi~l~

~U~ 11 1 ~E SHE~ (RULE 2~) Step 1: ~ ~.4.7-Tetr~ ro-5-rr(trifluornmP+~yl)slllfnnylln~ 7apina-l-~rl".~li~ s.~ imat~ et~ ester (.9.) and 2~3~6~7-Tetrshy~ro4-rr(t~rifluorom~t~vl)gt~lfnr~yllnyy~ 7P~inp-~ rboyyli~ acid 1.1-dimat~yle~l~yl ester (b) Following the general ~lucedule of ~XANrPLE 20, Step 2, and mslking non-critical variations but 8llh~ F 1-(1,1-dimethylethu~ l,onyl)-1,2,3,5,6,7-hexahy~Lù~7~ui..-4-one for 1-(1,1-dimethylethoxycarbonyl)4-piperidone and i~olst;n~ the r~ oi~nmars by chrom~ra~hy on silica gel (230 - 400 mesh, ethyl sce'st~hexane (5/95) eluent), the title culll,uoullds are obtsinP-~, (a) N~ (CDC13, 10 400 MHz) 5.87, 3.95, 3.55, 2.57, 1.95 and 1.46 ~ and (b) N~ (CDC13, 400 MHz) 5.90, 3.54, 2.69, 2.35 and 1.47 o.
Step 2: (~)-5-r4-r5-r(Ace~ min-)mPt~yll-~-n~n-3-nY~7nli~iTIyll-~-fluoro~har~.4.7-tetrshydro-l~-s7P~in~-~sll,n~li~ acid l l-dimathvlPtllyl ester Following the general ~.Jcev~l,e of ~XAMPLE 38, Step 1, and m~kin~ non-15 critical variations but sllh~ 2,3,4,7-tetrahydro-5-[[(trifluolv~eLh~ lllfonyl]
oxy]-1(1H)-~ pinFc~.l,u~ylic acid 1,1-dimethylethyl ester (EXAMPLE 75, Step 1(A)) for 3~6-dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-l(2H)-pyrirlinec~Lu~ylic acid 1,1-dimethylethyl ester, the title cu~ uuL~di8 obtained, NMR (CDCl3, 400 ~Iz) 7.31,7.12 - 6.95, 5.84, 4.76, 4.00, 3.98, 3.76, 3.61, 3.58, 2.51, 1.97, 1.85 and 1.42 ~.
20 Step 3: (R)-N-rr2-OYn-3-r3-fluoro4-r1-r(~Ptnyy)acetyll-2 ~.4 7_t~t~s~hy~1ro ~7P~in-5-yll;Dh~ yll-5-ny~7~nli~ mf~tll~yll~ptslmi~lp Following the general ~u~edul~ of T~xAlvlPLE 70, Step 3, and mAking non-critical variations but snh~l;l ~.l ;..g (S)-5-[4-t5-[(acetylamino)methyl]-2-oxo-3-oY~7nli~linyl] 2 fluorophenyU-2,3,4,7 tetrahydro-lH-~7ppin~-l-carboxylic acid 1,1-25 dimethylethyl ester (EXAMPLE 75, Step 2) for (S)-(-)-3-[4-[5-[(acetylamino)methyl]-2-oxo-3-oY~7nli~inyl]-2-fluorophenyl]-5,6-dihydro-1(2H)-pyri-line- s. ~Lu~ylic acid 1,1-di~eLllylethyl ester, the title ~ ~uulld is obtained, HR~IS c~ te~l for C22H26FlN3~6: 448-1884. Found: 448.1888.

30 T~'XAMPLE 76 (S)-(-)-N-rr3-r4-r1-(TTy.lr~,~y~cetvl)-2 .~.4.7-~t~ v~lro-~ 7~pin 5-yll-3-fluoro~?h~ yll-2-nyn-5-~y~7nli~ vyllm~*~yllacet~mi~l~
Following the general procedure of EXAMPLE 71, and mslking non-critical variations but ~llhst;t~lting (S)-N-[[2-oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-2,3,4,7-tetrahydro-lH-azepin-5-yl]phenyU-5-nY~7o~ nyl]methyl]~et~mi(le (EXAMPLE 75, 35 Step 3) for (S)-(-)-N-[[2-oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-5,6-dihydro-2H-pyridin-SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 3-yl]phenyl]-5-oY~7n~ inyl]methyl]~-~et~mi~e, t-h-e title c~ uuu~d is obt~ine-7, ~MR
(CDC13, 400 MHz, ~ Ule of rotamers) 7.41, 7.09 - 7.18, 6.07, 6.00, 5.87, 4.78, 4.25, 4.21, 4.05, 3.92, 3.87, 3.78, 3.67, 3.51, 2.63, 2.03 and 1.97 o and HRMS c~lc~ ted for C2ûH24F1N3~s 405-1700. Found: 405.1694.

F'XAl\/IPLE 77 (~)-(-)-N-rr2-o~yn-3-r3-fluoro4-rl-r(~t~ y)~ptyll-2~3~6.7 t.Ptr~h~y~ro-~ 7.~in4-yl~h~r~yll-5-nY~7:nli~ yllmPt.ll,,y~ P+~mi~P
Step 1: (~)-4-r4-r5-r(Acetyl~minn)lnpth~yll-2-r~yn-3-~-y-~7n~ yll-~-flllnrophar~
~ ~~ 6.7-tetr~h,y(lro-lFr-~7P~ina-l-f~rboxylic acid l l--limPthvlet~yl e~ter Following the general procedure of EXAMPLE 38, Step 1, and m~kinE non-critical variation~ but sllh~ F 2,3,6,7-tetrahydro-4-[[(trifluoromethyl)sulfonyl]
oxy]-l(lH)-~7epinPc~rboxylic acid l,l-dimethylethyl ester (EXAMPLE 75, Step l(B)) for 3~6-dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-l(2H)-pyri~inp~-~ . bul~ylic acid 1,1-~li~eLllylethyl ester, the title co ~pc.ulld is obt~inPtl, mp 164 - 165~C.
15 Step 2: (S)-(-)-N-rr~-OYn-3-r3-flllnro-4-rl-r(ace~nY~y~Ptyll-~ .~.6.7-tetrs~hy~iro P~Din-4-yl~7hpr~yll-5-ny~7r~ yllmF~t~l,yll~r~ P
Following the general procedure of EXAMPLE 70, Step 3, and m~king non-critical variations but sllh -~ I:..g (S)-4-[4-[5-[(acetyl~mino)methyl]-2-oxo-3-nY~7o~ inyl] 2 fluorophenyl] 2~3~6~7-tetrahydro-lH-~7spine-l-carboxylic acid 1,1-20 dimethylethyl ester (EXAMPLE 77, Step 1) for (S)-(-)-3-[4-[5-[(acetylamino)methyl]-2-oxo-3-nY~7olitlinyl]-2-fluorophenyl]-5~6-dihydro-1(2H)-pyri n~c~ w~ylic acid 1,1-di leLl~ylethyl ester, the title col..~uu~d is obtained, NMR (CDCl3, 400 ~Iz, ~il~Lu~ of rotamers) 7.39, 7.15, 6.22, 5.90, 4.79, 4.04, 3.80 - 3.50, 2.70, 2.50, 2.19 a~d 2.û2 ~ and Anal. calculated for C22H26FlN306: C, 69.05; H, 5.86; N, 9.39.
25 Found: C, 58.70; H, 5.80; N, 9.43.

F~Al\/rPLE 78 (s)-(-)-N-rr3-r4-rl-(I~ r~ yllcetyl)-~ .2 6.7-h~tt~hy~ro-lF~ gP~?in 4-yll-3-flllnrol?h~ -nyn-5-~yn7nlit~ yllm~vllacet~mitl~
Following the general plucedu~e of EXAMPLE 71, and m~kinF non-critical 30 variations but snh~ (S)-(-)-N-[[2-oxo-3-[3-fluoro-4-[1-[(acel~y)acetyl]-2,3,6,7-tetrahydro-lH-azepin4-yl]phenyl]-5-nY~7nli-1inyl]methyl]~et~mitle (EXAMPLE 77, Step 2) for (S)-(-)-N-[[2-oxo-3-[3-fluoro-4-[1-t(acetoxy)acetyU-5,6-dihydro-2H-pyridin-3-yl]phenyl]-5-oY~ linyl]methyl]~-~etsmi~e, the title compound is obtained, NMR
(CDCl3, 400 MHz, ~ e of rotamers) 7.41, 7.13, 6.08, 5.90, 4.78, 4.22, 4.04, 3.85 -35 3.59, 3.51 - 3.41, 2.70, 2.52 and 2.02 ~ and Anal. ~ te-l for C20H24FlN306: C, SUBSTITUTE SHEET (RULE 26) 59.26; H, 5.97; N, 10.36. Found: C, 58.91; H, 6.04; N, 10.19.

~XAhrPLE 79 (~ N-rr3-r4-rl-(~1y(ll.. xv cetvl)hPY~hv~ro-lT-T-~7.P.~in 4 yl13 ~ flllnroE~hPnvll-2-oxo-5-o~y~ n~ llmat-h~yllacet~mit~ --;x~ of ~ t~reomPrs) ~ Following the general procedure of EXAMPLE 48, and m~king non-critical v~ri~t;~nC but sllh~itllt;ng (S)-(-)-N-t[3-[4-[l-(hydlo~y~cetyl)-2~3~4~7-tetrahydro-lH
azepin-5-yl]-3-fluorophenyl]-2-oxo-5-oY~qnli~inyl]methyu~ e (EXAMPLE 76, Step 3) for (S)-(-)-N-[[3-[4-(3,6-dihydro-2H-pyran4-yl)-3-fluorophenyl]-2-oxo-5-10 nY~ linyl]methyl]qc~t~ P and ~U-;Çyillg the product by chrnm~t~graphy on silica gel (70 - 230 mesh, mPt~nollmethylene chloride (7.5/92.5) eluent), the title ~.,...p~.u,ld is obtained, HR~S r~lcl~ for C20H26FlN3O5 + Hl: 408-1935-Found: 408.1928.

15 ~xAlvlpLE 80 (I~)-N-rr3-r3-Fluoro4-(3.4-~lih~y~ro-2T-T-pyran-6-yl)phPlv11-2-oYn 5 n~.nlitlir~,yllmPt.hyll~c~l.~...i~la Step 1: 6-(trihutyl~t~nrurl)-3.4-~ihvr~ro-~T~ .v.l.o~.y~
A snlllt;on of 3,4-dihydro-2H-dihy-L~u~y-dn (2.000 g, 23.8 mmol) and N,N,N',N'-tetramethylethylanP~ minP (0.50 mT, 3.09 m~nol) under a nitrogen 20 At~no~phare was cooled to 0 ~C and treated with n-butyllithillm (19.30 mL of a 1.6 M solntinrl in hPY~nP, 30.94 mmol). The ,~l,~ue was then warmed to ~mhiant temperature overnight. The rP~lllt~nt ~ula was cooled to -78 ~C, dry tetrahylllvru~ (20 mL) was added, and then tribu~yl~in chloride (6.40 mL, 23.8 mmol). The ~ Lu~a was stirred at -78 ~C for 1 h and then warmed to ambient 25 temperature for 2 h. The reaction ~ ula was diluted with diethyl ether (50 mL), transferred to a sepal2ltc.~, funnel and washed with 5% aqueous ~mmnnnillm hydroxide and brine. The organic layer was then dried, filtered and con~ ated togive a crude product. Di~ffll~;nr of the residue under reduced plas~u.a afforded1.80 g (47~o) of the title compound with a purity of 55%.
30 Step 2: (,O-N-rr3-r3-Fluoro-4-(3.4-~1ih~ylro-2H-~yr~n-6-yl)~?hPnvll-7-~ -5 nYs~:nli~linvllm~t.h,yll~Pts~mi~
A sol~ltion of (S)N-[[3-[3-fluoro~-iodophenyl]-2-oxo-5-oY~Qli~linyl]methyl]
~-et~mi~e (0.200 g, 0.53 mmol) in 1-methyl-2-pyrroli~inone (5 mT-) under a nitrogen ~tmosphpre wag treated with Pd2dba3 (0.018 g, 0.02 mmol) and tri(2-35 furyl)ph-)srhine (0.009 g, 0.04 mmol). After stirring 10 min at ambient te"lpelaLu~e, the l~L~ was treated with 6-(tributylstannyl)-3,4-dihydro-2H-SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 dihydlopyl~ll (0.538 g, 66% purity, 0.80 mmol). The sltmosphpre was evS7~l~s te~l and filled with nitrogen three times and then the ll~L~lule heated to 90 ~C for 24 h.
At this time the reaction llli2~l,ule was cooled to stmhient temperature and poured into ethyl stcetstte A ple.-;pil~te was noticed and removed by filterinF the ll~ Lula 5 through Celite. The filtrate was transferred to a sepalat~ funnel and washed with water and brine, dried over 60dium sulfate, filtered and con~ l ated in vacuo.
The residue was chromsltographed over silica gel, eluting with hPyslne~ 20%
~cQtonP/hPYslnp-~ and finally 5% mPthslnol/dichlorompt~slne Appropriate fractions were comhinPtl and concentrated in uacuo to give 0.196 g of a mAtPrisll sontSlining a 10 small amount of 1-methyl-2-pyrroli~linonP. Recrystsllli7slt;~n provided 0.128 g (68%) of the title cu~ .uul~d. mp 161-163 ~C; MS(EI): m/z 334.

T~Al\/rpLE 81 (.C:)-N-rr3-r3-Fluoro-4-rl~slrbob~nY,yl~ -3-q7~t;-1ir~vll-phPr~
7.-oY-~-5-nYsl7.~ ir~yllmatllvll acetstmi~lp Step 1: 3~4-~min~ fluoroyhPr~yl) 3-}~y~ y-1-(1 1-~i~Dhprvlmpthvl~st7pt;~lin Sec. butyllithitlm (22.5 m~ of a 1.3M solllti~n in cy~lohPYstnp~ 29.5 m nol) was added dropwi~e to a stirred solllti~.n of 1-(3-fluorophenyl)-2~2~5~5-tetram~eth a,a-2,5-disilacyclopqnktnP (Ti'Yslmple 20, Step 1) (6.0 g, 23.7 mlnol) at -78~C under nitrogen in dry THF (75 mL). After 2 hr a solllti-n of 1-(1,1-20 diphenylmethyl)sl7Ptiflin3-one (5.6 g, 23.6 mmol) in dry l'~ (60 mT,) was added dropwise and stirring cv~t;~ P~l at -78~ for 2 hr, when the cooling bath was ~ Oved. ~fter reS ~hing room tempelaLule, a sol ~ti~n of sat~dted slmmr~nillm chloride (75 mL) was addedfollowed by water (200 mL). The lll~ e was extracted with ether (500 mL), 25 washed with brine (100 mL), dried over m~gnPRium sulfate, filtered and evaporated. The residue was dissolved in mPthsln~l (150 mL) and anhydrous potqRRillm carbonate (6.0 g, 43.5 mmol) added and then stirred ovPrnight The sllRpPnRion was filtered and the filtrate evaporated. The residue was partiff~npd between ether (500 mL) and water (200 mT-). The water was e~ led with 30 sl~itionstl ether (200 mT-) and the comhin~d ether extracts washed with brine (100 mL), dried over mslgnP~illm sulfate, filtered and t:vdpoidted to afford an orange foam. Chromslt~graphy over silica gel (150 g, 40-60 um) eluting with 25-50~o ethyl acetate-hPYSlnP gave the title compound as a pale yellow foam. lH NMR o (CDCl3):2.62, 3.53, 3.78, 4.41, 6.36, 6.41, 7.03, 7.14-7.30, 7.39-7.47.
35 Step 2: 3~N-Cslrbob~n7~yloxv-3-fluoroslnilin-4-vl)-3-l~y~l ~ o~ y-l-(1.1-hpr~ylmpthyl~sl7eti~ine Sll~ I~E SHEEr (RUI~26 W O 97/09328 PCT~US96/12766 To a sollltion of 3-(4-~mino-2-fluorophenyl)-3-llylllv~Ay-l-(l~l-diphenylmethyl)~7Ptitline (T~Y~mpla 81, Step 1, 5.10 g, 14.7 mlnol) in sltetona (75 mL) was added a solution of sollillm bicarbonate (2.52 g, 30.0 mmol) in water (40 mL) to give a ~;leallly suspension. Benzyl chlolofu,.,late (2.57 g, 15.1 mmol) was 5 added and stirring cor tinnP~ overnight. The sllRp~nRion was filtered and the sl~etona evaporated. The residue was parfftiona~l between ethyl acetate (200 mT~) and water (50 mL). The organic layer was washed with brine (50 mL), dried over m~na~illm sulfate, filtered and evaporated to leave an amber foam.
Chrom~t~. a~hy over silica gel (150 g, 40-60 ~M) eluting with 1-2% mPth~no 10 methylene chloride gave the title cc Ipou-ld as a cream foam. HRMS: meas.
483.2087, theory 483.2084.
Step 3: N-C~rbobPn7~ylo~Y~y-3-(N-~rbobenzyloY~y-3-flllnr~nilin-4-yl~-3-ll,y-l . ~ l7~pti~inp Benzyl chl.,rvruA..late (3.8 mL, 26.6 mmol) was added to a Rollltion of 3-(N-15 carbobenzyloxy-3 -fluoroanilin~-yl)-3-lly ~11 v,Ay - l-(1,1-diphenylmethyl)s~ ~Pti ~1 i n P
(h!y~mple 81, Step 2, 1.60 g, 3.32 mmol) in bPn7Pna (30 _L) and then heated under reflux under nitrogen for 2 hr. The benzene was evtApo~dted and the residue chrom~tc,~. d~hed over silica gel (150 g, 40-60 ~n) eluting with 20-60% ethyl acetate-hPY~nP The title c~ oulld was obtained as a white foam. lH NMR o 20 (CDC13): 3.32, 4.19, 4.42, 5.08, 5.17, 6.98, 7.11, 7.19, 7.24-7.43.
Step 4: N-C~rbobPn7,yl- Y,y-3-(N--~rbobPn7,yll Y,y-3-fluorn~nilin-4-yl)fl7P~irlina Triethylsilane (30 mL) and trifluoroacetic acid (12 mL) were added to a solllt;nn of N-carbobenzyloxy-3-(N-carbobenzyloYAy-3-fluoroanilin-4-yl)-3-l~ydlv~Ay~7el;rlinP (~.Y~mpla 81, Step 3, 4.3 g, 9.55 mmol) in methylene (~hlnri(le (40 25 mL) and stirred for 2 days. Removal of the solvents at 45~/0.75 mm gave an amber oil. Chrom~t~graphy over silica gel (150 g, 40-60 ~m) eluting with 1-3% mpth~n chlol~r..,.., yielded the title cv-~c,u. d as a solid, m.p. 95~.
Step 5: (R)-(-)-N-c~rboben~yl~cy-3-r2-fluoro-4-r5-l~ lpt ~Ysl7f)1itlir~ylk~har~ylls~7.Pti~inP~
n-Butyllithillm (5.25 mL of a 1.6 M sollltion in hPY~nP, 8.40 mmol) was added dropwise to a stirred solution of N-carbobenzyloxy-3-(N-carbobenzyloxy-3-fluoroanilin-4-yl)s-7eti~ine (~y~mple 81, Step 4, 3.63 g, 8.36 mmol) at -78~ under nitrogen in dry THF (30 mL), then stirred for 2 hr. A sol~ltinn of R-glycidyl buly,a~e (1.21 g, 8.40 mmol) in dry THF (3.0 mL) was added and the cooling bath removed after 15 min. After 18 hr, the solvent was removed and the residue partitinnP~l between ethyl acetate (150 mL) and saturated ~mmnnillm chloride SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCTrUS96/12766 soltl+inn (50 mL). The organic layer was washed with water (50 mL) and brine (50mL), dried over m~gnP~illm sulfate, filtered and evaporated leaving an amber oil.
Chrom~+~raphy over silica gel (150 g, 40-60 llm) eluting with 2-5% mPth~nnl chlorol~ gave the title colllpvulld as a sticky foam. FAB-T~RM~: theory 401.1513 5 (M+l); meas 401.1521.
Step 6: (R)-(-)-N-C~rboban7,yloxy-3-r2-flllnro-4-r5-rr(3-nitrouhPrwlRlllfnnvl)n~ m~+~ -a!-nyn-3-nysl7~nli~ hpr~ A7ptiflin~
3-NitrobPn7enPslllfonyl chloride (1.70 g, 7.67 mmol) was added to an ice cooled snllltion of (R)-(-)-N-carbobenzyloxy-3-t2-fluoro-4-[5-hydlu..y-llethyl-2-oxo-3-ny~7oliflinyl]-pheny]~7etilline (Example 81, Step 5, 2.79 g, 6.97 mmol) and triethylamine (1.41 g, 14.0 mmol) in methylene rhlnri~ç (40 mL). After 16 hr, water (50 mT,) and methylene chloride (100 mL) were added. The organic layer waswashed with brine (50 mL), dried over ma~nPcium sulfate, filtered and evaporated.
The residue was chrom~tographed over silica gel (150 g, 40-60 ,um) eluting with 25-100% ethyl acetate-heY~na to give the title compound as a sticky foam. FAB-HR~qS: theory 586.1290 (M+1); meas 586.1295.
Step 7 (.~)-(-)-N-C~rboban7,ylnYy-3-r2-flllnro-4-r5-~7itlnmPthyl 2 ~Yn 3 ~Ysl7:nli~ hPr~ 7pt~i~ina A ~Lu~-, of sorlillm azide (1.44 g, 22.1 mmol) and (R)~-)-N-carbobenzyloxy-3-[2-fluoro-4-t5-[[(3-nitrophenylsulfonyl)oxy]-methyl]-2-oxo-3-~Ysl7nli~iinyl]phenyl]p~pt;~line (T~Ys~mrlP 81, Step 6, 2.60 g, 4.44 mmol) in DMF (30 mT ) was stirred for 16 hr, then filtered. The solvent was removed at 38~/0.75 mm and the residue extracted with ethyl acetate (100 mL) and washed with water (3 x50 mT ) and brine (50 rnT ). After drying over m~EnPRium sulfate, filtration andt vapuldl,ion gave a yellow oil. ChromAt~.dphy over silica gel (150 g, 40-60 ~um) eluting with 1-3% mpth~nol-methylene ~hlori-lP gave the title colllpou~d as a pale yellow foam. FAB-T~Rlvr~: theory 426.1577 (M+l); meas. 426.1580.
Step 8~ )-(-)-N-C~rboban7,ylnY~y-3-r2-fluoro-4-r5-~minnmPtl ~yl-2-nYn-3-tYs-7nlitlir~ hPrw11~7Pt.itlina To a stirred sollltinn of (s)-(-)-N-carbobenzyloxy-3-[2-fluoro-4-t5-~7i~lompthyl-2-oxo-3-nY~701i-linyl]phenyl]~7et;-1inP (T1'Y~mphP 81, Step 7, 1.63 g, 3.84 mmol) in dry THF (20 mL) was added triphenylphosphine (1.11 g, 4.23 mmol). After 3 hr, water (0.69 mL, 38.4 mmol) was added and the reaction stirred for 2 days at which timethe solvents were evaporated. The residue was chrom~tographed over silica gel (150 g, 40-60 ,um) eluting with 5-10% meth~nnl-chlorofo~"l. The title colllpou~dwas i~nl~te~l as a viscous colorleRR oil. FAB-HRMS: theory 400.1672 (M+1); meas.

SUBSTITUTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 400.1676.
Step 9: (S)-N-rr3-r3-Fluoro4-rl-(~rbob~n7,yloxv)-3-~7.~titlir~ ;?h~ 2 nYn-5 n~s~7nli~ yllmf~hvlls~ t~mitl~
Pyridine (1.0 mL), acetic anhydride (1.0 mL) and a few crystals of 4-dimethylaminopyridine were added to a stirred 801lltion of (S)-(-)-N-cd~l,obenzyloxy-~ 3-[2-fluoro~-[5-~minom~t~yl-2-oxo-3-oY~7nli.1inyl]phenyl]~7et;~line (Example 81, Step 8, 1.42 g, 3.66 mmol) in methylene ~~hlorirl-q (30 mL), then stirred for 1 hr. The solvents were removed at 38~/0.75 mIn and the residue chrom~rJ~- aplled over silica gel (50 g, 40-60 ~lm) eluting with 1-2% m~t~l~nol chlol~ofo~ . The title cvlll,uuu~d was i~nlslt~ as a white foam. FAB-HRMS: theory 442.1778 (M+l); meas.
442.1777.

E~A~aPL E 82 (s)-N-rr3-r3-Fluoro-4-r3-~7eti~irurll~herLyll 2 nYn 5 ~Ysl7~nli~ yllmf~t~ tslmill~
A solntion of (s)-N-[[3-[3-fluoro-4-[l-(carbobenzyloxy)-3-~7~;~inyl]phenyl]-2 oxo-5-~Y~7nli~inyl]m ethyl]~ret~ mi~e (~Y~ m rle 81, Step 9, 1.44 g,3.26 mmol) in ethyl acetate (25 mL) and ~h~olllte eth~n-l(50 mL) was added to 10% Pd/C (1.0 g) and hydl~ ated at 30 psi for 7 hr. Filtration and ~v~old~ion gave the title ~,v~n~oulld as a white glassy solid. FAB-HR~qS: theory 308.1410 (M+1); meas.

308.1408.

E~Xl~aPLE 83 (.q)-N rr3-r3-Flllnro-4-r~ y~ t ~ 1)-3-~ti~iruyl~ h~rurll 2 nYn 5 nYsls~nlirlir~yllm~th,yl~ tslmitif~
Triethylamine (150 llL, 1.08 mmol) and methyl chlulvro~mate (65 llL, 0.84 mmol) were added to a chlororo~-ll (5 mT.) suspension of (S)-N-[[3-t3-fluoro-4-[3-~7e+i-linyl]phenyl]-2-oxo-5-ny~7nli~linyl]methyl]~et~mi~l~ (~.Y~mpie 82, 153 mg, 0.50 mmol) and stirred overnight ~ it;nn~l chlo.uÇc~ (25 mL) was added and the snhl~;on washed with water (15 mL) and brine (15 mL). Drying over m~ n~Qinm sulfate, filtration, and evaporation gave a foam. Chrom~t~graphy over silica gel (50 g, 40-60 llm) eluting with 1-3% m~th~nol-chloloru.~ll gave the title cv. ~ou~ld as a white solid. FAB-HR~IS: theory 366.1465 (M+1); meas. 366.1468.

EXAMPLE 84 (S)-N-rr3-r3-Fluoro-4-rl-(formyl)-3-~7etirlinvllI~h~r~yll 2 n~n 5 rYs~nli~ yllm~th~ ts~mill~
N-Formylbenzotriazole (115 mg, 0.78 mmol) was added to a stirred sllRp~n~ion of (S)-N-[[3-[3-fluoro4-[3-~eti~inyl]phenyl]-2-oxo-5-SU~ ITE SHEEr(RUI E26) W O 97/09328 PCT~US96/12766 oT~7oli~inyl]methyl]~-~e~ e (F'.YslmrlP 82, 153 mg, 0.50 mmol) in THF (5 mr ) and stirred overnight. The solvent was removed and the residue chrom~t~raphed over silica gel (50 g, 40-60 ~m) eluting with 2-5% mPth~nol-chlolof~ to give the title cvlllpoul~d as a white foam. FAB-HRMS: theory 336.1356 (M+l); meas.
5 336.1367.

~XAl\/rPLE 85 (s)-(-)-N-rr3-r4-rl-(4-o-x~ thi~7n~ yl)-4-~iDeri~ yll-3 fluoro~hf~ -6-~ Ysl7~ yllmpt~h~v~ p-t~mi(l~
A ~ L~L~c of (S)-(-)-N-[[2-oxo-3-[4-(4-piperir~inyl)-3-fluorophenyl]-5-10 ~y~7olirlinyl]methyl]sl~et~mille (EXAMPLE 20, 310 mg), methyl thiocy~n~to~cet~te(121 mg, Bull. Chem. Soc. Jpn. 1972, 46(6), 1507) and glacial acetic acid (55 mg) in s3h30]ll~ ethslnc-l (5 mT.) is stirred at reflux under N2 for 4 hrs and then cooled to ent te,..p~.dLu~c, diluted with methylene chloride (45 mL), washed with water (2 x 15 mL) and saline (20 mT.), dried over anhydrous sorlillm sulfate and 15 con~ aLed under reduced ,u-c~;ju~a. The residue i8 chrom~t~graphed on silica gel (230 - 400 mesh, 45 g), eluting with m~h~nol/methylene chloride (4/96), and those fractions with an Rf = 0.47 by TLC (mP~h~n-ll/chlolv~u~ , 10/90) are pooled and ~n~v .~-~ted to give the title compound, mp 222 - 224~C (~Pcomp.).

20 F~AMPLE 86 (~)-(-)-N-rr3-r4-rl-(4-Ox -2 ~ invl)-3.6-~ih~y~lro-~T~-~yri~in 5-yll-3-fluorovhal~yll-~ 5 ~ Yz~7nlirlir~vllmP.~ylls~at~mi~P
Following the general procedure of EXAMPLE 85, and m~kinF non-critical variations but snh~ F (S)-(-)-N-[t2-oxo-3-[4-(3,6-dihydro-2H-pyridin-4-yl)-3-fluorophenyl]-5-~.xP.~oli~linyl]methyl]~~t ~ (EXAMPLE 38) for (S)-(-)-N-[[2-oxo-25 3-[4~4-piperidinyl)-3-fluorophenyl]-5-ox~oli~linyl]methyl]~cet~mi~la~ the title cc,.l~puu~d i8 obt~inP~, mp 209 - 211~C (~lPcr~mp.).

~XAlVrPLE 87 (0-(-)-N-rr3-r4-r1-r5-MPtllyl-l.3.4-thi~ -2-yll-4-~Deri~
3-fluoro~hQr~ m~t~ pt~mirlQ
Step 1: ~_Rrr~m~-5-mPtll,yl-1.3.A ~hi~ 7.nla To a sollltion of aqueous hydlub~v~ic acid (48%, 40 mL) Cont~ininF a trace amount of copper powder at -10~C is added a ll~ixLuLe of 2-amino-5-methyl-1,3,4-t~ olp (2.88 g) and sodium nitrite (7.76 g) portionwise over 45 mins with vigorous stirring The resulting ~ u~e is stirred at -10~C for 1.5 hrs and at 35 ~mhient tempe~dl,u e for an s~ ition~l 1.5 hrs and is then cooled in an ice bath, neutralized with aqueous sodium hydlu~ide (50%), diluted with saturated aqueous SUBSTITUTE SHEET (RULE 26) sodium hydlu~ clllfite till the ~ u~a no longer turns pot~ccinm iodide-starch test paper blue and filtered to remove in.colllhle. ms-t~ri~31 (rinsing with hot water). The filtrate is extracted with methylene rhlnrirle (4 x 100 mL), and the comhin.o~
organic phase is dried over anhydrous sodium sulfate and conrPnt-ated under 5 reduced ,ulas::~ule to give the crude product which is then chrom~u~;~a~uhed on silica gel (70 - 230 mesh, 75 g), eluting with ethyl ~r!et~te~hexane (50/50). Pooling and conc~..t ,-Lion of those fractions with an Rf = 0.78 by TLC (mPt~ ~nol/chloLurul,,,.
10/90) gives the title co..l~uu~ld, mp 107 - 108~C.
Step 2: (~)-(-)-N-rr3-r4-rl-(~;-~Pt~yl-1.3.4-thi~ 7nl-2-yl)-3.6-rlihydro ~T-T
pyri(~in4-yll-3-flllnrophar~yll-2-oxo-5-nY~7.nli-1inyllmPt.h,~yll~r~ la A ~ ule of (S)~-)-N-[[2-oxo-3-[4-(4-piperidinyl)-3-fluorophenyU-5-nY~7~ inyl]methyl]~ret~mi~la (EXAMPLE 20, 550 mg), 2-bromo-5-methyl-1,3,4-~hi~ 7~le (EXAMPLE 87, Step 1, 323 mg) and pot~c~ m hydlu~ .hogph~t~ (571 mg) in dimethyl sl-lfn~ P (16 mT ) is stirred under N2 at 100~C for 2 hrs, cooled to ambient tempel~ure, diluted with water (20 mL) and ~l.ac~ed with methylene chloride (3 x 20 mL). The comhinP~ organic phase is washed with water (20 mL) and saline (10 mT.), dried over anhydrous sodium sulfate and conr~-.l-ated to give the crude product which is then chrom~t~. a~hed on silica gel (230 - 400 mesh, 45 g), eluting with a gradient of mpth~nol/methylene chloride (2/98 - 3l97). Pooling and conr~ aLion of those fractions with an Rf = 0.44 by TLC
(m~h~nnllchlulvrul~L., 10/90) gives the title cu-~lpuu--d, mp 193 - 195~C.

EXAMPLE 88 (~)-(-)-N-rr3-r4-rl-(5-l!/rpt~lyl-l.3.4-thi~ 7n1-~-yl)-3.6-~lih~ytlr ~-pyri(~in-5-yll-3-fluorouhPnvll-2-o~n-5-n~7.nli-1invllmP~thvll~3~Pts~mi~le Following the general procedure of EXAMPLE 87, Step 2, and m~king non-critical variations but snh,~ F (S)-(-)-N-[[2-oxo-3-[4-(3,6-dihydro-2H-pyridin-4-yl)-3-fluorophenyl]-5-nY~7nlitlinyl]methyl].~r~t~...i~1e (EXA~LE 38) for (S)-(-)-N-[[2-oxo-3-[4~4-piperidinyl)-3-fluorophenyl]-5-oy~7olirlinyl]methyl]~retsmirlp~ the title cu ,uuu-ld is obtained, mp 229 - 231~C (-lPcomp.).

SU_S 111 UTE SHEET (RULE 26) W O 97/09328 PCT~US96/12766 CXART A

(CH2)n ~_ R, ~ (CH2)m --~'N O
3 \~N~ ~Rs H

(CH2)n~ R R~
--(CH2)m~ ~N ~R5 Rl = -C(=OXCH2)h-~Rl-3 2 Rl = -C(=OXCH2)hOH 2' Rl = -C(sO)Rl l, or-C(=O)i-Het 3 Rl = -C(=O)OR1-2 Rl = Cl 6 alkyl optionally having one or more sl~h~;t~lento Rl = ~02(CH2)h-aryl ff W O 97/09328 PCTrUS96/12766 CHART B

R~N02 ~ 8tO2~

~

H2N~NH2 H~NH2 HN~l~ PhCH202CN~
R3 NH2 R3 NH C02CH2Ph 1~ 12 W O 97/09328 PCT~US96/12766 CHART B (Contir~ued) PhCH202CNL~R2 1 4 R~ \~,OH

PhCH202C N~

N~O ~
R3 H ~-- '--R' 16 PhCH20zCN~2 ~1~/ 14 R ~N O
H\~NH2 PhCH202C~N~2 Fl ~N O

HN~2 R~

R~ N ~~C ~ 5 W O 97/09328 PCTrUS96/12766 CHART C

Ph2CH N ~=o R~
R3 / \

Ph2CHN~NH2 Ph2CHN~NHCO2CH2Ph I

PhCH2O2CN~NHCO2CH2Ph I

R, PhCH202CN~>~NHCO2CH2Ph H N~ o N H C O R s CHART D

+ 1~ ~--H 5 2~. 25 R~ O

\--'(~ N ~C--R

ph--N ~ lMS
O' ~ \~ N 'C--R5 H~N O p R3 NH ~ Rs CHART E

2 ' CH302C

~
C 11 302C,~ H N~No2 ~ NH2 R~ NH2 HN
~ O
~--NJ~O
R3 \--~_NHCOR5 CHART F

r\ ~

X~NH2 R~ l X~ NHC02CH2Ph R,, R4 X~ ~NHCO2cH2Ph ' ;~ NHC02CH2Ph XL~--N O + X~ N O

CHART G

PhCH202C~ Br + X30 H

x~NRo X

H

X

~ N Q O
\~ NHC02CH2Ph X
~ N ~
\_~ NHC02CH2Ph W O 97/09328 PCT~US96/12766 CHART H

' s, ~ ,si' ,~1~ + ~-OSO2CF3 ~NH2 1~

~ INCO2CH2Ph ~ \~--NHcoRs O~N O

_9~_ CHART I

R~
BOCN ~ OS02CF3 + M~3S ~ ~ NHCOR5 53 ~ ~R3 ~

0 BOCN ~ N O BOCN ~ N O

~ NHCOR5 ~ NHCOR5 56 5~S

HN ~ N O HN ~ N O
R3 ~ NHCOR5 R3 ~ NHCOR5 W O 97/09328 PCT~US96/12766 CHART J

[~
CO2CH2Ph R~
S9 l 19 ~--NH2 PhCH202C R3 R~
~ NCO2CH2Ph PhCH2~2C R3 ISl R~ R4 C~3 NHC02CH2Ph ~ ~NHC02CH2Ph PhCH202C' R3 PhCH202C~ R3 ~2 1 ~ ~

C~ \~_NHCOR5 ~ \~,NHCOR5 U

Claims (15)

We claim:
1. A compound of the formula I:

or pharmaceutical acceptable salts thereof wherein:
X is a) NR1, b) S(O)g, or c) O;
R1 is a) H, b) C1-6 alkyl, optionally substituted with one or more OH, CN, or halo, c) -(CH2)h-aryl, d) -COR1-1, e) -COOR1-2, f) -CO-(CH2)h-COR1-1, g) -SO2-C1-6 alkyl, h) -SO2-(CH2)h-aryl, or i) -(CO)i-Het;
R1-1 is a) H, b) C1-6 alkyl, optionally substituted with one or more OH, CN, or halo, c) -(CH2)h-aryl, or d) -(CH2)h-OR1-3;
R1-2 is a) C1-6 alkyl, optionally substituted with one or more OH, CN, or halo, b) -(CH2)h-aryl, or c) -(CH2)h-OR1-3;
R1-3 is a) H, b) C1-6 alkyl, c) -(CH2)h-aryl, or d) -CO(C1-6 alkyl);
R2 is a) H, b) C1-6 alkyl, c) -(CH2)h-aryl, or d) halo;
R3 and R4 are the same or different and are a) H, or b) halo;
R5 is a) H, b) C1-12 alkyl, optionally substituted with one or more halo, c) C3-12 cycloalkyl, d) C1-6 alkoxy;
g is 0, 1, or 2;
h is 1, 2, 3, or 4;
i is 0 or 1;
m is 0, 1, 2, 3, 4, or 5;
n is 0, 1, 2, 3, 4, or 5;
and with the provisio that m and n taken together are 1, 2, 3, 4, or 5.
2. A compound of Claim 1 wherein R1 is selected from the group consisting of H, fluoroethyl, cyanomethyl, methyl sulfonyl, formyl, hydroxyacetyl, acetyl, methoxyacetyl, benzyloxyacetyl, acetoxyacetyl, dichloroacetyl, methoxy carbonyl, tert-butoxy carbonyl, benzyloxy carbonyl, 3-hydroxypropionyl, 3-methoxypropionyl, 4-oxopentanoyl, 2-indole carbonyl, 5-isoxazole carbonyl, 5-nitro-2-thiazoyl, 4-oxo-2-thiazolinyl, and 5-methyl-1,3,4-thiadiazol-2-yl.
3. A compound of Claim 1 wherein R2 is H, F, or CH3.
4. A compound of Claim 1 wherein R3 and R4 are the same and different and are H or F.
5. A compound of Claim 1 wherein R5 is methyl or methyl substituted with one or more F or Cl.
6. A compound of Claim 1 wherein m is 1 and n is 0.
7. A compound of Claim 1 wherein m and n taken together are 2.
8. A compound of Claim 1 wherein m and n taken together are 3.
9. A compound of Claim 1 wherein m and n taken together are 4.
10. A compound of Claim 1 which is an optically pure enantiomer having the S-configuration at C5 of the oxazolidinone ring.
11. A compound of Claim 1 which is (S)-N-[[3-[3-Fluoro-4-[1-(carbobenzyloxy)-(3-methyl)-3-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[3-methyl-3-azetidinyl]-phenyl]-2-oxo-5 oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(carboxymethyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro4-[1-(methoxyacetyl)-3(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(formyl)-3(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro4-[1-(dichloroacetyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(3-methoxypropionyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(3-hydroxypropionyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(4-oxopentanoyl)-3-(3-methyl)azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro4-[1-acetyl-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(2-fluoroethyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(cyanomethyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;

(S)-N-[[3-[3-Fluoro-4-[1-(5-nitro-2-thiazolyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(methanesulfonyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro4-[1-(benzyloxyacetyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-hydroxyacetyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(carbobenzyloxy)-3-azetidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[3-[3-Fluoro-4-[3-azetidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(carboxymethyl)-3-azetidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(formyl)-3-azetidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(5S)-N-[[3-[3-Fluoro-4-[1-(hydroxacetyl)-3-pyrrolidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(5S)-N-[[3-[3-Fluoro4-[1-(formyl)-3-pyrrolidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(5S)-3-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2 fluorophenyl]-1-pyrrolidinecarboxylic acid methyl ester;
(S)-N-[[3-[3-Fluoro-4-(3,4-dihydro-2H-pyran-6-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[3-Fluoro-4(dihydrothien-3-yl)-phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(5S)-N-[[3-[3-Fluoro-4-(2,5-dihydro-1-oxido-3-thienyl)-phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[3-[3-Fluoro-4-(4,5dihydro-1-oxido-3-thienyl)-phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(5S)-N-[[3-[3-Fluoro4(2,5-dihydro-1,1-diosido-3-thienyl)-phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[3-[3-Fluoro-4-(4,5-dihydro-1,1-dioxido-3-thienyl)-phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-4-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oxazolidinyl]phenyl]-3,6-dihydro-1(2H)-pyridinecarboxylic acid phenylmethyl ester;

(S)-(-)-N-[[2-Oxo-3-[4-(4-piperidinyl)phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-[(Benzyloxy)acetyl]-4-piperidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)-4-piperidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-[(Benzyloxy)acetyl]-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolindinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-[(Benzyloxy)acetyl]-4-piperidinyl]-3,5-difluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)-4-piperidinyl]-3,5 difluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-Indole-2-carbonyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Isoxazole-5-carbonyl)-4-piperidinyl]-3-fluorophenyu-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Methylsulfonyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-4-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2-fluorophenyl]-1-piperidinecarboxylic acid methyl ester;
(S)-(-)-N-[[3-[4-[1-(Cyanomethyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(2-Fluoroethyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Formyl)4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-4-[4-[5-[[(2,2-Dichloroacetyl)amino]methyl]-2-oxo-3-oxazolidinyl]-2-fluorophenyl]-1-piperidinecarboxylic acid 1,1 dimethylethyl ester;
(S)-(-)-2,2-Dichloro-N-[[2-oxo-3-[3-fluoro-4-(4-piperidinyl)phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-2,2-Dichloro-N-[[2-oxo-3-[3-fluoro 4-[1-[(acetoxy)acetyl]-4-piperidinyl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-2,2-Dichloro-N-[[2-oxo-3-[3-fluoro-4-[1-(hydroxyacetyl)-4-piperidinyl]phenyl]-5-oxazolidinyl]methy]acetamide;
(S)-(-)-N-[[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-4-piperidinyl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-pyran-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[Tetrahydro-2H-pyran-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-thiopyran-4-yl)3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S,S-dioxide;
(S)-(-)-N-[[3-[3-Fluoro-4-(tetrahydro-2H-thiopyran-4-yl)phenyl]-2 oxo-5-oxazolidinyl]methyl]acetamide S,S-dioxide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-pyran-4-yl)phenyl]-2-oxo-5-oxazolidinyllmethyl]acetamide;
(S)-(-)-N-[[3-[4-[Tetrahydro-2H-pyran-4-yl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4(3,6-Dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4(3,6-Dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S,S-dioxide;
(S)-(-)-N-[[3-[4(3,6-Dihydro-2H-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S-oxide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S-oxide;
(S)-(-)-N-[[3-[4(Tetrahydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S,S-dioxide;
(S)-(-)-N-[[3-[4-[1(4-Oxo-2-thiazolinyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1(4-Oxo-2-thiazolinyl)3,6-dihydro-2H-pyridin-5-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)-3,6-dihydro-2H-pyridin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[2-Oxo-3-[4-(3,6-dihydro-2H-pyridin-4-yl)-3-fluorophenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-3,6-dihydro-2H-pyridin-4-yl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-Hydroxyacetyl)-3,6-dihydro-2H-pyridin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Formyl)-3,6-dihydro-2H-pyridin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)4-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2-fluorophenyl]-3,6-dihydro-1(2H)-pyridinecarboxylic acid methyl ester;
(S)-(-)-N-[[2-Oxo-3-[4-(3,6-dihydro-2H-pyridin-4-yl)phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[2-Oxo-3-[4-[1-[(acetoxy)acetyl]-3,6-dihydro-2H-pyridin-4-yl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-Hydroxyacetyl)-3,6-dihydro-2H-pyridin-4-yl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Formyl)-3,6-dihydro-2H-pyridin-4-yl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-4-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oxazolidinyl]phenyl]-3,6-dihydro-1(2H)-pyridinecarboxylic acid methyl ester;
(S)-N-[[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-5,6 dihydro-2H-pyridin-3-yl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[3-[4-[1-(Hydroxacetyl)-5,6-dihydro-2H-pyridin-3-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-2,3,4,7-tetrahydro-1H-azepin-5-yl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)-2,3,4,7-tetrahydro-1H-azepin-5-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-2,3,6,7-tetrahydro-1H-azepin-4-yl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)-2,3,6,7-tetrahydro-1H-azepin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(5S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)hexahydro-1H-azepin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-3,4-dihydro-2H-pyridin-5-yl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)-3,4-dihydro-2H-pyridin-5-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; or (S)-(-)-N-[[3-[4-[1-Formyl-4-fluoro-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide.
12. A compound of Claim 11 which is:
(S)-N-[[3-[3-Fluoro-4-[1-carboxymethyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(S)-N-[[3-[3-Fluoro-4-[1-(formyl)-3-(3-methyl)-azetidinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;
(5S)-N-[[3-[3-Fluoro-4-[1-(hydroxyacetyl)-3-pyrrolidinyl]phenyl]-2-oxo-5 oxazolidinyl]methyl]]acetamide;
(5S)-N-[[3-[3-Fluoro-4-[1-(formyl)-3-pyrrolidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(5S)3-[4-[5-[(Acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2-fluorophenyl]-1-pyrrolidinecarboxylic acid methyl ester;
(S)-(-)-N-[[3-[4-[1-(Hydroxyacetyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-N-[[3-[4-[1-(Formyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-pyran-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-2,2-Dichloro-N-[[2-oxo-3-[3-fluoro-4-[1-(hydroxyacetyl)-4-piperidinyl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[2-Oxo-3-[3-fluoro-4-[1-[(acetoxy)acetyl]-3,6-dihydro-2H-pyridin-4-yl]phenyl]-5-oxazolidinyl]methyl]acetamide;
(S)(-)-N-[[3-[4-[1-[Hydroxyacetyl)-3,6-dihydro-2H-pyridin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-3,6-Dihydro-2H-pyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)N-[[3-[4[3,6-dihydro-2H-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S,S-dioxide;
(S)-(-)-N-[[3-[3-fluoro-4-(tetrahydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S,S-dioxide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S,S-dioxide;
(S)-(-)-N-[[3-[4-[Tetrahydro-2H-pyran-4-yl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[3,6-Dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide S-oxide;
(S)-(-)-N-[[3-[4-(3,6-Dihydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolinyl]methyl]acetamide S-oxide;
(5S)-N-[[3-[3-Fluoro-4-(2,5-dihydro-1-oxido-3-thienyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-N-[[3-[3-Fluoro-4(2,5-dihydro-1,1-dioxido-3-thienyl)-phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1(Hydroxyacetyl)-2,3,6,7-tetrahydro-1H-azepin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-(4-Oxo-2-thiazolinyl)-3,6-dihydro-2H-pyridin-5-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(S)-(-)-N-[[3-[4-[1-5-Methyl-1,3,4-thiadiazol-2-yl)-3,6-dihydro-2H-pyridin-5-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; or (S)-N-[[3-[3-Fluoro-4-[1-formyl)-3-azetidinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide.
13. A methode for treating microbial infections in patients comprising:
administering to a patient in need thereof an effective amount of a compound of Formula I as shown in Claim 1.
14. The method of Claim 13 wherein said compound of Formula I is administered orally, parenterally or topically in a pharmaceutical composition.
15. The method of Claim 13 wherein said compound is administered in an amount of from about 0.1 to about 100 mg/kg of body weight/day.
CA002228647A 1995-09-01 1996-08-13 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings Abandoned CA2228647A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US314995P 1995-09-01 1995-09-01
US60/003,149 1995-09-01

Publications (1)

Publication Number Publication Date
CA2228647A1 true CA2228647A1 (en) 1997-03-13

Family

ID=21704418

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002228647A Abandoned CA2228647A1 (en) 1995-09-01 1996-08-13 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings

Country Status (27)

Country Link
US (7) US5968962A (en)
EP (1) EP0856002B1 (en)
JP (1) JPH11512386A (en)
KR (1) KR100463772B1 (en)
CN (1) CN1072222C (en)
AT (1) ATE207487T1 (en)
AU (1) AU716493B2 (en)
BR (1) BR9610474A (en)
CA (1) CA2228647A1 (en)
CZ (1) CZ49398A3 (en)
DE (1) DE69616366T2 (en)
DK (1) DK0856002T3 (en)
ES (1) ES2165516T3 (en)
FI (1) FI980452A (en)
HK (1) HK1014946A1 (en)
HU (1) HUP9901979A3 (en)
MX (1) MX9801578A (en)
NO (1) NO311520B1 (en)
NZ (1) NZ315469A (en)
PL (1) PL186524B1 (en)
PT (1) PT856002E (en)
RU (1) RU2175324C2 (en)
SK (1) SK283487B6 (en)
TW (1) TW419468B (en)
UA (1) UA52620C2 (en)
WO (1) WO1997009328A1 (en)
ZA (1) ZA966935B (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9901979A3 (en) * 1995-09-01 2000-03-28 Upjohn Co Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings and pharmaceutical compositions containing the same
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
EP0994874A1 (en) * 1997-07-11 2000-04-26 PHARMACIA &amp; UPJOHN COMPANY Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US6083967A (en) * 1997-12-05 2000-07-04 Pharmacia & Upjohn Company S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
AU764184B2 (en) 1998-01-23 2003-08-14 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
ID30299A (en) * 1998-06-05 2001-11-22 Astrazeneca Ab OKSAZOLIDINON DERIVES, THE PROCESS OF MAKING IT AND THE PHARMACY COMPOSITION THAT CONTAINS IT
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
CN1142158C (en) 1999-02-01 2004-03-17 法玛西雅厄普约翰美国公司 Process to prepare cyclic-sulfur fluorine containing oxazolidinones
SI1149089T1 (en) * 1999-02-01 2003-10-31 Pharmacia & Upjohn Company PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
MY120189A (en) * 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
AU782078B2 (en) * 1999-12-21 2005-06-30 Pharmacia & Upjohn Company Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
PE20020044A1 (en) 2000-06-16 2002-01-30 Upjohn Co THIAZINE OXAZOLIDINONE
ES2245698T3 (en) 2000-06-30 2006-01-16 PHARMACIA &amp; UPJOHN COMPANY LLC COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS CONTAINING A COMPOUND OF OXAZOLIDINONE, SULBACTAM AND AMPICILLIN.
ES2268011T3 (en) * 2001-04-07 2007-03-16 Astrazeneca Ab OXAZOLIDINONES CONTAINING A SULFONIMIDE GROUP AS ANTIBIOTICS.
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
CA2439959A1 (en) 2001-04-20 2002-10-31 Pharmacia & Upjohn Company A method for the preparation of oxazolidinones
WO2002085849A2 (en) * 2001-04-20 2002-10-31 Pharmacia & Upjohn Company Process to prepare oxazolidinones
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
AU2002354579A1 (en) * 2001-07-12 2003-01-29 Pharmacia And Upjohn Company Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
DE60315413T2 (en) * 2002-01-24 2007-12-06 Pharmacia & Upjohn Co. Llc, Kalamazoo ANTIMICROBIAL DIHYDROTHIAZIN AND DIHYDROTHIOPYRANOXAZOLIDINONE
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AR038536A1 (en) * 2002-02-25 2005-01-19 Upjohn Co N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20030216330A1 (en) * 2002-03-29 2003-11-20 Pharmacia & Upjohn Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
WO2003097640A1 (en) * 2002-05-22 2003-11-27 Orchid Chemicals & Pharmaceuticals Ltd. Oxazolidinone derivatives as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
CA2491287A1 (en) * 2002-08-12 2004-02-19 Pharmacia & Upjohn Company N-aryl-2-oxazolidinones and their derivatives
EP1565186B1 (en) * 2002-11-21 2006-11-02 Pharmacia & Upjohn Company LLC N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
CA2515311A1 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
MXPA05007937A (en) * 2003-02-07 2005-09-30 Warner Lambert Co Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents.
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
EP1625124A1 (en) * 2003-05-06 2006-02-15 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
WO2004113329A1 (en) * 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
KR100854211B1 (en) * 2003-12-18 2008-08-26 동아제약주식회사 Novel oxazolidinone derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same for antibiotics
WO2005082892A2 (en) * 2004-02-17 2005-09-09 Dr. Reddy's Laboratories Ltd. Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
CA2576041A1 (en) * 2004-08-06 2006-02-16 Pharmacia & Upjohn Company Llc Oxazolidinones containing oxindoles as antibacterial agents
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
DE502006009169D1 (en) 2005-10-04 2011-05-05 Bayer Schering Pharma Ag NEUE POLYMORPHE FORM VON 5-CHLOR-N-(ä ( 5S )-2-0X0-3-Ä4-( 3-OXO-4-MORPHOLINYL)-PHENYLÜ-1,3-OXAZOLIDIN-5-YLü -METHYL)-2-THIOPHENCARBOXAMID
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
EP2181993A1 (en) 2006-03-31 2010-05-05 Research Foundation Itsuu Laboratory Antimicrobial oxazolidinone derivatives
US7875958B2 (en) * 2006-09-27 2011-01-25 Taiwan Semiconductor Manufacturing Company, Ltd. Quantum tunneling devices and circuits with lattice-mismatched semiconductor structures
WO2008143649A2 (en) * 2006-12-04 2008-11-27 Dr. Reddy's Laboratories Limited Novel oxazolidinone compounds as antiinfective agents
US20090279441A1 (en) * 2007-01-11 2009-11-12 Foundry Networks, Inc. Techniques for transmitting failure detection protocol packets
CL2008001003A1 (en) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION.
JPWO2009044777A1 (en) 2007-10-02 2011-02-10 財団法人乙卯研究所 Oxazolidinone derivatives having a 7-membered heterocycle
KR101023174B1 (en) * 2008-09-24 2011-03-18 주식회사 레고켐 바이오사이언스 Novel Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and Pharmaceutical Compositions thereof
RU2522582C2 (en) 2008-11-20 2014-07-20 Панацеа Биотек Лтд. New antimicrobial agents
US20130172554A1 (en) * 2010-09-07 2013-07-04 Symed Labs Limited Processes for the preparation of 4-morpholin-3-one
AR093396A1 (en) * 2012-11-09 2015-06-03 Syngenta Participations Ag DERIVATIVES OF DIHYDROTIOPHENE AS INSECTICIDE COMPOUNDS
EP3914587A4 (en) * 2019-01-18 2022-11-23 Merck Sharp & Dohme LLC Oxazolidinone compounds and methods of use thereof as antibacterial agents
AU2022291768A1 (en) 2021-06-16 2023-11-30 Celgene Corporation Azetidinyl compounds comprising a carboxylic acid group for the treatment of neurodegenerative diseases
CN115724823B (en) * 2021-08-27 2023-11-24 中国科学院大连化学物理研究所 Method for preparing dihydrothiophene derivative

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1250538A (en) * 1969-03-18 1971-10-20
FR2356422A1 (en) * 1976-03-01 1978-01-27 Delalande Sa NEW HYDROXYMETHYL-5 OXAZOLIDINONE-2, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THERAPEUTICS
FR2380780A2 (en) * 1977-02-22 1978-09-15 Delalande Sa Psychotropic medicaments - comprising 5-hydroxymethyl-3-phenyl-2-oxazolidone derivs.
FR2500450A1 (en) * 1981-02-25 1982-08-27 Delalande Sa NOVEL AMINOMETHYL-5-OXAZOLIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USE THEREOF
JPS59118721A (en) * 1982-12-25 1984-07-09 Nippon Zeon Co Ltd Process for addition reaction of unsaturated compound
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
FR2574796B1 (en) * 1984-12-18 1990-11-02 Kaseihin Cy Inc C S PROCESS FOR THE PREPARATION OF SILICON-CONTAINING ISOCYANATE COMPOUNDS
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) * 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
JP3176626B2 (en) * 1991-11-01 2001-06-18 ファルマシア・アンド・アップジョン・カンパニー Substituted aryl- and heteroarylphenyloxazolidinones useful as antimicrobial agents
SK283420B6 (en) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them
DE4425613A1 (en) * 1994-07-20 1996-01-25 Bayer Ag 5-membered heteroaryl oxazolidinones
DE4425609A1 (en) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl and Benzothienyloxazolidinone
HUP9901979A3 (en) * 1995-09-01 2000-03-28 Upjohn Co Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings and pharmaceutical compositions containing the same
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
NZ501412A (en) * 1997-05-30 2001-11-30 Upjohn Co Oxazolidinone antibacterial agents having a thiocarbonyl functionality
GB9717807D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
CN1142158C (en) * 1999-02-01 2004-03-17 法玛西雅厄普约翰美国公司 Process to prepare cyclic-sulfur fluorine containing oxazolidinones
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
CZ49398A3 (en) 1998-08-12
PT856002E (en) 2002-04-29
HUP9901979A3 (en) 2000-03-28
FI980452A0 (en) 1998-02-27
US6358942B1 (en) 2002-03-19
AU716493B2 (en) 2000-02-24
US6313307B1 (en) 2001-11-06
US6043266A (en) 2000-03-28
KR100463772B1 (en) 2005-11-09
US6166056A (en) 2000-12-26
FI980452A (en) 1998-02-27
WO1997009328A1 (en) 1997-03-13
UA52620C2 (en) 2003-01-15
DK0856002T3 (en) 2002-02-11
BR9610474A (en) 1999-03-02
AU6718196A (en) 1997-03-27
MX9801578A (en) 1998-08-30
EP0856002A1 (en) 1998-08-05
EP0856002B1 (en) 2001-10-24
PL325152A1 (en) 1998-07-06
NO311520B1 (en) 2001-12-03
US5968962A (en) 1999-10-19
HK1014946A1 (en) 1999-10-08
TW419468B (en) 2001-01-21
HUP9901979A2 (en) 2000-02-28
ATE207487T1 (en) 2001-11-15
JPH11512386A (en) 1999-10-26
NO980855D0 (en) 1998-02-27
RU2175324C2 (en) 2001-10-27
KR19990044238A (en) 1999-06-25
DE69616366D1 (en) 2001-11-29
CN1072222C (en) 2001-10-03
ES2165516T3 (en) 2002-03-16
PL186524B1 (en) 2004-01-30
SK19598A3 (en) 1998-11-04
US20050054683A1 (en) 2005-03-10
NO980855L (en) 1998-04-30
ZA966935B (en) 1998-02-16
DE69616366T2 (en) 2002-07-04
NZ315469A (en) 2000-01-28
SK283487B6 (en) 2003-08-05
US6051716A (en) 2000-04-18
CN1197457A (en) 1998-10-28

Similar Documents

Publication Publication Date Title
CA2228647A1 (en) Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
CZ20023527A3 (en) Oxazolidinone derivatives, process of their preparation and pharmaceutical preparations in which they are comprised
US6093736A (en) Isoxazoline derivatives useful as antimicrobials
KR20110090895A (en) Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
US11286252B2 (en) Alkene spirocyclic compounds as farnesoid X receptor modulators
JP7264905B2 (en) Polycyclic compounds as farnesoid X receptor modulators
US20050032861A1 (en) Oxazolidines containing a sulfonimid group as antibiotics
EP1446403A1 (en) Aryl substituted oxazolidinones with antibacterial activity
US7049443B2 (en) Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
SG188346A1 (en) 1,4-oxazepane derivatives
US6875784B2 (en) Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7101874B2 (en) Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
ZA200006694B (en) Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued